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SCOPE OF THIS THESIS 
In 1973, Barbeau developed a framework in which the function of 
the striatum in the central nervous system of man is no longer 
considered as purely motor, but more as integrating sensory, motor 
and mental processes in the brain. Barbeau based his framework up-
on the until then available knowledge about the clinical and neuro-
pathological findings in patients with Parkinson's disease, i.e. 
a disease in which a dysfunctioning striatum is involved. Ever 
since then, many studies have been focussed on the unravelling of 
the function of the striatum on all research levels both in man 
and animal (for review: Cools et al. 1977, Divac and öberg 1979, 
Evered and O'Connor 1984, Marsden and Fahn 1982, McKenzie et al. 
1984). 
In this thesis attention is particularly focussed on the function 
of the striatum in programming motor and non-motor behaviour in 
animals, and the (tentative) analogy between animal and man in 
this respect. 
By programming motor behaviour we understand the formal 
aspects of cerebral processes that give rise to changes in the 
spatio-temporal relationships between the whole organism or dis-
tinct parts of the body and its immediate environment. Thus, the 
execution of motor acts such as walking is the consequence of 
programming a particular motor behaviour. 
By programming non-motor behaviour we understand the formal 
aspects of control processes that give rise to changes in the 
individual relationship between the organism and its environment. 
Thus, social interactions are the consequence of programming non-
motor behaviour. 
The processes themselves are called 'higher-order' (Cools and 
Van den Bereken 1977) or 'cognitive' (Öberg and Divac 1979) in 
animal and man. 
Since the display of changes in the individual relationship 
between the organism and its environment often involves the 
execution of motor acts, it is useful to point out that pro-
gramming non-motor behaviour is often superimposed upon the 
programming of motor behaviour. 
In Section I literature is reviewed to provide cornerstones for 
the hypothesis that the striatum in animals and man is involved 
in programming motor and non-motor behaviour. For that purpose 
a survey of the anatomical aspects is given (Chapter 1). Against 
this background it becomes possible to integrate present-day 
data about the function of the striatum in animals (Chapter 2). 
In Section II experimental data collected in animal studies 
are presented in order to validate the hypothesis presented in 
Section I (for a brief outline of the involved chapters, see 
Section II: Chapter 3 Introduction). 
In Section III a survey is given of the present-day insight 
into the neuropathological and clinical aspects (Chapter 8) and 
the pharmacotherapeutic effects (Chapter 9) of Parkinson's dis-
ease in the light of the conclusion about the function of the 
striatum in programming motor and non-motor behaviour drawn 
from Section II (for a short outline of this conclusion, see 
Section II: epilogue). From the neurological diseases in which 
the striatum is involved Parkinson's disease is chosen because 
of the central role of the striatum in the involved patho-
physiology. 
2 
SECTION I 

CHAPTER 1 
STRIATUM: ANATOMY 
INTRODUCTION 
Anatomists consider the corpus striatum as the compilation of the 
caudate nucleus (CN), the putamen (PUT), the globus pallidus (GP) 
and the nucleus accumbens (NAcc), whereas the CN plus the PUT is 
called the striatum. To avoid further confusion and in accordance 
with the use of predominantly the latter description in the litera-
ture, the collective noun corpus striatum will not be used in this 
thesis. In higher mammals, such as carnivores and primates, the CN 
and PUT are almost completely separated by the internal capsule. 
In small mammals, such as rodents, however, the internal capsule 
hardly exists, which makes it impossible to divide the striatum 
into CN and PUT on gross anatomical grounds. Due to this, the fol-
lowing terminology will be used: 
striatum : in cases where the reference is to the whole striatum 
in all mammals; 
neostriatum: in cases where the information is specifically derived 
from the striatum studies of the rat and it is imposs-
ible to simply extrapolate this information to higher 
mamma1s ; 
CW and PUT : in cases where the information is specifically derived 
from these structures in monkey or human studies. 
In fig. 1.1 the human brain is drawn so that some of its internal 
structures are visible. The striatum, the largest subcortical struc-
ture, is closely related to the cortex not only because of common 
telencephalic origin, but also because of their proximity: the CN 
and PUT are surrounded by almost the entire cortex, whereas the 
CN and PUT in turn surround deeper layers of the brain. A mass of 
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fig. i.I ГЛе human brain: a view on its internal structures 
(from Nauta and Feirtag (1979), with permission) 
connections (to and fro) exists between the cortex and a number of 
subcortical nuclei on the one hand and the striatum on the other. 
Some of these connections and the internal organization of the 
striatum are dealt with here. 
b 
AFFERENT CONNECTIONS OF THE STRIATUM 
The afférents originate from several brain structures (see Dray 
1980, Graybiel 1979, Nieuwenhuys 1977) of which the cortex and two 
nuclei of the midbrain, the substantia nigra (SN) and the ventral 
tegmental area of Tsai (VTA), will be described in detail, since 
these afférents are thought to play a major role in the regulation 
of the function of the striatum (see Chapter 2). 
Cortex 
Although the striatum is the main subject of this thesis, a basic 
knowledge of the anatomical complexity of the cortex will underline 
the importance of the cortico-striatal connections. 
In man, most particularly, the cortex is often described as composed 
of a series of bilateral lobes (fig. 1.2). Each lobe consists of a 
number of lobules, separated from each other by sulci. The division 
of the cortex in lobes and lobules is purely topographic and has no 
precise meaning as regards to the architecture or functioning of 
cortical areas. The description according to Brodmann (cf. fig. 1.3) 
is based on cytoarchitectonic characteristics. A third manner of de-
Fig. 1.2 The human brain: description of the lobes 
{from Nieuwenhuys et al. (1978), with permission) 
1 = occipital pole 7 
2 = occipital lobe 8 
3 = parietal lobe 9 
4 = temporal lobe 10 
5 = fronto-panetal operculum 11 
6 = temporal operculum 
A: lateral view; B: medial view 
= frontal operculum 
- temporal pole 
= frontal lobe 
- frontal pole 
= limbic lobe 
big. 1.3 The human bram: description according to Brodmann 
(from Nieuwenhuys et al. (1978), with permission) 
A: lateral view; B. medial view 
scribing the cortex of mammals is phylogenetically: the 'older' 
allocortex (hippocampus and pyriform cortex) and the 'younger' 
neocortex (frontal cortex, cingolate cortex, parietal cortex, 
insular cortex and occipital cortex). A fourth description is 
based on the laminar organization, the efferent and afferent 
connections and consequently the function m behaviour: the 
'primary sensory-motor' cortex (area 1, 2, 3a, 3b, 4, 17, 18,19, 
22 according to Brodmann) versus the 'association' cortex (the 
remainder of the cortex; Pandya and Seltzer 1982, Swanson 1983). 
A remarkable difference between the 'sensory-motor' cortex and 
the 'association' cortex is, that the former has direct sensory in-
put and motor output whereas the latter derives its input from cor-
tical and subcortical structures and directs its output back to 
cortical and subcortical structures. 
Because the monkey has the best developed cortex next to man, this 
species was the prime subject in studying cortico-cortical connec-
tions. Most of these connections were revealed by studies using the 
autoradiographic method (Goldman-Rakic 1984, Künzle 1978, Jones et 
al. 1978, Pandya and Seltzer 1982, Van Hoesen 1982, Yeterian and 
Van Hoesen 1978). Radioactive amino acids are injected into 
a brain structure, where they are taken up by the neuronal 
cell bodies and transported through the neurons to the terminals, 
which could then be visualized. In fig. 1.4 a number of ipsilateral 
Fig. 1.4 Ά scheme of cortico-cortical connections in monkeys 
abbreviations: see table 1.1 
cortico-cortical connections, derived from these studies, is drawn 
schematically. Note that the scheme has no intention of being com-
plete, not only with respect to the cortico-cortical connections 
themselves, but also with respect to the topographically arrange-
ment and the connections within each structure. The scheme is meant 
to make clear the existence of a number of reciprocal pathways be-
tween cortical areas, thus providing evidence for the anatomical 
substrates of possible a neuronal integration of information pro-
cessing and visualizing neuronal connections which will be mention-
ed further on (see Chapter 2). Thus it should be kept in mind that 
no part of the cortex can be thought of as an isolated structure, 
although for the sake of clearness one often refers to a particular 
part in both anatomical and functional studies. 
Cortico-striatal pathways are also extensively studied in 
monkeys with the following methods: a) Lesion method in which the 
degeneration of neurons due to a restricted lesion in the cortex 
is determined, b) Retrograde labelling method in which the protein 
horseradish peroxidase (HRP) is injected ipsilaterally into the CN 
and PUT. HRP is taken up by nerve terminals and transported back 
to the cell bodies, which can then be visualized. 
Studies according to method a), viz. Kemp and Powell (1970), or 
b), viz. Jones et al. (1977), showed that all parts of the cortex 
project to the striatum in a topographical manner, and that no 
part of the CN or PUT is under the sole influence of one struc-
tural or functional area of the cortex. The use of the autoradio-
graphic method shows some differentiation in the cortico-striatal 
projections (Goldman and Nauta 1977, Jones et al. 1977, Künzle 
1975, Kunzle 1978, Percheron et al. 1984, Ungerleider et al. 1984, 
Van Hoesen et al. 1981, Weber and Yin 1984, Yeterian and Van Hoesen 
1978). A summary of the ipsilateral pathways of the studies is 
given in table 1.1. The primary 'sensory-motor' cortex can be seen 
to project predominantly to the PUT, and that within this projec-
tion a distinction can be made between the projections of the 'leg', 
'face' and 'arm' areas (Künzle 1975, Percheron et al. 1984). By con-
trast the 'association' areas project predominantly to the head of 
the CN (Goldman and Nauta 1977, Yeterian and Van Hoesen 1978). In 
addition projections of both 'sensory-motor' and'association' areas 
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are scattered throughout the CN and PUT, although the projections to 
the body of the CN are scanty. Contralateral projections exist from 
almost all areas, but they are much less dense. 
In rats too studies using retrograde and anterograde labelling 
methods show topographically organized cortico-cortical (for example 
Miller and Vogt 1984, Vogt and Miller 1983) and cortico-striatal 
pathways. The latter projections also show an extensive overlap 
between the projection fields of the different cortical areas 
(Akers and Killackey 1978, Beckstead 1979a,b, Cospito and Kultas-
Ilinsky 1981, Kelley et al. 1982, Veening et al. 1980). Some re-
striction is made in the dorsal-ventral plane: the neocortex pre-
ferentially projects to the dorsal neostriatum, while the allo-
cortex preferentially projects to the ventral and extreme medial 
neostriatum (Heimer et al. 1982: the ventral striatum, including 
the nucleus accumbens and the olfactory tubercle). Still Walaas 
(1981) has found some overlap of projections from neocortex and 
allocortex to the nucleus accumbens and the ventral neostriatum. 
The dorsal-ventral differentiation is also reflected in the SN 
and VTA projections to the neostriatum (see substantia nigra). 
Up to now there has been no clear evidence that within the neo-
striatum a differentiation exists between the 'association' 
prefrontal areas and the 'sensory-motor' cortex nor between the 
'leg', 'face' and 'arm' projection. However, with the anterograde 
labelling method 1) Beckstead (1979a) found prefrontal cortex pro-
jections in the ventral and the most medial part of the neostriatum; 
2) Cospita and Kultas-Ilinsky (1981) found motor cortex projections 
predominantly in the rostral and intermediate dorsolateral parts of 
the neostriatum; and 3) Kelley et al. (1982) found that the rostral 
sensorimotor cortex projects to the rostral dorsolateral, the inter-
mediate dorsal and the caudal medial-ventral part of the neostriatum. 
In contrast Veening et al. (1980) found labelled cells predominantly 
but not exclusively in the frontal cortex areas 8, 10 and areas 4, 6 
after HRP injections respectively in the rostral and caudal parts of 
the neostriatum, all other cortical areas contained labelled cells 
after most injections. This difference in projection field between 
the anterograde and retrograde labelling methods is often seen and 
it is ascribed to a greater sensitivity of the retrograde labelling 
11 
TABLE 1.1 
Topography of ipsilateral cortico-striatal projections in monkeys 
Lesion 
(c) 
Retrograde 
(b) (a) (d) (e) 
Anterograde 
(g) (h) (i) 
CAUDATE NUCLEUS 
Head , rostral 
Dorsal : lateral 
medial 
Middle : ventral 
medial 
Ventral: lateral 
medial 
PMC, PMA, 
PFA, SMA 
PMC, PFA 
PFA 
PFA 
Λ 
. PMC, 
Γ PMA, 
SMA, 
PFA, 
PSAA, 
PLAA 
J 
PFA 
PMC PFA PLAA, PSAA PLAA, PSAA PSAA 
PFA PLAA PSAA 
PFA 
PSAA 
PSAA 
PLAA, 
PSAA, 
PSAA 
PLAA 
PSAA, 
PLAA 
PSAA, 
PSAA, 
PSAA, 
PLAA 
PFA, 
PLAA 
PFA 
PFA, 
Head*, intermediate 
Dorsal : lateral 
medial 
Middle : lateral 
medial 
Ventral: lateral 
medial 
PMA, SMA 
PLAA 
PFA, PLAA 
PFA 
PFA 
> 
PFA 
PMC, 
PMA, 
SMA, 
PFA, 
PSAA, 
PLAA 
PFA 
PSAA, PLAA 
PSAA 
PSAA, PLAA 
PSAA 
PSAA 
PSAA, PLAA PSAA 
PSAA 
PSAA, PLAA 
PSAA, PLAA 
PFA, PLAA 
PSAA, PFA 
Head , caudal 
Dorsal : lateral 
medial 
Middle : lateral 
medial 
Ventral: lateral 
medial 
PMA, SMA 
PLAA 
PLAA 
> 
PMC, 
PMA, 
SMA, 
PFA, 
PSAA, 
PLAA 
Body ** 
Dorsal : lateral 
medial 
Middle : lateral 
medial 
Ventral: lateral 
medial 
SC, PSAA 
PSAA 
PSAA 
PFA 
SMA PLAA 
PSAA 
PMA 
PSAA, PLAA 
PSAA 
PSAA 
PLAA, PSAA PSAA 
PSAA 
PSAA, PFA 
PSAA, PLAA 
PSAA, PFA, 
PLAA 
PSAA, PFA, 
PLAA 
PFA 
SMA, 
PMA 
PFA 
PFA 
PSAA 
PSAA 
PSAA 
PSAA 
PSAA 
PSAA 
PSAA 
continued on next page 
Tail ***, dorsal limb 
Dorsal : lateral 
medial 
Middle : lateral 
medial 
Ventral: lateral 
medial 
SC 
SC 
sc 
Tail***, ventral limb 
Dorsal : lateral 
medial 
SC, PSAA 
Middle : lateral 
medial 
Ventral: lateral 
medial 
SC, PSAA 
SC, PSAA 
PFA 
PMA 
PFA 
SMA, 
PMA 
FMA 
PLAA 
PLAA, 
PLAA, 
PSAA 
PSAA 
PSAA, PLAA 
PSAA, PLAA 
PSAA 
PSAA 
SC, PSAA, 
PLAA 
SC, PSAA, 
PLAA 
PSAA 
SMA, 
PMA 
SNA 
PSAA 
PLAA 
SC, PSAA, 
PLAA 
SC, PSAA, 
PLAA 
PFA 
PFA 
PSAA 
PSAA 
PSAA 
PLAA, PSAA 
PSAA, 
PSAA, 
PSAA, 
PSAA, 
PLAA 
PLAA 
PLAA 
PLAA 
PSAA 
PSAA 
PSAA 
PSAA 
Legends table 1.1 
a = Goldman and Nauta (1977) 
b = Jones et ai. (1977) 
с = Kemp and Powell (1970) 
d = Kdnzle (197S) 
e = Kùnzle (1978) 
f = Percheron et al. (1984) 
g = Van Hoesen et al. (1981) 
h = Setenan and Van Hoesen (1978) 
ι = Weber and Yin (1984) 
* = A 25.0 - A 17.2 
**= A 16.4 - A 13.4 (according to Szabo and 
***= A 12.1 -A 5.6 
SC = sensory cortex (1, 2, 3a, 3b, 17, 18, 19) 
PMC = primary motor cortex (4) 
SUA = supplementary motor area (6M) 
PMA = premotor area (6D, 6V) 
PFA = prefrontal area (9, 10, 11, 12, 46) 
PLAA = paralimbic association area (cingulate 
gyrus, posterior corbital frontal cortex, 
temporal pole, parahippocampal gyrus) 
PSAA = parasensory association area (5, 7, 20, 21, 
22, 57) 
1984) 
TABLE I .I cont inuat ion 
Lesion 
(с) 
Retrograde 
(b) (b) 
Hand Leg 
(d) 
Face 
Anterograde 
(e) (f) 
Arm Leg 
(g) (i) 
PUTAMEN 
Rostral * 
Dorsal : lateral 
medial 
Middle : lateral 
medial 
Ventral: lateral 
medial 
PMC, SMA, 
PMA, PFA 
PFA, PSAA 
PFA 
У 
PMC, 
PMA, 
SMA, 
PFA, 
PSAA, 
PLAA 
SC, 
PMC 
PMC 
PMC 
PMC 
PMC 
SMA, 
PMA 
SMA, 
PMA 
PMA 
PMA 
PMA 
PMA 
PMC 
PMC 
PLAA 
PLAA 
PLAA, 
PLAA, 
PSAA 
PSAA 
PSAA 
PSAA 
Intermediate ** 
Dorsal 
Middle 
: lateral 
medial 
: lateral 
medial 
SMA, PMA, 
PMC, SC 
PSAA, PLAA 
PMC 
•4 
• 
PMC, 
PMA, 
SMA, 
PFA, 
PSAA, 
PLAA 
SC, 
PMC 
SC 
PMC 
PMC 
PMC 
PMC SMA, 
PMA 
PMC 
PMC 
PSAA 
PSAA 
PSAA 
PSAA 
Ventral: lateral 
medial 
Ventral*** 
Dorsal : lateral 
medial 
Middle : lateral 
medial 
Ventral: lateral 
medial 
SC, PMC, 
PSAA 
PMA 
SC 
SC, PSAA 
J 
\ 
PMC, 
PMA, 
SMA, 
PFA, 
PSAA, 
PLAA 
PMC PMA PLAA, PSAA 
PMC PMA 
PMC PMC 
SC, 
PMC 
sc 
PMC 
PMC 
PMC 
PMC 
SMA 
SMA 
PMA 
PSAA 
PSAA 
PSAA 
PSAA 
PMA PLAA, PSAA 
method (e.g. Jones et al. 1977, Fallon and Moore 1978; see also sub-
stantia nigra). Contralateral cortico-striatal projections were found 
in all cases. 
All cortico-striatal fibres use glutamate (GLU) as transmitter (Fon-
num 1984, Fonnum et al. 1981, McGeer et al. 1984; see intrinsic 
organization). 
The terminal areas of the cortico-striatal projections are 
neither uniform nor random, but instead form a mosaic like pattern 
in which the terminals are concentrated in irregular shaped patches. 
These patches are arranged in clusters in the CN and in stripes in 
the PUT. It is thought that within this mosaic pattern striatal af-
férents from the cortex and other sources 'alternate' and that in 
this way information from different brain structures becomes 
intermingled (Goldman-Rakic 1984, Goldman and Nauta 1977, Künzle 
1975, Künzle 1978, Van Hoesen et al. 198 1, Yeterian and Van Hoesen 
1978; see intrinsic organization). 
Substantia nigra and ventral tegmental area of Tsai (see fig. 1.5) 
The SN is a midbrain structure, situated dorsal to the cerebral 
peduncle and ventral from the medial lemniscus. Classically, the SN 
is divided in two parts: the pars compacta (SNpc), a cell rich part, 
and the pars reticulata (SNpr), a part with a well-organized neuro-
pil but relatively few cells (for review Dray 1979). Presently, the 
SN is further subdivided after the cytological characteristics of 
the neurons (Poirier et al. 1983); however, the separation of the 
SNpc from the remainder of the SN is still clear in rat, monkey and 
human. 
The VTA is also a midbrain structure, situated medially to the cere-
bral peduncle and medial lemniscus, and ventrally to the red nucleus. 
The lateral part of the VTA forms a continuum with the medial part 
of the SNpc. 
Like the cortex, the midbrain structures are divided according 
to structural and functional considerations into a 'sensory-motor' 
part and 'limbic' part. In a recent review Swanson (1983) shows 
that the limbic system consists of the hippocampal formation, the 
adjacent part of the associative cortices, i.e. part of the cingu-
18 
/MRN 
Fig. 1.5 A summary of afferent and efferent connections of the 
striatum. 
Top: 'nonlimbic'; bottom: 'limbic' (sec text) 
abbreviations: see list of abbreviations 
(from Nieuwenhuys (1984), with permission) 
late gyrus, the prefrontal area and the perirhinal area, and the 
subcortical septo-amygdalar complex. The projections from the 
19 
sensory-motor cortex and related association areas on the one hand 
and the limbic system on the other hand divide midbrain structures 
into 'sensory-motor' and 'limbic' related structures. The SN and 
VTA are thought to belong to the former and the latter respectively 
(e.g. Mogenson et al. 1980). 
Although both the SN and VTA receive input from and project to 
quite a number of cortical and subcortical structures, only the 
projections to the striatum and the adjacent nucleus accumbens 
(NAcc) and olfactory tubercle (ОТ) will be considered here. In 
addition, some remarks will be made on the cortical projections. 
The NAcc lies anterior in the brain, ventromedially to the rostral 
part of the striatum. No clear boundaries are seen between these 
structures. The ОТ is clearly delineated in the rat as a structure 
lying anterior in the brain, ventrally to the neostriatum and NAcc. 
Especially at the rostral level a continuity is seen between the 
ОТ, NAcc and ventral part of the neostriatum. This, together with 
the common pattern of extrinsic connections, led to the introduc­
tion of the 'ventral' striatum as opposed to the 'dorsal' striatum 
(Heimer et al. 1982). 
The projections from the SN and VTA to the striatum, NAcc and 
ОТ were found to share a common feature: they use dopamine (DA) as 
transmitter (Anden et al. 1964, Lindvall and Bjorklund 1974, Unger-
stedt 197 1). The SNpc cells from which dopaminergic neurons origi­
nate are called A9 cells; the VTA cells from which dopaminergic 
projections originate are called AIO cells; whereas caudally to 
the SN and partly in the caudal VTA a third dopaminergic projec­
tion originates from so-called A8 cells (Dahlstrom and Fuxe 1964). 
On the borderline of the medial SNpc and lateral VTA, the A9 and 
AIO cells cannot be distinguished. 
The dopaminergic projections from the SNpc and VTA to the neo­
striatum, NAcc, ОТ and cortex are extensively studied in the rat 
with both the anterograde and retrograde labelling method. In 
tables 1.2 and 1.3 a summary is given of the results from repre­
sentative studies in this field (Albanese and Minciacchi 1983, 
Beckstead et al. 1979, Fallon and Moore 1978, Veening et al. 1980). 
This summary shows some notable points. A) The SNpc and VTA are 
divided into subregions in the lateral-medial and dorsal-ventral 
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direction by all authors, whereas each part in the rostral-caudal 
localization distributes fibres throughout the rostral-caudal length 
of the neostriatum. B) The projections of the subregions of the SNpc 
and VTA show a topographical arrangement with an overlap in the ven­
tral and most medial parts of the neostriatum. The central part of 
the neostriatum predominantly receives projections from the middle 
region of the SNpc and is relatively free from VTA projections. 
C) The NAcc and ОТ receive predominantly input from the VTA, al­
though both the medial and middle parts of SNpc are found to send 
some projections to these areas too. D) Again it is seen that the 
retrograde labelling method shows less restricted projection areas 
than the anterograde labelling method. 
Other dopaminergic projections are found in the neocortex and allo­
cortex (Beckstead 1979, Fallon and Moore Ι97Θ, Lindvall and Bjork-
lund 1974, Lindvall and Bjorklund 1978, Swanson 1982). These pro­
jections too show a distinction between the SNpc and VTA: both the 
SNpc and VTA project to neocortical areas, viz. frontal lobe, cin-
gulate cortex and enthorhinal cortex, however, without overlap. 
The VTA projects also to allocortical structures, viz. piriform 
cortex. As mentioned before (see cortex) the cortex also projects 
to the neostriatum. Beckstead (1979b) found cortical areas, inner­
vated by respectively the VTA and SNpc, sending projections to the 
same parts in the neostriatum as respectively the VTA and SNpc. 
Thus, next to the overlap of cortical, SNpc and VTA terminals in 
the neostriatum, there also seems to exist a relation between 
these projections via the cortex. 
The dopaminergic projections from the SNpc and VTA to the CN 
and PUT in monkeys display a wide spatial distribution comparable 
to the distribution in the rat (cf. Carpenter et al. 1976, François 
et al. 1984, Hemphill et al. 1981, Parent et al. 1983, Szabo 1980). 
Clusters of cells distributed through the entire SNpc project either 
to the CN or the PUT. These clusters of cells are closely inter-
mingled but never overlap, and appear to run continuously in the 
rostral-caudal direction. The VTA predominantly projects to the 
rostroventral CN. 
Unlike the patchy cortico-striatal projection, the terminals 
of the nigro- and tegmento-striatal fibres are evenly distributed. 
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TABLE 1.2 
Topography of ipsilateral projections from the SNpc and VTA to the neostriatum in rats 
Retrograde Anterograde 
(a) (c) (e) (b) (c) 
NEOSTRIATUM 
Rostral * 
Dorsal : lateral (SNpc-VTA)ve-me SNpc,mi SNpc,mi,la 
central SNpc SNpc,mi SNpc,mi,la 
VTA,la 
medial VTA,la,ve VTA,me,ce,la VTA,me,la 
SNpc,me,ve SNpc,me SNpc,me 
Middle : lateral SNpc,mi SNpc,mi,la 
central (SNpc-VTA)ve-me, SNpc,mi SNpc,mi,la 
do-ve 
medial VTA,la,ve (SNpc-VTA)ve-me VTA,me,ce,la VTA,me,la 
SNpc,me SNpc,me 
Ventral: lateral VTA,me,la SNpc,mi,la 
SNpc,la 
central (SNpc-VTA)do-la VTA,me,ce 
SNpc,mi 
medial VTA,la,ve VTA,me,ce VTA,me,la 
SNpc,me,ve SNpc,me SNpc,me 
Intermediate 
Dorsal lateral 
central 
medial 
SNpc 
VTA,la 
SNpc,mi,ve 
SNpc,mi,ve 
Middle lateral 
central 
medial 
SNpc 
VTA,la 
SNpc,mi,ve 
SNpc,mi,ve 
Ventral: lateral 
central 
medial 
SNpc,mi,ve 
SNpc,la 
VTA,la,ve 
SNpc,me 
SNpc,mi SNpc,mi,la 
(SNpc-VTA)ve-me SNpc,mi SNpc,mi,la 
VTA,me,ce,la VTA,me,la 
SNpc,me SNpc,me 
(SNpc-VTA)do-la SNpc,la,mi SNpc,mi,la 
(SNpc-VTA)ve-me SNpc,mi SNpc,mi,la 
do-la 
(SNpc-VTA)do-la VTA,me,ce,la VTA,me,la 
SNpc,me,mi SNpc,me 
(SNpc-VTA)do-la SNpc,la,mi SNpc,mi,la 
SNpc,mi SNpc,mi,la 
(SNpc-VTA)do-la VTA,me,ce VTA,me 
continued on next page 
Caudal *** 
Dorsal : lateral 
central 
medial 
SNpc 
VTA,la 
SNpc,me,ve 
SNpc,me,ve 
SNpc,mi 
SNpc,mi 
VTA,me,ce,la 
SNpc,me,mi 
SNpc,mi,la 
SNpc,mi,la 
VTA,me 
Middle : lateral 
central 
medial 
SNpc 
VTA,la (SNpc-VTA)do-la 
SNpc,la 
SNpc,mi 
VTAme.ce 
SNpc,mi 
SNpc,mi,la 
SNpc,mi,la 
VTA,me 
Ventral: lateral 
central 
medial 
SNpc,la,ce 
SNpc,la,ce 
(SNpc-VTA)do-la 
(SNpc-VTA)do-la 
SNpc, la 
SNpc,la 
VTA,me,ce 
SNpc,la 
SNpc,la 
SNpc,ca 
SNpc.ca 
VTA,me 
SNpc,ca 
a = Albanese and Minchiacci (1983) 
b = Beckstead et al. (1979) 
с = Fallon and Moore (1978) 
e = Veening et al. (1980) 
* = A 9650 
** = A 7470 
*** = A 6060 
A 7890 
A 6260 
A 3430 
according to König and Klippel (1963) 
SNpc = substantia nigra, pars compacta 
VTA = ventral tegmental area of Tsai 
la = lateral 
ce = central 
ne = medial 
mi = middle 
ve = ventral 
do = dorsal 
TABLE 1.3 
Topography of ipsilateral projections from the SNpc and VTA to the NAcc and ОТ 
NUCLEUS ACCUMBENS 
Dorsal : lateral 
medial 
Middle : lateral 
medial 
Ventral: lateral 
medial 
^ 
J 
> 
(a) 
VTA 
SNpc,me 
Retrograde 
(c) 
SNpc,me 
VTA,la,ve 
(d) 
VTA 
SNpc,me 
Anterog 
(b) 
VTA,ce,me,la 
SNpc,me 
VTA,ce,me 
VTA,ce,me,la 
SNpc,me 
VTA,ce,me 
VTA,ce,me,la 
SNpc,me 
VTA,ce,me 
rade 
(с) 
SNpc,me,mi 
VTA 
SNpc,me,mi 
VTA 
SNpc,me,mi 
VTA 
SNpc,me 
OLFACTORY TUBERCLE 
Dorsal : lateral 
medial 
Middle : lateral 
medial 
Ventral: lateral 
medial 
> 
VTA,ve,la,mi 
SNpc,me 
VTA,ce.me 
VTA,ce,me 
VTA,ce,me 
VTA,ce,me 
VTA,ce,me 
VTA,ce,me 
SNpc,me,mi 
VTA 
SNpc,me,mi 
VTA 
SNpc,me,mi 
VTA 
d = Swanson et al. (1982) For other abbreviations, see table 1.2 
However, within the projection areas itself, denser fields of 
terminals are observed after the anterograde labelling as well 
as with histofluorescence analysis (Arluison et al. 1982, Beck-
stead et al. 1979, Fallon and Moore 1978, Graybiel and Ragsdale 
1983; see intrinsic organization). 
Other afférents 
It has already been pointed out that the striatum also receives 
projections from other areas of the brain, viz. globus pallidus, 
basolateral amygdala, thalamus, dorsal raphe nucleus, subthalamic 
nucleus, locus coeruleus, nucleus tegmenti pedunculopontine (for 
review: Dray 1980, Graybiel 1984a, Graybiel and Ragsdale 1979, 
Nauta and Domesick 1984). Only some highlights are mentioned here, 
to stress once more the anatomical heterogeneity of the striatum. 
Adjacent to the striatum lies the globus pallidus (GP). In primates 
the GP is divided into a lateral, or external part (GPe, medial to 
the PUT), and a medial, or internal part (GPi). In lower mammals, 
the GP cannot be subdivided into segments. The entire GP of non-
primates is thought to be the analogue of the GPe in primates. The 
entopeducular nucleus (EP) in non-primates is considered to be the 
analogue of the GPi in primates. In the rat, the EP is a small cell 
mass in the internal capsule medio-caudal to the GP (cf. Nieuwen-
huys 1977). The ventral pallidum is considered to be the ventral 
part of the GPe and GPi in primates and the ventral, subcommissural 
part of the GP in rats in the entire rostral to caudal direction 
(Heimer et al. 1982). The GP is known as a target for striato-pal-
lidal fibres (see efferente). There exists, however, also a reci-
procal topographically arranged pallido-striatum projection (Beck-
stead 1983, Staines et al. 1981). Recently, Staines and Fibiger 
(1984) found that at least a part of the GP cells projecting to 
the neostriatum also sends fibres to the SNpr. The transmitter 
used by these neurons is thought to be gamma-aminobutyric acid 
(GABA). 
The basolateral amygdala, part of the 'limbic' amygdaloid nuclei, 
seems to avoid the rostral, dorso-lateral part in the neostriatum 
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(Kelley et al. 1982, Russchen and Price 1984). Still Fass et al. 
(1984) found labelled cells scattered throughout the basolateral 
amygdala after HRP injections in the rostral, dorsolateral neo-
striatum. In monkeys, the amygdala projects to the ventral and 
caudal CN and ventral PUT in a topographical and patchy manner 
(Russchen et al. 1985). 
The thalamus, a nuclear complex in the diencephalon, has 
reciprocal connections with the cortex (cf. Nieuwenhuys et al. 
1978) and sends a mass of fibres to the striatum. The thalamo-
striatal projection arises from the intralaminar nuclei. The 
projections from two of these nuclei, the centromedian nucleus 
(CM) and the parafascicular nucleus (Pf), show a clear distinc-
tion in their terminal field. In the monkey, the CM projects to 
the CN, whereas the Pf projects to the PUT in a patchy manner 
(Kalil 1978, Parent et al. 1983). In the rat the CM and Pf pro-
jections show overlap in the intermediate, ventral and the caudal 
parts of the neostriatum, but show separated projections to resp, 
the rostral-intermediate, dorsolateral part and the rostral, ven-
tral part of the neostriatum respectively (Veening et al. 1980). 
The transmitter used by these neurons is still unknown. 
The dorsal raphe nucleus, a part of the 'limbic' raphe nuclei in 
the midbrain, shows a restricted projection to the striatum in 
the monkey, viz. the ventral CN and the dorsolateral PUT (Parent 
et al. 1983, Szabo 1980), as well as in the rat, viz. the ventral 
neostriatum (Steinbusch 1981, Veening et al. 1980). Thus this pro-
jection shows complete overlap with the VTA projection in the CN 
respectively the neostriatum. The transmitter present in these 
neurons is serotonin (5-hydroxytryptamine, 5-HT). 
The projection fields of striatal afférents from the cortex 
and the 'limbic' structures VTA,amygdala and raphe nucleus led the 
striatum to be divided into a so-called 'sensory-motor' or 'non-
limbic' part, i.e. the PUT in primates and the rostral, dorso-
lateral neostriatum in rats, and a so-called 'association' or 
'limbic' part, i.e. the CN in primates and the remaining part of 
the neostriatum in rats (cf. resp. Percheron et al. 1984 and 
Kelley et al. 1982). However, the striatal afférents from the 
SNpc and thalamus show an integration of 'non-limbic' and 'limbic' 
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areas in the monkey's CN as well as the rat's neostriatum. The 
finding of basolateral amygdaloid projections to the rostral, 
dorsolateral neostriatum also points to this integration (Fass 
et al. 1984). 
EFFERENT CONNECTIONS OF THE STRIATUM 
The efferente from the striatum are restricted to the GP and SN. 
These projections show topographical arrangements in the rostral 
to caudal, dorsal to ventral, and lateral to medial directions as 
revealed by lesion, anterograde and retrograde labelling studies. 
In the rat, the striatal efferente again stress the earlier 
mentioned division into a 'dorsal' and 'ventral' striatum. The 
'dorsal' striatum projects to the dorsal-middle GP, the EP and 
the ventral-middle SNpr, whereas the 'ventral' striatum projects 
to the ventral GP, the dorsal SNpr and an adjacent part of the 
SNpc (Brann and Emson 1980, Bunney and Aghajanian 1976, Domesick 
1981, Heimer et al. 1982, Tulloch et al. 1978). Almost all 
striato-nigral neurons pass through the GP. 
Bunney and Aghajanian (1976) found that all portions of the neo-
striatum project to the SN, except for a rostro-medial core. 
Nagy et al. (1978), in turn, found that a rostro-dorsal core 
projects specifically to the GP, whereas the remainder of the 
neostriatum projects to the GP, EP and SN. However, when the 
transmitters present in the efferente are taken into account, 
the neostriatum can be subdivided into a 'rostral' part, viz. 
A > 7470 according to König and Klippel (1963), and a 'caudal' 
part, viz. A < 7470 according to König and Klippel (1963) (Brown-
stein et al. 1977, Cuello and Kanazawa 1978, Cuello and Paxinos 
1978, Fonnum et al. 1978, Jessel et al. 1978, Nagy et al. 1978, 
Staines et al. 1980, Wamsley et al. 1980). It is known that a) 
from the 'rostral' neostriatum substance P-(SP)-containing 
neurons project to the GP, EP, SNpr and SNpc; GABA-containing 
neurons project to the rostral GP, EP and sparsely to the SNpr; 
enkephalin-(ENK)-containing neurons project to the GP; while b) 
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from the 'caudal' neostriatum predominantly GABA-containing 
neurons project to the GP, EP, SNpr and SNpc; and a few ENK- and 
SP-containing neurons project to the GP, and SN plus EP respect-
ively. Bolam et al. (1981) found that the bulk of the neostriatal 
output projects to the SN. They wondered whether the striato-pal-
lidal neurons are independent or collaterals from the striato-
nigral neurons. The presence of different transmitters in the 
neurons from the 'rostral' neostriatum points to an independency 
(cf. Kanazawa et al. 1980); however, the presence of the same 
transmitter in neurons from the 'caudal' neostriatum does not ex-
clude the existence of collaterals. The compartmentalization of 
the striatum (see intrinsic organization) still makes it possible 
that the latter efferente originate from independent cells grouped 
into islands or patches. Indeed, in monkeys the majority of the 
striatal efferente have been found to be independent (see below). 
In monkeys there also exists a spatial distribution of the 
efferente from the CN and PUT towards the GP, GPi and SN as already 
described by Szabo (1962, 1967, 1970, 1972). Recently Percheron et 
al. (1984) described a model on the basis of the latest knowledge 
on this spatial organization of the striato-pallidal-nigral bundle, 
as depicted in fig. 1.6. In fig. 1.6A the differences of the den-
dritic topography between the striatum and GP is represented as 
small circles, i.e. the arborization of spiny striatal neurons 
(see intrinsic organization) and large disks, i.e. the arboriza-
tion of pallidal neurons. The axons from the spiny striatal 
neurons form small bundles of fibres (fascicles) on their way to-
wards the GP. In the 'association' territory (horizontal hatching 
fig. 1.6B; see cortex) these fascicles lead to a further inter-
mingling of the terminal fields of afférents, whereas in the 
striatal 'sensory-motor' territory (remainder part of the PUT; 
see cortex) these fascicles lead to intermingling of axons from 
different somatotopic strips ('pile' in fig. I.6A). In the GP, 
the striatal fascicles are funnelled from lateral to medially un-
til they form a bundle of fibres towards the SN. From lateral to 
medially the pallidal neurons ('disks'; see fig. 1.6C) can make 
contact with increasing numbers of striatal axons from different 
fascicles, leading towards an increasing convergence between the 
29 
the 'association' and 'sensory-motor' components. 
Within the bundle of axons leaving the GP, the topographical ar-
rangement of the CN and PUT axons still exists. The axons from the 
CN project to the rostral, middle-medial SNpr, and the axons from 
the PUT project to the caudal, lateral SNpr (Parent et al. 1984, 
Percheron et al. 1984, Szabo 1962, 1967, 1970, 1972). 
The above described data concerning the striato-pallidal-nigral 
bundle, also suggest that the striato-nigral neurons may give rise 
to collaterals while running through the GPe and GPi. Recent double 
labelling studies of Parent et al. (1984) and Feger and Crossmann 
(1984), however, have led to the conclusion that only a small part 
of the striatal efferents have collateral projections to both the 
GP and SN, wheras the majority are either striato-pallidal or 
striato-nigral neurons. Parent et al. (1984) injected the retro-
grade labelling tracers into the GPi and SN, and they found resp. 
single labelled cells in the PUT plus dorso-lateral CN and CN plus 
ventromedial PUT, whereas few double labelled cells were found in 
the fields of overlap. Feger and Crossmann (1984) injected the 
retrograde labelling tracers into the whole GP and SN, and they 
fcand a wide distribution of single labelled cells from both 
structures throughout the CN and PUT, whereas few double labelled 
cells were found in the whole striatum but predominantly in areas 
near to the GP. 
Thus, the CN and PUT project to the GPe and SNpr, the PUT and 
a dorso-lateral part of the CN, in addition, project to the GPi 
(cf. also DeVito et al. 1980), whereas collateral projections to-
wards the GP and SN originate from the CN and PUT. 
Until recently, it was presumed that the striatal efferents in 
monkeys, by analogy with the rat, contained the transmitters GABA, 
ENK and SP; without, however, paying any attention to the actual 
distribution of these transmitters. The development of the immuno-
histochemical methods made it possible to fill up this gap in our 
knowledge. Haber and Eide (1982) studied the distribution of ENK-
immunoreactive fibres and terminals. They found moderate immuno-
reactivity with densely and very densely stained patches, thought 
to represent immunoreactive cell bodies, throughout respectively 
the dorsolateral and ventromedial, rostral parts of the CN and PUT. 
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Fig. 1.6 Spatial model of the stnato-pallidal complex 
(for explanation see text) 
(from Percheron et al. (1984), with permission) 
31 
In addition, they found very densely stained patches in the adja-
cent caudal, lateral NAcc and olfactory areas. The striatal target 
structures GPe and the medial part of the SNpr contained evenly 
distributed very dense immunoreactivity and the GPi hardly any. 
Beach and McGeer (1984) studied the distribution of SP in the 
baboon and human basal ganglia. They found a moderately stained 
background with densely stained patches throughout the entire 
length of the CN, PUT and NAcc. Immunoreactive cell bodies were 
found clustered within these dense patches. In the striatal tar-
get structures, so-called 'woolly fibres' were found in a loose 
network along the perimeter of the dorsal GPe and the entire 
ventral GPe, whereas a tight network was found throughout the GPi 
and SNpr. The SNpc contained no 'woolly fibres' but only immuno-
reactivity in punctate elements and beaded axons. No detailed 
distribution has yet been reported concerning GABA in the mon-
key's basal ganglia, but from the above-mentioned data there is 
reason to believe that GABA-containing fibres originate through-
out the CN, PUT and NAcc and project towards the GPe, GPi and SN. 
None of the striatal efferente were found to project bilaterally. 
A schematic summary of the specific afférents and efferente 
of respectively the 'dorsal' and 'ventral' striatum is drawn in 
figs. 1.5 and 1.7 (Nieuwenhuys 1984, Nieuwenhuys and Cools 1984). 
Although the striatal efferente are rather limited, their target 
areas have numerous connections with other parts of the brain. 
—»PY —·ΡΜΝ(Α) 
- »FB—.PMN(C) 
"PMNIEI 
-*PY »PMNIB) 
_.PMN(0) 
Fig. 1.7 A scheme of afferent and efferent connections of the 
striatum (see fig. 1.5) 
abbreviations : see list of abbreviations 
(from Nieuwenhuys and Cools (1984), with permission) 
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Thus, information to the striatum might be funnelled in the striatal 
efferents, and beyond the striatal target areas distributed to a 
variety of brain areas. 
INTRINSIC ORGANIZATION OF THE STRIATUM 
As mentioned above, the striatum is a heterogeneous structure with 
respect to the terminal fields of afférents, the distribution of 
efferent neurons and the transmitters present in these neurons. 
With neurochemical staining methods for cells, receptors, trans-
mitters, enzymes and neural connections, even a higher degree of 
heterogeneity is found. In this part an attempt is made to visua-
lize the present complex picture of the internal organization of 
the striatum. 
Morphology 
Neurons consist of a receptive or input part (the dendrite, cell 
body and part of the axon), a conductive part (the axon) and an 
output part (the axon terminal). In the striatum the neurons are 
classified by the shape of the cell body and nucleus, the size, 
arborization as well as the appearance of the dendrites and axon, 
and the transmitter(s) used by the neurons. The striatum is com-
posed of at least 8 morphologically distinct types of neurons (see 
table 1.4A). The majority of these neurons (spiny I, spiny IA and 
spiny II) have arborized axons leaving the striatum, viz. efferent 
neurons. The spiny I neurons also have a dense axon-arborization 
within the striatum. In addition four types of afferent fibres are 
described (table l.AB). 
The point at which a terminal makes contact with a dendrite, a 
cell body or another axon is called a synapse. Synapses are found 
a) between axon terminals and dendritic spines, asymmetric synapses; 
b) between axon varicosities and dendritic spines, varicosities 
or shafts, perikarya and initial segments of axons, i.e. 'en 
passant' or symmetric synapses. These synapses occur betwec 
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TABLE 1.4В 
Identified afferent axons in the striatum 
Appearance 
Arborization 
density 
appearance 
density 
Origin 
Contact * 
Transmitter 
Type I 
thick, long 
branched 
+ 
(thick to thin) 
varicose 
+ 
diencephalon (VTA) 
brainstem 
'en passant' 
DA 
Type II 
thick 
0 
(thin) 
appendaged 
++ 
thalamus 
asymmetric 
? 
Type III 
moderate 
++ 
(thin) 
beaded 
0 
SN, DRN, LC 
'en passant' 
asymmetric 
DA, 5HT, 
NA 
Type IV 
thin, long 
('twigs') 
cortex 
asymmetric 
GLU 
0 = few, + = moderate, ++ = dense 
DA = dopamine, CCK = cholecystokmir., 5HT = 5-hydroxytryptamine, NA = noradrenaline, 
GLU = glutamate, SN = substantia nigra, DRN = dorsal raphe nucleus, LC = locus coeruleus, 
VTA = ventral tegmental area 
* - see text 
.References.· Arluison et al. (1982), DiFiglia et al. (1э78), Fonnum (1984) 
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ferent axons and spiny I neurons, axons of interneurons and spiny I 
neurons as well as between spiny I neurons reciprocally. Until now, 
no anatomical evidence has been found of striatal afférents making 
direct contact with interneurons, and vice versa. From this fact, 
it appears that the medium sized, spiny neurons occupy a key posi-
tion in the striatal circuitry: they receive all input and direct 
all output. It must be stressed that, although no direct contact is 
found, the different afférents and interneurons can come into close 
contact when projecting to the same dendritic spine. For example, 
corticostriatal afférents terminate on dendritic spine endings, 
whereas dopaminergic afférents as well as cholinergic interneurons 
terminate on the necks of dendritic spines, dendritic shafts or 
cell bodies. Thus, synaptic contacts and non-synaptic contacts seem 
to exist (Bolam 1984, Butcher and Woolf 1982, Chesselet 1984, Freund 
et al. 1984, Lehmann and Langer 1983; see below). 
Receptors 
Within a synapse, information is passed by the release of trans-
mitter from the terminals (presynaptic) and the interaction of 
this transmitter on the receptive (postsynaptic) part. In case of 
non-synaptic contact, it is assumed that diffusion of the trans-
mitter over very short distances is responsible for the interaction 
(see morphology). 
Transmitters interact with specific recognition sites, designated 
as receptors, which are proteins located in the membranes of neu-
rons. It is beyond the scope of this thesis to go into detail about 
the sequence of physicochemical events after the interaction of a 
transmitter with its receptor. Some general remarks on the (hypo-
thetical) sites and subsequently the nomenclature of receptors are 
in order, however, to stress further the complicated picture of 
the neostriatum. 
As already mentioned, the transmitter passes information by react-
ing with receptors on the postsynaptic side, these receptors are 
called postsynaptic receptors. When the transmitter interacts via 
a non-synaptic contact, the receptor is thought to lie on the axon 
terminal of a neuron, and is subsequently called a presynaptic 
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receptor. Recently Laduron (1984) named such a receptor presynaptic 
heteroreceptor as opposed to a presynaptic autoreceptor which is 
thought to exist on the presynaptic side of the transmitter releas-
ing neuron itself and is sensitive to the transmitter originating 
from that neuron. Both types of presynaptic receptors are assigned 
to regulate the synthesis, metabolism and release of transmitter as 
well as the firing rate of the neuron (Carlsson 1975, Langer 1981, 
Rand et al. 1982, Starke 1981, Starke and Langer 1978). The activ-
ity of neurons can also be regulated via a feedback loop from the 
postsynaptic or non-synaptic neurons to the presynaptic neuron's 
dendrites, cell body or axon terminal resp. on postsynaptic recep-
tors and presynaptic heteroreceptors. When feedback takes place 
between an axon collateral with its own neuron or between neurons 
using the same transmitter, for example the GABA-ergic medium sized 
spiny neurons in the striatum, both types of receptors are called 
autoreceptors. Until now there has been no consensus about the 
presynaptic autoreceptors. For example, on the one hand Laduron 
(1984) and Kalsner (1982) deny their existence. Laduron (1984) 
claims that the activity of the presynaptic neuron is solely regu-
lated via the feedback loop system (recently confirmed by Compton 
and Johnson 1985). On the other hand, in vitro experiments with 
synaptosomes, viz. isolated 'pinched off' nerve terminals, have 
clearly demonstrated the existence of such presynaptic autorecep-
tors (De Langen 1979, Schoffelmeer 1983). It must be borne in mind 
that, in the living organism, all these regulation processes exist. 
In addition, another receptor phenomenon is also of importance: 
the existence of subtypes. The evidence of receptor subtypes for 
one and the same transmitter is derived from both in vitro and 
in vivo functional studies (for review see Snijder 1984). Con-
cerning the striatum a number of (putative) transmitters (table 
1.4A,B) as well as receptor subtypes have been determined (for 
review see Graybiel and Ragsdale 1983). Some of them will be 
introduced in Chapter 2. 
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Compartmental izat ion 
Specific (imniuno)histochemical compounds directed against cell 
organelles, transmitters, their enzymes or receptors within the 
striatum reveal the distribution of the specific neuronal orga­
nization under study. When this distribution is uneven, so-called 
neurochemically distinct compartments appear. 
Although the morphology of striatal cells has been extensive­
ly studied, the distribution of the cell types has been less studied 
on morphological grounds. An interesting example is the study of 
Goldman-Rakic (1982). She found, with the Nissl staining method, 
that cells in the CN of primates were subdivided in so-called 
small 'island' cellular compartments scattered in a large 'matrix' 
cellular compartment. In the PUT and in the neostriatum of rats no 
such 'island' compartments were found. The 'islands' varied in 
size and shape (coronal 300-600 Urn, sagittal 500-1500 Urn), and ac­
counted for only a small fraction of the CN. An 'island' comprised 
densely packed medium sized cells (13-18 μιη) with one or two larger 
cells (> 20 \im). Because of the size of the 'islands' and the known 
distribution of the dendritic arbors of the medium sized cells (see 
table 1.4A), it was presumed that these dendrites radiate into the 
surrounding 'matrix'. The 'islands' were surrounded by a cell-sparse 
capsule, in which axons and dendrites both from the 'island' and 
'matrix' cells as well as few large cells (30-50 pm, probably aspiny 
II) were present. These large cells are situated in close contact 
with both 'island' and 'matrix' components. The 'matrix' contained 
less densely packed cells, slightly larger (20 μιη) than 'island' 
cells and distributed more heterogeneously showing heavier concen­
trations of neurons in bands. In addition, Goldman-Rakic (1982) 
found prefrontal cortex projections to the CN terminating discon-
tinuously in the 'matrix', clearly avoiding the 'islands' (see 
cortex) but coming into close contact with the dendrites of these 
cells. Unfortunately, the method used by Goldman-Rakic (1982) made 
it impossible to classify further the 'island' medium sized cells. 
Recently, Graveland and DiFiglia (1985) found that, within the 
primate CN, the portion of intrinsic medium sized neurons with 
indented nuclei, viz. aspiny I neurons, was greater than found 
in the primate PUT as well as in the neostriatum of rats and mice. 
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No cellular distribution was given, so it is open whether these 
cells are the same as the medium sized cells in the 'islands' of 
Goldman-Rakic (1982), or that these latter cells represent clusters 
of medium sized cells visualized by other staining methods (see be-
low) . 
Today, many studies are focussed on the distribution of neurons 
containing specific transmitters, their enzymes or receptors in the 
mammalian brain with more or less selective neurochemical staining. 
Hardly any distribution is found to be homogeneous in the striatum. 
For example: 
a) Dopaminergic fibres form a dense plexus of the fluorescence 
throughout the neostriatum of rats, with regions of stronger in-
tensity in the ventromedial part as well as islands of stronger 
intensity rostral along the dorsal and lateral border of the corpus 
callosum and scattered in the intermediate part (Arluison et al. 
1982). 
b) In monkeys, fields of ENK immunoreactive neurons appeared 
throughout the CN and PUT, interrupted by rounded and irregularly 
shaped zones in which neurons are unstained or stained only at 
background levels (Graybiel and Chesselet 1984). 
c) Elongated patches of immunoreactive SP neurons have been found 
throughout the CN and PUT in monkeys, comprising the immunoreact-
ive cell bodies (Beach and McGeer 1984). In the rat, SP-like 
immunoreactive patches were found in the rostral, dorsal to ven-
tral extend of the neostriatum (Gerfen 1984). 
d) With the immunohistochemical technique for glutamate decar-
boxylase (GAD), a biosynthetic enzyme for GABA, randomly distri-
buted GAD-positive puncta have been found in the neostriatum of 
rats. These puncta comprised 2 types of neurons: medium to large 
and medium sized (Oertel and Mugnaini 1984). 
e) Patches of cholecystokinin-CCK-immunoreactive fibres have been 
predominantly found in the ventral and medial part in the neo-
striatum of rats (Zaborszky et al. 1985). 
f) In the past, several methods were used to visualize cholino-
ceptive neurons in the brain. One of the latest was the staining 
method for the enzyme acetylcholinesterase (AChE). However, it 
appeared that within the striatum so-called cholinoceptive neurons 
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existed, that contained AChE but were not cholinergic neurons 
(Marshall et al. 1983, for review see Butcher and Woolf 1982, 
Fibiger 1982). Presently, two methods are available to detect 
chclinoceptive neurons with a high probability of identifying 
genuine cholinergic neurons. The first method is the use of 
antibodies against the ACh-synthetizing enzyme choline-acetyl-
transferase (ChAT). The second method is staining brain struc-
tures for newly synthetized AChE within a few hours after treat-
ment of the animals with the AChE inhibitor di-isopropylphospho-
fluoridate (DFP). Using either or both methods in rat and monkey, 
cholinergic interneurons of type aspiny II were found scattered 
throughout the striatum (Mesulam et al. 1984, Satoh et al. 1983, 
Smith and Parent 1984, Sofroniew et al. 1982). 
The studies of Graybiel and co-workers (for summary see Graybiel 
1984b) on the appearance of so-called AChE-poor striosomes in 
the mammalian striatum and whether or not other neuronal com-
ponents co-exist with these striosomes, are difficult to inter-
pret presently, because no use was made of the DFP/AChE staining 
method (see above). The use of other combined neurochemical 
staining for different histological markers revealed also a 
mosaic-like appearance of two distinct compartments in the neo-
striatum of rats. The so-called 'patch' compartment is identified 
by dense opiate receptor binding, ENK- and SP-immunoreactivity, 
retrogradely labelled neurons to the SNpc and anterogradely 
labelled limbic cortico-striatal afférents. The second, so-cal-
led 'matrix' compartment is identified by sensorimotor cortex 
input, retrogradely labelled striatal projection to the SNpr, 
anterogradely labelled Pf afférents, a high AChE activity and 
somatostatin immunoreactive fibres. Somatostatin immunoreactive 
cells were found in both compartments, possibly forming a link 
between the two compartments (Gerfen 1984, Herkenham and Pert 
1981). The 'patches' were found throughout the neostriatum, 
with no apparently different distribution up to now in the 
'dorsal' and 'ventral' or 'non-limbic' and 'limbic' part of the 
neostriatum (see SN and VTA). 
The 'patch' compartment found by Gerfen (1984) and Herken-
ham and Pert (1981), the striosomes found by Graybiel (1984b) 
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as well as the cell patches found by Goldman-Rakic (1982) all point 
to a network of three dimensional clusters in the striatum. Although 
future studies are required to fit other striatum components into 
the pattern, for example the dopaminergic afférents (which are 
heterogeneously distributed, cf. Arluison et al. 1982; see SN and 
VTA), the cholinergic and GABA-ergic interneurons, the GABA-ergic 
efferente and the co-existence of transmitters in one neuron, it 
is already shown that, within the heterogeneous striatum, a number 
of contacts between afferent, intrinsic and efferent neurons are 
possible. These contacts, synaptic or non-synaptic (morphology), 
pre- or postsynaptic (receptors), in- or outside a compartment 
(compartmentalization) are nowadays known to lead to the integrat-
ed function of the striatum in both motor and non-motor behaviour 
(see Chapter 2). 
41 

CHAPTER 2 
STRIATUM: FUNCTION 
INTRODUCTION 
Recently Van Dongen (1980, Van Dongen and Van den Bereken 1981) ad-
vanced a framework that consists of strictly defined concepts on 
structure and function of the nervous system, with the help of which 
the 'function' of a brain structure can be clarified. The reader is 
referred to these publications for a detailed discussion that led to 
the development of this framework. The basic point is to answer the 
question: what is the effect of input on the output of a defined 
structure? This input/output relation can be studied at a variety 
of levels (fig. 2.1): a) intrinsic to the defined structure: the 
molecules, molecular levels, intracellular machinery, neurons, the 
neuronal network within the structure, and b) extrinsic to the de-
fined structure: the neuronal network between defined structures, 
the manifestation of the output of the structure on central organs, 
peripheral organs, the muscular apparatus, glands, the spatiotemporal 
relationship between parts of the organism and the spatiotemporal 
relationship between the organism and its environment. In this 
chapter the accent is put on the role of the input/output relation 
(function) of the striatum at the extrinsic levels, predominantly 
at the 'in vivo' level of the spatiotemporal relationship of the 
whole organism and its environment, i.e. behaviour. 
At all levels the effects of transmitters, precursors of the 
transmitters, drugs that mimic the effects of the neurotransmitter 
(agonists) and drugs which block the agonist-induced effects 
(antagonists) are used to study functional aspects of the striatum. 
Before going into detail on the subject of behaviour, some examples 
will be given below of the role of the input/output relation of the 
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simplified scheme: system analysis, CNS, behavior 
SURROUNDINGS S5 
ORGANISM S4 
CNS S3 
S2 
О—< 
Si 7 
other 
regions 
other 
tissues 
abiotic elements 2 
other organisms 
Diagram to illustrate the various levels in the 
application of system analysis to the CNS and to 
behaviour. SI and S2: intrinsic to a defined 
structure; S3 to S5: extrinsic to a defined struc­
ture (see text for explanation; from Van Dongen 
1980, with permission). CNS: central nervous system. 
striatum at the other levels. Because the function of DA is most 
extensively studied on almost all levels, the results from these 
studies will serve as examples. 
At the molecular level changes in the chemical conformation of the 
drugs turned out to be coupled to functional alterations. The iden-
tification of the chemical conformation of DA revealed that DA can 
exist in two conformations. DA agonists brought into one or the 
other DA-like conformation differentially activated the DA recep-
tor(s) (Horn and Rodgers 1980). 
At the macromolecular level, the receptors are found to be build 
up of several units (Stevens 1979). The transmitter can induce 
changes in the conformation of the complex resulting in the open-
ing or closing of an ion channel or a more or less susceptibility 
to its transmitter. The nicotinergic cholinergic receptor is an 
example of a receptor-complex with an ion channel. When ACh binds 
to the complex, a channel is opened through which sodium and 
potassium ions can pass, resulting in changes in the membrane 
potential (Stevens 1979). The GABA receptor is an example of a 
receptor complex with both an ion channel and a regulatory sub-
unit. When GABA binds to its receptor, the ion channel is opened 
and chloride ions enter the neuron, thereby inducing hyperpolari-
zation. The regulatory unit is susceptible to benzodiazepines. 
Binding of benzodiazepines results in an increased binding of GABA, 
resulting in an increased passage of chlor ions (Harris and Allan 
1985, Mohler and Richards 1984). As yet the DA receptor complex is 
not established. 
At the level of the membrane, transmitter-receptor interaction is 
studied with the receptor-binding technique. The capacity of radio-
active labelled drugs to interact with ('bind to') neurons in cere-
bral tissue preparation serves as measure for the selectivity of 
these drugs to the receptor. Binding studies with dopaminergic 
drugs led to the classification of at least three different DA 
receptors (for review: Seeman 1981). However, up to now no clear 
evidence exists that all binding sites are indeed representative 
of functionally active receptors (Cools 1981a, Jenner and Marsden 
1982). 
The transmitter-receptor interaction is also studied at the level 
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of the membrane potential of neurons. In behaving animals (see be-
haviour: neuronal activity) or in anaesthetized animals, recording 
electrodes are placed directly into a brain structure and the act-
ivity of neurons during movements or during drug application resp. 
is measured. The latter electrophysiological recordings revealed 
that DA iontophoretically applied to the striatum elicited both an 
excitatory postsynaptic potential (EPSP) and an inhibitory post-
synaptic potential (IPSP; Herrling and Hull 1980, Kitai et al. 
1976, Norcross and Spehlmann 1978, for review: Feger et al. 1979). 
Moreover it was found recently in awake monkeys that iontophoret-
ically applied DA decreased the spontaneous firing rates of the 
majority of striatal neurons, thereby lowering the firing thres-
hold of the neurons (Rolls et al. 1984). 
Numerous biochemical variables (central and peripheral) can be 
measured to enlighten the function of a brain structure (for re-
view: Iversen et al. 1975). At the level of intracellular machinery, 
changes in the activity of the enzyme adenylate cyclase are found to 
be important in the differentiation of DA receptors into D-1 and D-2 
types in the striatum. Stimulation of these receptors resulted re-
spectively in a stimulation and an inhibition of neuronal activity, 
as measured by the changes in the concentration of cyclic adenosine 
monophosphate (cAMP; for review Stoof and Kebabian 198A). The in-
fluence on the synthesis, turnover rate and/or release of trans-
mitter(s) is another biochemical approach. Each DA system appears 
to have its own characteristic synthesis rate, turnover rate and 
even specific metabolic enzymes (Anden et al. 1983, Bannon et al. 
1981, Demarest et al. 1980, Garrick and Murphy 1980). In addition, 
despite the rather homogeneous distribution of the cholinergic 
enzymes AChE and ChAT in the striatum (see Chapter 1), regional 
differences are found in the ACh levels and the activity of the 
enzymes (Guyenet et al. 1977, Takano et al. 1980). The reciprocal 
interactions of the different neurotransmitters in the striatum, 
predominantly DA, ACh, GABA and GLU, are highly complicated. The 
latter studies use an increased or decreased transmitter contents, 
transmitter turnover or elements of a transmitter's metabolism 
often as a marker for the effect of one transmitter on the other 
(for a summary of Bartholini 1980, Gale and Casu 1981, Nieuoillon 
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et al. 1983: see table 2.1). Furthermore, the different DA receptors 
appear to have different influences on the striatal transmitters: 
stimulation of the D-2 receptor with the specific agonist LY 141865 
in striatal tissue inhibited the release of ACh and DA but not of 
GABA and GLU from striatal tissue, and this effect was antagonized 
by the D-2 antagonist sulpiride; D-1 specific drugs did not affect 
release of any transmitter in striatal tissue (Stoof et al. 1982). 
TABLE 2. 1 
Summary of reciprocal interactions 
of striatal neurotransmitters 
Drug-induced Measured changes 
activity in activity 
DA ACh GABA GLU 
DA + -
ACh + + + 
GABA + - - + 
GLU + + + 
+ = increased activity 
- = decreased activity 
BEHAVIOUR 
Behaviour: introductory remarks 
The behaviour of animals has long been used as functional variable 
by ethologists, psychologists and physiologists. All of the latter 
research approaches have shared one common feature, their interest 
in behaviour. Nevertheless, they use different frames of reference: 
behaviour of the animal in its natural surroundings, behaviour of 
animals shaped by their environment, and physiological processes 
underlying behaviour, respectively. Finally, psychopharmacology 
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has introduced a fourth frame of reference: changes in behaviour 
as tool to study effects of neuronally active drugs, i.e. behav­
iour is used as dependent variable (for review Iversen and Iversen 
1981). Integration of the four disciplines has led to a neuroetho-
logical approach in the search for 'rules of order' in the cerebral 
organization of behaviour and in the search for the brain processes 
which direct these rules. It has been found that a) detailed stu­
dies on the postnatal development of movement (Altman and Sudarshan 
1975, Golani et al. 1981), grooming (Fentress 1983) and posture and 
locomotor skills (Altman and Sudarshan 1975) in rats have led to 
the concept of 'hierarchically patterning of behaviour' (for review 
Fentress 1983); b) a detailed study on the behaviour of rats follow­
ing the recovery from lateral hypothalamic lesions has led to the 
concept of 'hierarchically organized systems inside the brain' 
(Teitelbaum et al. 1983); с) detailed studies on the characteris­
tics of motor programs underlying arm movements in monkeys and 
humans have led to the concept of 'hierarchically arranged feed­
back systems in the control of movement' (Bizzi and Polit 1979, 
Keele 1981, Polit and Bizzi 1979). 
These concepts together with the theory of Powers ( 1973) that 
behaviour is the control of the input of the organism and that 
this control is a hierarchy of feedback systems in the brain, 
led Cools and his coworkers to a functional scheme of the brain 
(fig. 2.2) derived from the following approach of behaviour in 
neuroethology (for review Cools 1985): 
Frame of reference: brain processes and behavioural phenomena 
form part of a single entity; the mutual relationship between 
brain, organism and environment is thereby conceived as an in­
tegrated whole. 
Research strategies: I) 'Input/output function' strategy. 
Characteristic of this strategy is that insight into the input/ 
output function of a particular brain region at the cellular 
level offers guidelines for understanding behavioural changes 
following manipulations with that brain region, because both 
input and output of the target unit under study ultimately con­
tain crucial information about the way in which the organism 
maintains its dynamic relation with the environment. In practice, 
48 
ΐ>Γ~1 c o r t e x 
1 cori ico 
sír/σ'σ/ //a 
'' ' ^ - о Д caudate 
Scortico 
Ъ/ ¿Sf ¡¡/l'I пІЯгаІ 
•V· / , / Τ ^ - ^ Β nigra(SNR) 
ScorííCO 
collicuhr 
V. ' " '' ^ ^ ^ Γ Ί colliculus 
exterotoptc 
ontrol 
L • ^ . 
» V ^ t ^ ^ ^ > B FR 
Iffy 
A cort/co 
reticular 
device 
environment proximal result s of 
effectors 
Fig. 2.2 A functional scheme to illustrate the non-lmear, 
overlapping hierarchy of negative feedback systems 
of which the striatum (in particular the caudate 
nucleus 1 forns a part (from Cools et al. 1984a, 
with permission). 
SNR: substantia nigra, pars reticulata; 
DL: deeper layers; FR: formation reticularis 
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this approach implies a) delineating the brain region under study 
within the frame of reference, in which the chosen target unit is 
an entity; b) defining the function of this target structure in 
terms of input/output relationship with the help of electrophysio-
logical studies, for instance (see below); and c) analyzing behav-
ioural changes triggered by selective manipulations with the target 
unit in terms of being consequences of changes in the latter func-
tion (Van Dongen 1980). 2) 'consequence' strategy. Characteristic 
of this strategy is the idea that behavioural changes following a 
selective manipulation with a particular brain region have to be 
considered as phenomena being consequences of a common underlying 
mechanism, i.e. mechanisms that do not themselves demonstrate ob-
servable behaviour but by virtue of their properties account for 
observable behaviour. In practice this approach implies a) de-
lineating the borderlines of the brain region under study within 
the frame of reference, in which the chosen target unit is a 
single entity; b) defining the common features in behaviour dis-
played by organisms of which the activity of the chosen target 
unit is selectively modified; and c) analyzing the input/output 
function of the brain region under study in terms of the latter 
common features (Cools 1985). 
The caudate nucleus takes rather a high place in the hier-
archy of feedback systems that control behaviour (fig. 2.2). 
Observable behaviour can be described at various levels (table 
2.2; Cools 1981b). These levels also may imply a form of hier-
archy: the complexity increases from 1 to 6. Normally behaving 
organisms nearly permanently change activities, i.e. switches, 
at the levels 1 to 3. In contrast, organisms may or may not main-
tain switches at levels 4 to 6. 
The input of the organism can be divided into two groups of sig-
nals: exteroceptive stimuli, i.e. emanating from the physical 
environment, and non-exteroceptive stimuli, i.e. signals emanat-
ing from muscles, tendons and joints (proprioceptive) or from the 
interior of the body (interoceptive). Since behaviour is defined 
as the control of the input of the organism, much attention is 
payed lately to the role of the exteroceptive and non-exterocept-
ive stimuli on the switching of behaviour by the organism (for 
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TABLE 2.2 
Arbitrarily chosen levels of description: specific units 
1. Motor elements 
2. Motor components 
3. Motor complexes 
4. Motor patterns 
5. Behavioural items 
6. Behavioural strategies 
motor synergies, responsible for 
observable changes in contractions/ 
relaxations, of muscle groups. E.g. 
keeping the eyes open 
motor synergies, responsible for 
observable changes in spatio-
temporal relationships between 
parts of extremities. E.g. stretch-
ing a limb 
motor synergies, responsible for 
observable changes in spatio-
temporal relationships between 
various body parts. E.g. maintain-
ing a particular posture 
motor synergies, responsible for 
observable changes in spatio-
temporal relationships between 
body and its surroundings. E.g. 
walking 
ways in which the organism main-
tains a dynamic relationship with 
its environment. E.g. exploring 
the environment 
ways in which the organism alters 
the gap between the actual situ-
ation and desired state. E.g. 
preventing a conflict situation 
review: Cools et al. 1984a). Because changes in switching at the 
behavioural levels 1 to 4 nearly always result in 'pure' motor 
disturbances (see behaviour: drugs), the effect of a dysfunction-
ing striatum on these behaviours is easy observable. In contrast, 
changes in switching at the levels 5 and 6 are only visible when 
the environment of the organism demands the performance of the 
behaviour at these levels (see behaviour: drugs, neuronal activity). 
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According to the consequence strategy, the question whether the 
switching in behaviour is guided and/or directed by exteroceptive 
and/or non-exteroceptive stimuli, might be answered by inducing a 
small disturbance in the normally behaving organism and then ana-
lyzing the changes in the way(s) the organism still switches 
behaviour. In the remainder of this chapter and in the next section 
the attention is focussed on that strategy. From the data, it will 
be concluded that the striatum enables the organism to switch its 
behaviour by integrating non-exteroceptive and exteroceptive 
stimuli. Furthermore, it will be shown that decreased activity in 
the striatum in animals induces disturbances that are analogous 
to certain motor and non-motor disturbances found in patients with 
Parkinson's disease (see Chapter 8). 
Behaviour: electrical stimulation 
Methods 
Current passed through an electrode placed intra- and extracellu-
larly into a brain structure can induce behavioural changes. In 
a review on this subject Ranck (1975) proposed that: "what is 
stimulated from a given electrode(s) will depend on a) the elec-
trical properties and anatomy of the neural elements, b) the 
distance and orientation of the neural elements relative to the 
electrode(s), c) the resistance of the tissue, d) the pattern of 
current flow which is determined by configuration of electrode(s) 
and the resistance of the tissue, e) the current passed (its 
shape, duration and magnitude)". Because of the large number of 
variables, the electrical stimulation method seems not specific 
enough to study clear-cut effects of a particular brain structure 
on behaviour. 
Behaviour: lesions 
Methods 
One of the oldest and still widely used approaches in the study of 
brain function is to analyze the behavioural effects of a lesion 
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of a defined brain region. Lesions may be produced surgically by 
the direct removal of brain tissue or by the destruction of brain 
tissue either electrically or by the injection of relatively 
specific chemical neurotoxins directly into a brain region, for 
example 6-hydroxy-dopamine (60HDA) to destroy dopaminergic and/ 
or noradrenergic (NA) neurons, and kainic acid to destroy (not 
specific) neuronal cell bodies. The problems of the lesion 
technique are twofold: the lack of specificity (Ben-Ari et al. 
1979, Hattori and Fibiger 1982, Schoenfeld and Hamilton 1977) 
and the recovery from and adaptation to the lesion (Reisine 1981, 
Schoenfeld and Hamilton 1977). This method too seems not suitable 
for studying the specific relation between (parts of) a brain 
structure and behaviour. However, concerning the function of the 
striatum the method of 60HDA injections into the SNpc or striatum 
is so often used, that it should not be passed by in this thesis. 
For reviews concerning the effects of other lesions the reader is 
referred to Oberg and Divac (1979) and Steg and Johnels (1979). 
Reported_ find ings 
After unilaterally applied 60HDA into the SNpc in rats an initial 
induced motor asymmetry (Dravid et al. 1984) and sensory inatten-
tion contralaterally to the injected side (Ljungberg and Unger-
stedt 1976) is seen. Moreover it appeared that predominantly A9 
dopamine neurons are involved in this phenomenon, whereas both 
AIO and A8 dopamine neurons potentiated its severity (Lees et 
al. 1985). 'Spontaneous' recovery is exhibited after a few 
weeks (Dravid et al. 1984), i.e. the initial motor asymmetry dis-
appears and the orientation to contralaterally presented visual, 
auditory and olfactory stimuli is regained (Ljungberg and Unger-
stedt 1976). However, the rats never regained their ability to 
orient to contralateral tactile stimuli, but they did show other 
signs (sniffing and screaming), which indicated that the stimuli 
are sensed but not sufficiently strongly for turning to be ini-
tiated towards them. Since visual, auditory and olfactory stimuli 
can be registered bilaterally, the proper contralateral orienta-
tion may be initiated by projections crossing from the unlesioned 
side (see Chapter 1). 
In rats trained to perform a reaching task with the preferred 
forelimb towards a non-visually presented food-pellet, 60HDA 
injections into the contralateral SNpc abolished reaching with 
the preferred forelimb and increased reaching with the non-
preferred forelimb (Siegfried and Bures 1980). The rats were, 
however, still able to use the preferred forelimb in grooming, 
grasping a rod and picking up food from the cage floor. The 
similarity in both above-mentioned disturbances is that the 
rats were not longer able to initiate the contralateral move-
ment without the appropriate exteroceptive stimuli. Indeed, 
recently it was found that in the case of a bilateral auditory 
stimulus, rats with a unilateral SNpc lesion were able to de-
press a lever in order to avoid a shock. However, the initia-
tion time to perform the response was increased, and the in-
crease was related to the size of the lesions, i.e. the 
largest lesions (> 90% decrease of DA) abolished the response 
(Spirduso et al. 1985). 
Similar experiments have been done with rats that received 
unilateral 60HDA injections directly into the striatum. After 
an initial tendency to response towards the lesioned side, 
independent of the side of the stimulus, i.e. response bias, 
rats showed a delayed but not abolished initiation to respond 
to contralateral, visual stimuli (Carli et al. 1985). In the 
food searching task Siegfried and Bures ( 1980) and Sabol et 
al. (1985) found that rats, after unilateral injections of 
60HDA in the striatum, recovered from initially impaired 
reaching with the preferred, contralateral forelimb. In both 
tasks, the rats could use exteroceptive, i.e. visual, stimuli 
to initiate the reaching movement. However, in the latter 
study the rats were forced to grasp the food-pellet rather 
than take it towards themselves across the bottom as rats could 
do in the former study. This difference between the tasks re-
vealed that a 60HDA-induced lesion into the rostro-lateral neo-
striatum abolished the precision of grasping the pellet without 
visual stimuli: the rats could not use non-exteroceptive, i.e. 
proprioceptive, stimli anymore. A 60HDA-induced lesion in the 
rostro-medial neostriatum did not influence grasp performance 
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(Sabol et al. 1985). This functional heterogeneity of the striatum 
is thought to result from the anatomical heterogeneity of the 
striatum (see Chapter 1; behaviour: drugs). In addition, a differ-
ence is seen in the performance of the reaching itself in the two 
latter groups of rats: continuously directed by exteroceptive 
stimuli and directly towards the pellet respectively. 
Unilateral lesions of the output of the neostriatum, i.e. the 
rostral GP, induced also an inability to grasp the pellet 
(Schneider and Olazabal 1984), i.e. similar effects to those re-
sulting from lesioning the rostro-lateral part of the neostriatum 
that projects towards the rostral GP (see Chapter 1: efferente). 
In the test used the rats were able to take the pellet towards 
themselves by placing the paw behind the pellet. Thus, when the 
test allows it the rats can overcome their deficit by using an-
other way of solving the problem (see behaviour: drugs). 
The data from the lesion studies confirm that the effects depend 
on the place and size of the lesions, as well as the length of 
the recovery period. As will be shown below, the increased de-
pendency on exteroceptive stimuli, illustrated by a delayed 
initiation and a disturbed straight forward reaching, appears 
to be an effect specifically related to the destruction of A9 
DA neurons. 
Behaviour: drugs 
Behavioural effects elicited by drugs, administered either 
intracerebrally or peripherally, i.e. intraperitoneally, oral-
ly or intramuscularily, are also widely used to study the 
functional aspects of the striatum. Two types of studies can be 
considered: a) behavioural studies dealing with the effects of 
drugs upon syndromes previously induced, viz. behaviour is used 
as dependent variable to understand the mechanism of action of 
drugs; b) behavioural studies dealing with the effects of drugs 
in animals showing normal behaviour, viz. behaviour is used as 
tool to offer insight into tha function of (neurotransmitters 
within) specific brain structures. The number of studies of the 
striatum is enormous, and there is no alternative but to select 
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those that are relevant to the goal of this thesis: to clarify the 
specific function of the striatum in programming motor and non-
motor behaviour. For this purpose the studies are divided into 
three groups. In the first group, studies are sampled which are 
focussed on 'pure' motor ('pathological') disturbances induced by 
dopaminergic, cholinergic and GABA-ergic drugs in animals showing 
normal behaviour. These studies give insight into the involvement 
of the striatum in the pathological phenomena related to the 
clinical phenomena of Parkinson's disease (see Chapter 8). How-
ever, these pathological phenomena can also be induced by inter-
ference with the activity of other brain structures (see below), 
thus the striatum-specific function is not clarified with these 
studies. In the second group, studies are sampled which are 
focussed upon the interactions between DA, ACh and GABA within the 
striatum using behaviour as a dependent variable. These studies 
provide insight into the influence of DA, ACh and GABA on the 
information processing within the striatum. In the third 
group, studies are sampled which are specifically focussed on 
the effects of selective drugs on the switching ability of ani-
mals showing normal behaviour at the levels 5 and 6 in specially 
designed tasks. These studies, together with the studies in this 
thesis, provide insight into the function of the striatum in 
programming motor and non-motor behaviour. 
^Pure' motor_disturbances 
Methods. The drugs are injected either peripherally or intra-
striatally (unilaterally or bilaterally). The effects of the 
drugs are studied in experimental paradigms varying from an 
open field to a restraint situation. With respect to details 
on methodological factors the reader is referred to Myers (1974), 
Cools (1981c) and Section II. 
Reported findings. Detailed descriptions of the pure motor disturb-
ances induced by dopaminergic, cholinergic and GABA-ergic drugs have 
been published recently (Cools and Van Rossum 1980, Pycock 1980, 
Scheel-Kriiger 1983, 1985, Scheel-Kriiger and A m t 1985, Schultz 
1982). The effects can be described at the four lowest levels of 
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table 2.2). For example (see also table 2.3): 
Level 4: turning after unilateral intrastriatal injections of 
dopaminergic, cholinergic and GABA-ergic drugs (for review: Pycock 
1980); hyperkinesia or hypokinesia after bilateral intrastriatal 
injections, i.e. an increased activity (locomotion and rearing) 
after a DA agonist, ACh agonist of GABA antagonist, and a decreased 
activity (catalepsy) after intrastriatal injections of a DA antag-
onist or GABA agonist (for review: Scheel-Kriiger 1983, 1985). 
Level 3: torticollis after unilateral intrastriatal injections 
of a DA agonist, ACh agonist or GABA antagonist, i.e. increased 
activity involving the muscles of the neck, which causes an abnor-
mal turn and/or posture of the head (Cools et al. 1975a, Grossman 
et al. 1984). 
Level 2: compulsive alternations of rapid flexions and ex-
tensions of extremities or parts of extremities after intrastriatal 
injections of dopaminergic drugs, cholinergic drugs or GABA antag-
onist (chorea-athetosis; Cools et al. 1975a, Grossman et al. 1984). 
Level 1: isolated movements of muscles after dopaminergic, 
cholinergic or GABA-ergic drugs, which cause a) orofacial dys-
kinesia, i.e. tongue protrusion (dynamic or static), ear flatten-
ing, teeth chattering, grimacing (monkeys), chewing, ptosis of 
the upper eyelid (for review: Scheel-Kriiger and Arnt 1985); 
b) tremor, i.e. rhythmic, regular, oscilating movements of (parts 
of) limbs, trunk or head (see below: ACh); c) muscular rigidity, 
i.e. a tonic electromyographic activity (Ellenbroek et al. 1985b, 
1986, Turski et al. 1984). 
Furthermore, the effects of DA agonists are often described 
in terms of 'stereotypy'. 'Stereotypy' can be defined as repetition 
of invariant sequences of behaviour (Robbins 1982). DA agonists 
cause with increasing dose, an increasing rate of responding with-
in a reducing number of response categories (Lyon and Robbins 
1975). Stereotyped behaviour can be seen at all behavioural levels. 
Thus, stereotypy is actually an increased change in activity, i.e. 
an increased switching, at all behavioural levels. To summarize 
different types of stereotypy is not recommended, because that 
will not give any information on what is actually induced by the 
drugs (see below). 
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TABLE 2.3 
Summary of drug-induced effects at the behavioural 
levels 1 to 4 (see text for explanation) 
Behavioural Inj. Drug Effect 
level site 
DA ACh GABA 
(table 2.2) ag antag ag antag ag antag 
4 b χ χ χ χ χ 
с χ 
C X X 
a χ 
b x x χ 
a χ 
с x x 
X 
X 
X 
X 
X 
turning 
hyperkinesia 
hypokinesia 
hypokinesia 
torticollis 
dyskinesia 
dyskinesia 
tremor 
rigidity 
a = peripheral ; b = intrastnatal, unilateral; с = mtrastriatal, bilateral; 
ag = agonist; antag = antagonist. 
The drugs induce the following effects: 
In general. Increasing the dose of agonist or antagonist of the 
three transmitters elicited motor disturbances at decreasing levels, 
i.e. low doses induced observable disturbances at level 4, high doses 
induced observable disturbances at level 1. However, detailed analy­
sis of the motor disturbances elicited by a high dose, reveals a 
successive appearance of motor disturbances from level 4 to 1 (Cools 
et al. 1975a, Lyon and Robbins 1975, Scheel-Krüger 1983, Szechtman et 
al. 1985). Thus, the increased pathology of the striatum produces a 
great variety of totally different movements. Furthermore, it is 
found that the majority of the above-mentioned 'pure' motor disturb-
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anees can also be elicited by local drug injections into other brain 
structures, for example level 4: turning from the SNpr (Pycock 1980), 
catalepsy from the thalamus (Dichiara et al. 1981, Klockgether et al. 
1985) and reticular formation (Dunstan et al. 1981, Hartgraves and 
Kelly 1984), hyperactivity from the GP (Scheel-Kriiger 1983) and the 
superior colliculus, deeper layers (SCdl; Cools et al. 1983a); level 
3: torticollis from the subthalamic nucleus (STN; Grossman et al. 
1984); level 2: similar effects as described above from STN and GP 
(Grossman et al. 1984); level 1: muscular rigidity from SNpr (Have-
mann et al. 1983), thalamus (Klockgether et al. 1985) and SCdl 
(Ellenbroek et al. 1984), stereotypy from the SNpr (Scheel-Kriiger 
1983). It is found that the behavioural effects elicited from the 
latter brain structures could be potentiated but not blocked by 
simultaneously influencing neuronal activity in the striatum (cf. 
Cools et al. 1984b, Ellenbroek et al. 1985a). From these data and 
with the simplified functional scheme of fig. 2.2 (see fig. 2.3) 
it can be concluded that a successively increased pathology of the 
striatum results in an increased pathology of successively lower-
order systems in the hierarchy (for review: Cools et al. 1984a). 
However, the 'consequence' strategy demands to look for a common 
denominator that lies at the basis of the disturbances due to a 
dysfunctioning striatum (see behaviour: introduction). None of 
the above-mentioned 'pure' motor disturbances seems suitable to 
point to that common denominator, since these disturbances might 
be due to a dysfunction of other, lower-order brain structures. 
Therefore, analysis is needed of the effects of dopaminergic and 
cholinergic drugs in doses lower than those inducing the above-
mentioned 'pure' motor disturbances in order to establish the 
specific function of the striatum in behaviour (see below). 
The 'specific' effects of dopaminergic, cholinergic and GABA-ergic 
drugs, in addition, elicited the following notable effects. 
DA. The A9 and AIO dopamine neurons influence functionally 
different postsynaptic receptors, resp. DAe and DAi (Cools 1984, 
Cools and Van Rossum 1980). The two receptors are sensitive to 
different dopaminergic drugs. For example apomorphine (APO) and 
haloperidol (HALO) are a strong DAe agonist and DAe antagonist 
respectively, (3,4-dihydroxyphenylimino)-2- imidazolidine (DPI) and 
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ergometrine are a specific DAi agonist and DAi antagonist resp., 
whereas both ΛΡΟ and HALO act as weak DAi antagonists when in­
jected in high doses. The latter effect is probably due to a nor­
adrenergic component (see below). The time-course of the elicited 
behavioural responses differ: effects triggered by influencing the 
DAe receptors are short-lasting, whereas effects triggered by in­
fluencing the DAi receptors are long-lasting. The two receptor 
types work in opposite direction. For example, unilateral stimu­
lation of the DAe and DAi receptors results in resp. contralateral 
(CT) and ipsilateral (IT) turning. Bilateral stimulation of DAe 
receptors results in increased sniffing and exploratory activities 
(i.e. parts of the apomorphine stereotypy, see below; Cools 1977a), 
whereas stimulation of DAi receptors results in long-lasting in­
hibition of locomotion. The activity at the level of the DAi re­
ceptor is inhibitory influenced by alpha-like noradrenaline (α-like 
NA) receptors, whereas the activity at the level of the DAe recep­
tors is not. Functional interactions are found between the two 
receptor types: 
a) the licking and gnawing stereotypy induced by peripherally 
injected APO appears to result from an influence of activity at the 
level of both the DAe and DAi receptors: simultaneous stimulation 
at the level of both DAe and (via NA?) DAi receptors results in 
licking, and stimulation at the level of the DAe receptors and in­
hibition at the level of the DAi receptors results in gnawing; 
b) simultaneous inhibition of activity at the DAe receptor and 
stimulation at the level of the DAi receptor (via ΝΛ?) results in 
catalepsy (see Chapter 5), although previously catalepsy was thought 
to result from simultaneous inhibition at the level of both DAe and 
DAi receptors (Cools 1984); 
c) the activity at the level of the DAi receptor is found to in­
fluence activity at the level of the DAe receptor, i.e. increased 
DAi activity leads to decreased DAe activity. 
Furthermore, information which leaves the mesolimbic system is fun-
neled via the nigrostriatal neurons, since part of mesolimbic re­
sponses can be influenced by changing nigrostriatal DAe activity. 
There exists, however, also behavioural effects which, once elicit­
ed by influencing mesolimbic structures, are not influenced by 
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changes of nigrostriatal DAe activity, for example tremor (see 
below; Cools 1984). 
Dopaminergic drugs, selected for their capacity to influence D-1 
and/or D-2 receptors in biochemical and pharmacological studies, 
have only recently been studied for their effects upon behaviour. 
Slowly decreasing activity resulting in long-lasting catalepsy is 
found after peripheral injections of SCH 23390 (D-1 antagonist; 
Hoffman and Beninger 1985, Meiler et al. 1985). Peripheral injec-
tions of the D-1 agonist SKF 38393 or the D-2 antagonists sulpiride 
and spiroperidol in rats induced repetitious opening and closing of 
the mouth and high frequency clonic jaw movements ('perioral' move-
ments according to Rosengarten et al. 1983). The S-enantiomer of 
SKF 38393 elicited episodes of prominent grooming behaviour (Mol-
loy and Waddington 1984). Unilateral intrastriatal injections of 
(-)sulpiride (D-2 antagonist) induced ipsilateral asymmetry; re-
markably metoclopramide (also a D-2 antagonist) did not (Costali 
et al. 1983). 
Thus, behavioural effects induced by dopaminergic drugs need 
selective analyses for assessing the functional spectrum of these 
drugs on the functionally defined DAe/DAi receptors as well as on 
the biochemically defined D-l/D-2 receptors. 
ACh. Peripheral injected cholinergic agonists, for example 
tremorine and arecoline, induced tremor and catalepsy (for re-
view: Scheel-Krüger 1985). However, an intrastriatally applied 
cholinergic agonist, for example carbachol (CARB), induced no 
tremor nor catalepsy in freely moving rats (Baker and Kratky 1980, 
Scheel-Krüger 1985) and in mildly restrained monkeys (Velasco et 
al. 1982), whereas CARB did induce tremor in restrained cats 
(Connor et al. 1966) and restrained rats (Matthews and Chiou 1979), 
but still no catalepsy. Since exclusive lesions of the SNpc do not 
induce tremor (Fillion 1979, Péchadre et al. 1976) and only lesions 
of the NAcc attenuate tremorine-induced tremor (Dickinson and Slater 
1982), it must be concluded that the experimentally induced tremor 
is due to an increased activity in the mesolimbic area. Since 
catalepsy needs a simultaneous inhibition of the nigrostriatal 
and stimulation of the mesolimbic area, and since cholinergic 
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agonists in the striatum mimic the effects of an activation of 
DAe receptors and an inhibition of DAi receptors (see below), 
it must be concluded that catalepsy induced by peripheral in-
jections of cholinergic agonists is the result of influencing 
another cholinergic brain area (cf. Hartgraves and Kelly 1984). 
Unilateral, intrastriatal injections of cholinergic agonists in-
duce contralateral turning and predominantly contralateral in-
creased 'motor' activities (Cools et al. 1975a, Matthews and 
Chiou 1979, Murphey and Dill 1972, Velasco et al. 1982, Wester-
mann 1981). In sum, these data indicate that ACh in the striatum 
works in the same direction as DA on the DAe receptors, whereas 
ACh works in an opposite direction to that of DA on the DAi re-
ceptors . 
GABA. Intrastriatally injected GABA-ergic drugs elicit 
opposite effects as compared to DAe-ergic drugs and cholinergic 
drugs (for review: Scheel-Krüger 1983, Scheel-Krüger and Arnt 
1985). The GABA agonist muscimol (MSC) injected into an area 
near the GP (see Chapter 1) induces catalepsy (Scheel-Krüger 
et al. 1981). The GABA antagonist picrotoxin (PTX) injected 
into the NAcc induces continuous and well-coordinated loco-
motion (Morgenstern et al. 1984). Unilaterally intrastriatal 
injections of GABA agonists or antagonists induce ipsilateral 
and contralateral turning resp. (Cools and Janssen 1976, 
Grossman et al. 1984). These data indicate that GABA works in 
the opposite direction to that of DA at the level of the DAe 
receptors and in the same direction to that of DA at the level 
of the DAi receptors. 
Transmitter interactions 
Methods. All the drug-induced effects mentioned in the pre-
vious section can be used to study transmitter interactions. 
The most often used are the so-called 60HDA-rotation model, 
APO- and amphetamine-(AMPH-)induced stereotypy, hyperactivity 
(see below), and behaviours related to typical clinical symptoms 
of Parkinson's disease, i.e. tremor, rigidity and catalepsy (see 
above, Chapter 8). 
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60HDA-rotation model. As described before, a rat exhibits 
rotational behaviour following an unilateral injection of 60HDA 
into the SNpc (see behaviour: lesions). This initial activity 
disappears, but after peripherally administered drugs, either 
dopaminergic or cholinergic, circling is again induced. The 
induction of circling and direction of circling towards the 
lesioned side (IT) or away from the lesioned side (CT) is used 
as criterion to assess a) the DA agonistic activity of drugs, 
and b) the dopaminergic-cholinergic interaction in the striatum. 
This effect is ascribed to the change in sensitivity of resp. 
DA and ACh in the DA denervated striatum (Ungerstedt 1971, for 
review: Pycock 1980). The inhibition of circling induced by a 
DA agonist is used as a criterion to assess the DA antagonistic 
action of drugs. However, the picture is not as simple as that, 
following the discovery of two functionally different DA recep-
tors (see above). Unilaterally, the nigrostriatal DA neurons are 
destroyed, but the mesolimbic DA neurons on the same side are 
unaffected. The analysis of the direction, time-course and per-
formance of circling is needed to differentiate between drugs 
that influence DAe and/or DAi receptors. 
Stereotypy. The way in which drugs influence stereotyped 
behaviour induced by peripherally administered APO or AMPH, is 
another model used to study the dopaminergic activity of drugs 
as well as the reciprocal interactions of DA, ACh and GABA. It 
is known that AMPH is an indirect DA agonist releasing DA from 
central nerve terminals both in the mesolimbic and nigrostriatal 
DA neurons. Administered in high doses, AMPH additionally acts 
as an indirect NA agonist (Van Rossum 1970). APO is a DAe 
agonist when administered in a low dose (< 0.7 mg/kg), a DAe 
agonist and NA agonist when administered in a moderate dose 
(0.7-0.9 mg/kg), and in addition a DAi antagonist when ad-
ministered in a high dose (> 0.9 mg/kg; Cools and Van Rossum 
1980). Thus, knowledge of the (different) stereotyped behav-
iour induced by either AMPH or APO in low or high doses (see 
also above: motor disturbances) is a prerequisite for being 
able to conclude what kind of dopaminergic effect is at the 
basis of changes in that behaviour induced by simultaneously 
administered drugs (for review: Iversen 1977, Rebec and Bashore 
1984). 
Hyperactivity. Since Pijnenburg and Van Rossum (1973) de-
scribed the appearance of long-lasting hyperactivity after the 
local injections of ergometrine into the NAcc, the inhibition of 
hyperactivity served as model to assess DA antagonist potency. 
However, ergometrine is found to act as a DAi antagonist and, 
therefore, inhibition and not stimulation of DAi receptors in-
duces long-lasting hyperactivity. Stimulation of DAe receptors 
induces short-lasting hyperactivity (Cools and Oosterloo 1983, 
Cools and Van Rossum 1980). Thus, hyperactivity can be used as 
a model to assess the DAe-DAi components in the functional 
spectrum of dopaminergic drugs as well as the interactions of 
DA, ACh and GABA in the mesolimbic and nigrostriatal areas. 
Reported findings. For detailed reviews of the data, the reader 
is referred to Cools (1984), Pycock (1980), Scheel-KrUger (1983, 
1985), and Scheel-Krüger and Arnt (1985). 
In general. These data ccnfirin the conclusions drawn 
after the results of the single injections: 
a) the A9 DA neurons stimulate the ACh interneurons they project 
upon, whereas both the A9 DA neurons and ACh interneurons stimu-
late GABA efferente. 
b) The AIO DA neurons and the ACh interneurons in the terminal 
fields of the AIO neurons exert a mutually inhibitory influence, 
and inhibit and stimulate respectively the GABA efferente they 
project upon. 
DA. The importance of the different involvement of DAe and 
DAi receptors in the behavioural models has already been described. 
The involvement of the D-l/D-2 receptors are not yet clear. Peri-
pheraly injected D-1 and D-2 agonists induced CT in the 60HDA-ro-
tation model and this turning was inhibited by D-I and D-2 antag-
onists respectively (Arnt and Hyttel 1985). APO-induced CT in the 
60HDA-model was partially (maximally 50%) antagonized by the D-l 
antagonist SCH 23390 and the D-2 antagonist clebopride, but not 
by the D-2 antagonist spiroperidol (Arnt and Hyttel 1985, 
Herrera-Marschitz and Ungerstedt 1985). The effects of pheri-
pherally injected D-l/D-2 drugs on APO-induced stereotypy was also 
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inconsistent (Boyce et al. 19Θ5, Ljungberg and Ungerstedt 1978, 
Molloy and Waddington 1984, Rosengarten et al. 1983). This is 
understandable since it is found that the type of induced stereo­
typy depends on the peripherally injected dose of APO (see above: 
'pure' motor disturbances). The effects of both (-)sulpiride (D-2 
antagonist) and SCH 23390 (D-l antagonist) either injected directly 
into the antero-dorsal striatum or into the NAcc on APO-induced 
stereotypy, i.e. increased licking/gnawing and decreased locomotion 
respectively, show that indeed the APO-induced stereotypy is not a 
suitable behavioural model for differentiating between D-l and D-2 
receptors; on the contrary, it points to different effects upon DAe 
and DAi receptors (Scheel-Krüger and Arnt 1985). The classification 
of the DA antagonists as one group, i.e. neuroleptics, is no longer 
acceptable, because it is found that the different and sometimes 
contradictory behavioural effects could not only be ascribed to 
a putative different influence at the level of DAe/DAi or D-l/D-2 
receptors, but also at the level of ACh, NA and 5HT receptors. All 
these factors are involved in the effects of peripherally admini-
stered 'neuroleptics' upon behaviour, and should therefore be taken 
into consideration during the analysis of this behaviour (for re-
view: Cools 1983). 
ACh. Contradictions as described above are also found between 
the effects of peripherally and intrastriatally injected cholin-
ergic drugs in the behavioural models (for review: Scheel-Krüger 
1985). Intrastriatal injections revealed the existence of two 
functionally different cholinergic target sites, related to the 
striatal terminal fields of the A9 and AIO DA neurons (see Chapter 
1; Scheel-Krüger 1985, Scheel-Krüger and Arnt 1985). Moreover, 
intranigral injections of cholinergic drugs showed that this struc-
ture has to be the target site of cholinergic drugs to elicit the 
effects opposite to those of the A9 neurons (Scheel-Krüger and Arnt 
1985, Wolfarth et al. 1978). 
GABA. The effects of GABA-ergic drugs in the behavioural models 
are predominantly studied after intrastriatal injections. The over-
all conclusion is that intrastriatally injected GABA-ergic drugs 
influence the GABA-ergic efferents: the GABA-induced behaviours 
can only be potentiated but not blocked by dopaminergic and cholin-
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ergic drugs, whereas DA- and ACh-induced behavioural effects can be 
potentiated and blocked by GABA-ergic drugs (for review: see Scheel-
Krüger 1983, Scheel-Krüger and Arnt 1985). 
Programming_behaviour 
Methods. To study the function of the striatum at the behavioural 
levels 5 and 6, animals are brought into an environment that either 
demands the performance at the level 5, for example novel as op-
posed to familiar environment and living in a social group, or at 
level 6, for example solving a task. To establish the function of 
the striatum in programming behaviour the attention is focussed on 
the weight of non-exteroceptive and exteroceptive stimuli in the 
programming (switching) of the ongoing behaviour of the animals. 
In a novel environment, ongoing behaviour is likely to be 
directed by the new exteroceptive stimuli, whereas in a familiar 
environment exteroceptive as well as non-exteroceptive stimuli may 
guide the ongoing behaviour. This model may serve to study the in-
fluence of the striatum on programming motor behaviour at level 5. 
The ongoing behaviour of an animal living in a social group 
is determined by its own preceding behaviour (non-exteroceptive) 
and by the preceding behaviour of the partner(s) (exteroceptive). 
This model may serve to study the influence of the striatum on 
programming non-motor (social communication) behaviour at level 5. 
In behavioural tasÄs animals learn to perform a particular 
motor sequence, directly or with a time-delay, after a so-called 
discriminative stimulus in order to gain a reward or avoid punish-
ment (for more details see: Iversen and Iversen 1981, Oberg and 
Divac 1979). Behavioural tasks may serve as models to study the 
influence of the striatum on programming, i.e. switching, of 
motor behaviour at level 6 provided that the animals are not over-
trained (conditioned). Since the involvement of the striatum in 
behavioural tasks will also be described in the next part (see 
behaviour: neuronal activity), only one task will be elaborated 
here, whereas the specificity of the striatal effects will be 
discussed. A clear example of a behavioural task in which the 
switching of motor patterns, i.e. the choice of the motor stra-
tegy, can be studied is the performance of cats walking on a 
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treadmill (fig. 2.4; Jaspers et al. 1984). During walking the cats 
continuously have the freedom to alter their ongoing behaviour, 
and switch motor patterns, by approaching the front panel of the 
treadmill, pushing their head through the small opening in this 
panel and collecting food-pellets by bending their head towards 
a hidden food dispenser; auditory, visual and olfactory stimuli 
signalling the presence of food behind the panel were absent. In 
this experimental set-up it can be detected whether the cat ap-
proaches the front panel, i.e. switches, by continuously match-
ing stimuli inherent to the treadmill (exteroceptively directed, 
i.e. fixating parts of the front panel) or without using observ-
able exteroceptive stimuli (non-exteroceptively directed). 
Fia. 2.4 Cat walking on a treadriill in front of a food dispenser 
(from Sontag et al. 1984, with permission) 
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Furthermore, it can be detected whether a cat is conditioned, i.e. 
the whole sequence of movements to collect food is performed imme­
diately after the belt starts running (for more details see: Cools 
et al. 1984a, Jaspers et al. 1984). 
A prerequisite in all the studies mentioned, is that the dose of 
the injected drug is too low to induce 'pure' motor disturbances, 
which may interfere with the performance of the animals. Since 
intrastriatally injected GABA-ergic drugs induce a fixed striatal 
output, so that an altered input of the striatum has no influence 
anymore, these drugs are not suitable to study the role of the 
striatum in programming behaviour. Therefore, only dopaminergic 
and cholinergic neurons are used. 
Reported findings. A selective increase in activity at the A9 DA 
neurons in the striatum with APO and the cholinergic striatal 
interneurons with CARB both emancipated the switching of behaviour 
from exteroceptive control. In contrast, selectively decreasing the 
activity of the neurons mentioned above, with respectively HALO and 
scopolamine (SCOP), induced an enhanced dependence on exteroceptive 
stimuli to switch from the ongoing behaviour. 
In novel environments increasing or decreasing dopaminergic 
and cholinergic activity in the neostriatum of rats did not in­
fluence the performance of exploratory behaviour (Cools 1980, 
Neill and Grossman 1970). In a familiar environment, however, 
animals with an increased dopaminergic activity in the striatum 
were still able to switch behaviour (Cools 1980, Schmidt 1984). 
In contrast, animals with a decreased dopaminergic activity in 
the striatum ceased switching unless adequate exteroceptive 
stimuli were present (Cools 1980, Schmidt 1984). 
Peripherally injected low doses of APO or ΑΚΡΗ in animals 
in a social set-up, increased behavioural activities independent 
of, i.e. not directed by, the partners (Miczek and Gold 1983, 
Schmidt 1984). Local injections of CARB in the caudate nucleus 
of monkeys living in a social group elicited the same effect: 
increase of behavioural activities not directed by the partners 
(Van den Bereken 1979, Van den Bereken and Cools 1982). Peri­
pherally injected HALO in ferrets (Schmidt 1984) and intra-
caudate injections of the cholinergic antagonist atropine in 
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monkeys (Van den Bereken 1979) increased behavioural activities 
directed by the partnerCs), i.e. most of the activities of the 
ferrets was directed to the partner and the preceding behaviour 
of the partners determined the ongoing behaviour of the experi-
mental monkey respectively. It is interesting to note that the 
effects of changes in dopaminergic and cholinergic activity in 
the caudate nucleus differed between dominant and subdominant/ 
submissive monkeys (Miczek and Gold 1983, Van den Bereken 1979). 
With respect to the behavioural tasks, two remarkable 
points should be kept in mind by all who want to investigate 
the function of the striatum in behavioural tasks: 
a) An overtrained or conditioned performance in tasks, i.e. 
the animal switches towards the required movement sequence im-
mediately after the trigger stimulus, is not influenced by 
blocking or facilitating dopaminergic and cholinergic activity 
in the neostriatum in rats (Prado-Alcalá et al. 1978, Robbins 
and Sahakian 1983), and in the caudate nucleus of cats (Prado-
Alcalá and Cobos-Zapiain 1977, Jaspers et al. 1984) and monkeys 
(Ridley et al. 1981). 
b) A not overtrained, but maximal rate of performance can-
not be improved by increasing dopaminergic and cholinergic act-
ivity (Evenden and Robbins 1983b, Jaspers et al. 1984, Prado-
Alcalá and Cobos-Zapiain 1979, Prado-Alcalá et al. 1984, Robbins 
and Sahakian 1983). However, selectively inhibiting dopaminergic 
activity at the level of the A9 neurons in cats by intra-caudate 
injections of HALO, selectively decreased the performance of non-
exteroceptively directed behaviour, and increased the performance 
of exteroceptively directed behaviours. This effect could be 
countereacted by intra-caudate injections of APO (Jaspers et al. 
1984). And selectively increasing cholinergic activity in the 
neostriatum and caudate nucleus in poorly performing rats and 
cats respectively not only increased the performance rate but 
also decreased the response-latency, i.e. increased the initia-
tion of switching of the behaviour (Prado-Alcalá et al. 1984, 
Prado-Alcalá and Cobos-Zapiain 1979). 
The effects found are specific for the so-called 'nonlimbic' 
striatum (see Chapter 1): 
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1) Influencing cholinergic activity in the amygdala of cats and 
monkeys did not influence the switching ability of these animals 
in a behavioural task and in the social group respectively 
(Prado-Alcalá and Cobos-Zapiain 1977, Van den Bereken 1979). 
2) Decreasing the cholinergic activity in the so-called 'limbic' 
striatum inhibited the whole performance in a behavioural task 
(Prado-Alcalá and Cobos-Zapiain 1977, Prado-Alcalá et al. 1984). 
In contrast, it increases the response to emotion-evoked stimuli, 
i.e. a response related to an increased activity at the level of 
the DAi receptor (see below point 4; Neill and Grossman 1970). 
3) The injection of PTX into the SNpr mimicks the effects of the 
decreased activity of the GABA-ergic striato-nigral efferente. 
It is found that cats after the injection of PTX into the SNpr 
were no longer able to use static proprioceptive, i.e. non-
exteroceptive, stimuli to switch behaviours (Cools et al. 1983b). 
However, dynamic proprioceptive stimuli induced by the environment, 
i.e. exteroceptive stimuli, can be used to switch behaviour as is 
seen in experiments with cats on the treadmill: when the belt was 
not running, the PTX-treated rats remained sitting in a frozen 
posture, but at the initiation of the movement of the belt the 
cats immediately jumped from the frozen sitting position and 
walked with constant speed in an undisturbed manner. By fixating 
the front panel, these cats were also able to walk towards it 
(Sontag et al. 1984). 
4) Increasing dopaminergic activity in the nucleus accumbens with 
AMPH, i.e. increasing activity at the level of the DAi receptors, 
produced a) in rats an increased responding on a conditioned re-
inforced lever: the rats remained pushing on the lever producing 
a light formerly correlated with water (Taylor and Robbins 1984), 
b) in marmorsets a persistent choosing an originally rewarded 
object (Annett and Ridley 1985). Since an increased activity at 
the level of the DAi receptor results in a decreased activity at 
the level of the DAe receptor, it becomes understandable that 
after intra-accumbens AMPH, the rats are no longer able to switch 
behaviour without appropriate exteroceptive stimuli. Indeed, the per 
pherally applied low dose AMPH in rats increased lever pressing 
in visually triggered response-choice tasks, however after AMPH 
the rats did not press different levers in order to obtain the 
reward, but remained pressing the previously rewarded lever 
(Evenden and Robbins 1983a). The same effect is found after peri-
pherally injected AMPH in rats and monkeys performing a visual 
discrimination task: a decrease of the percentage of correct 
(rewarded) responses without influencing the total response rate 
(Ridley et al. 198 1, Robbins and Sahakian 1983). Since peripher-
ally injected AMPH increases activity at the level of the DAe and 
DAi receptors, and the 'limbic' striatum is found to be involved 
in behavioural responses to emotion provoking stimuli (in the 
examples above the previously rewarded levers; see behaviour: 
neuronal activity), it has to be concluded that peripherally in-
jected AMPH elicits increased switching due to the influence at 
the level of the DAe receptor, however the switching occurs with-
in an emotion-bound behavioural sequence due to the influence at 
the level of the DAi receptor (cf. Evenden and Robbins 1985). In 
contrast, peripheral injections of APO in low doses, i.e. speci-
fically increasing the activity at the level of the DAe receptors 
(see above), induced increased switching between a variety of be-
havioural strategies (Cools 1980, Schmidt 1984). Recently, it is 
found that 'specific' lesioning of the A9 DA neurons or AIO DA 
neurons elicited similar differential effects: placed in a novel 
environment with free accessible food, A9-lesioned rats were able 
to perform a variety of behaviours (see also above), whereas A10-
lesioned rats turned towards the food and predominantly remained 
eating during the test session (Evenden and Carli 1985). 
Thus, the use of specific drugs is a prerequisite when they are 
injected peripherally in order to study the function of a specific 
part of the brain. 
Behaviour: neuronal activity 
Since the effects of intrastriatal injections of drugs pointed to 
the role of exteroceptive (sensory) stimuli in a dysfunctioning 
striatum and in diseases in which the striatum is involved (for 
example Parkinson's disease, see Chapter 8), a number of research 
groups focussed their attention on the changes in the firing rate 
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of striatal neurons during the application of exteroceptive stimuli 
to cats (for review see Lidsky et al. 1985), and during behavioural 
tasks with or without exteroceptive stimuli performed by monkeys 
and humans (see below). The results of the latter studies will be 
elaborated here, because these are closely connected with and even 
performed because of the reported findings in the previous section 
(behaviour: drugs) and in the next. 
Methods. In man neuronal activity is recorded either with electro-
encephalography (EEG) at particular places on the skull (cf. Korn-
huber 1984) or with the regional cerebral blood flow method (rCBF) 
in which the total change of metabolism in brain structures is 
measured (fig. 2.5: Roland et al. 1980a, b, Roland et al. 1982). 
In monkeys, the activity of individual neurons can be recorded 
with micro-electrodes directly into a brain structure. This so-
called single cell recording makes it possible to visualize the 
activity of different types of neurons within a brain structure. 
However, it must be borne in mind that no evidence is presented 
concerning the exact place of the micro-electrode, i.e. in which 
part of the neuron, nor the nature of the neurons, i.e. afferent, 
intrinsic or efferent. The development of these sensitive methods 
to measure neuronal activity (for review see Bullock 1981) has 
made it possible to study the role of the cortex and subcortical 
structures like the striatum and its output structures in man and 
monkeys during the performance of behavioural tasks. Man and mon-
keys learned to perform a particular task. These tasks varied from 
simple (level 2), viz. the repetition of an isolated movement, to 
complex (level 6), viz. the delayed-response tasks. The basis of 
these latter tasks is that an instruction stimulus (cue) is given 
and after a short time delay, in which the subject is 'set' to 
react, a trigger stimulus is given as the start signal for the 
beginning of the movement (for other tasks, see results). During 
the recording the tasks have to be executed voluntarily. The cha-
racteristics of neuronal activity during the tasks will be de-
scribed, first of the major input structures of the striatum 
(cortex and SNpc), then of the effects in the CN and PUT and in 
addition some remarks will be made on the neuronal activity in 
the output structures of the striatum: the GP and SNpr (see Chapter 
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capacity 2 •106cps 
5 Block diagram of the equipment and the principle of 
the rCBF method (from Roland et al. 1980а, with 
permission) 
EEG = electro-encephalography; EMG = electro-myography 
1). The activity of neurons can either be increased or decreased, 
dependent on the baseline level of activity. The basic activity in 
the cortex, SNpc, CN and PUT is low, the neurons in the GP have 
either a low basic activity with bursts of high basic activity or 
regular high basic activity, and the neurons in the SNpr have a 
high basic activity. Thus in the cortex, SNpc, CN and PUT the 
changes in the neurons will be increased activity, whereas in the 
GP and SNpr the changes in the neurons will be decreased activity. 
Äeported findings. It is found that within the cortex the primary 
sensory and motor cortex are directly related to resp. sensory in-
put and motor output, whereas the associative areas receive infor-
mation from the primary sensory cortex. This information is trans-
lated into an area-specific output to the motor cortex and sub-
cortical structures, thereby influencing 'learning', 'planning' 
and/or 'execution' of the motor performance. The subcortical 
structures too appear to translate the cortical input together 
with the input of other subcortical structures into structure-
related output, which also influences motor performance on 
various levels either by sending the output back to the motor 
cortex or futher to lower brain structures (see fig. 1.7). The 
specificity of the above-mentioned output will be best clarified 
by means of examples of so-called motor tasks. 
According to Kornhuber (1984) the 'what to do' and 'how to 
do it' is regulated by the prefrontal cortex as a result of its 
massive mnemonic and sensory input. The prefrontal cortex shows 
bilaterally activity related to the instruction stimulus, the 
time-delay period, the trigger stimulus as well as to the ini-
tiation of movements in a variety of delayed response tasks in 
man and monkey (Fuster 1984, Ito 1982, Kornhuber 1984, Roland 
et al. 1980a, b). The prefrontal cortex is found to play a role 
in the integration of sensory and mnemonic information to motor 
output and thereby making the organism better suited ('set to 
react' or 'attention') for planning and carrying out extended 
sequences of behaviour. 
In tasks which require a sequence of movements, the activ-
ity of the SMA is related to the trigger stimulus as well as 
during the performance of the movements (Kornhuber 1984, Kurata 
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Fig. 2.6 Motor sequence test. A whole run is shown. 
The second half is the mirror image of the first half. 
The test consists of a sequence of flexion-extensions 
of the thumb and the corresponding ulnar finger, inter-
rupted by oppositions of the thumb. The test goes on 
continuously run after run during the rCBF measurement 
(from Roland et al. 1980a, with permission) 
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MOTOR SEQUENCE TEST 
Fig. 2.7 Motor sequence test (fig. 2.6) and the repetitive 
flexions of the index finger (fig. 2.9) shown as 
Markov sources to demonstrate the amount of infor-
mation needed to program the motor sequences 
(from Roland et al. 1980a, with permission) 
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and Tanji 1985, Tanji 1984, Tanji and Kurata 1985, Wise and Strick 
1984). The former activity is often called the readiness potential 
(the 'when to do it' of Kornhuber 1984). When the time-delay be-
tween the instruction and trigger stimulus is kept very short, 
activity is found in the SMA related to the instruction stimulus 
(Kurata and Tanji 1985). The function of the SMA is most striking-
ly demonstrated in human subjects when they were asked to think of 
a motor sequence task (figs. 2.6 and 2.7) without actually execut-
ing it: only the SMA showed a bilaterally increased rCBF (Roland 
et al. 1980a). Most of the tasks had to be performed with one of 
the forelimbs, nevertheless the SMA is activated bilaterally. The 
SMA is only contralaterally activated when a task is performed by 
the distal hindlimb while the remainder of the monkey is fixed 
(Tanji and Kurata 1981). The role of the SMA in skilled voluntary 
movements is described as the internal programming and initiating 
of motor subroutines (for review see Eccles 1982). 
The premotor area is in close contact with the SMA. In all 
tasks in which the SMA is activated, the premotor area showed 
moderate activity except during the internal programming of the 
sequence task (see above; Roland et al. 1980a, Wise and Strick 
1984). A more specific activity is found in a task performed by 
human subjects. In the maze test (fig. 2.8; Roland et al. 1980b) 
subjects were asked to make a sequence of fast movements of one 
arm and hand over a frame on verbal commands without vision. The 
premotor area showed a strong increase in the rCBF bilaterally. 
The premotor area seems to be involved predominantly in the 
interaction of both exteroceptive (sensory) and internal (SMA) 
guidance of movement (Wise and Strick 1984; recently confirmed 
by Kalsaka and Hyde 1985). 
Dependent on the cues used in the tasks, viz. visual, 
auditory or proprioceptive, the corresponding primary and as-
sociative sensory areas showed neuronal activity (Roland et al. 
1980a, b, 1982). The neuronal activity in the primary sensory 
cortex is also related to the sensory input derived from the 
execution of the movements (Kornhuber 1984). The role of the 
sensory cortices is to register the input and direct it to the 
other brain structures. 
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Fig. 2.8 Maze test: the frame and the hand viewed from above 
with the index finger in the start position. On 
verbal commands from the experimenter, the subject 
moves the finger from field to field in a specified 
direction (from Roland et al. 1980b, with permission J 
In all tasks the primary motor cortex showed activity in the 
corresponding parts of the body elements involved in the movements, 
and when the task is performed unilaterally the activity is found 
contralaterally (Kornhuber 1984, Kurata and Tanji 1985, Roland et 
al. 1980a, Tanji and Kurata 1985). During the performance of a 
simple repetitive movement (figs. 2.7 and 2.9) by humans, the rCBF 
is only increased in the contralaterally primary motor and sensory 
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Fig. 2.9 Device used for the torceful repetitive flexions and 
the sustained isometric contractions 
(from Roland et al. 1980a, with permission) 
cortex (Roland et al. 1980a). The role of the primary motor area in 
behaviour is to transfer information directly to the executive motor 
apparatus. 
Single cell recording in monkeys revealed that within the 
prefrontal cortex, the SMA and the premotor cortex different types 
of neurons exist. In general, these types can be divided into three 
groups: related to a specific type of cue or movement, related to 
any type of cue or movement, and closely related to the function of 
the area next in line to be involved in the task, for example in the 
80 
prefrontal cortex part of the neurons were active during motor set 
or preparation whereas in the SMA part of the neurons were active 
during the execution of the movement (Fuster 1984, Ito 1982, Kurata 
and Tanji 1985, Tanji and Kurata 1985). 
From the above-mentioned findings and the known reciprocal cortico-
cortical connections (fig. 1.4) it appears as if behaviour is com-
pletely controlled by the interactions within the cortex. However, 
cortico-subcortical and subcortical-cortical projections also exist, 
of which the massive projections to the CN and PUT and via the GP 
and SNpr to the thalamus back to the cortex (figs. 1.5 and 1.7) sug-
gest that these areas may also be involved in the planning and exe-
cution of behaviour. An example of simultaneous neuronal activity of 
cortical and subcortical areas is given by Roland et al. (1982) with 
the rCBF method in humans performing a motor sequence task unilateral 
ly. Next to an increased rCBF bilaterally in the SMA, premotor area 
and parietal cortex and unilaterally in the sensory-motor cortex, 
the rCBF is moderately increased bilaterally in the CN, PUT and 
thalamic-subthalamic areas and ipsilaterally in the GP, whereas the 
rCBF is strongly increased in the contralateral GP. The disadvantage 
of the rCBF method is that no time-relation between the successive 
involvement of brain structures can be measured. With single cell 
recordings in monkeys, however, this time-relation can be esta-
blished (see below). 
Another important projection to the CN and PUT comes from the 
SNpc. Single cell recordings in the SNpc from monkeys during a 
visuomotor task revealed that neurons were active just before and 
after the execution of movement but were not related to a specific 
type of movement (DeLong et al. 1984, Schultz et al. 1983). Single 
cell recordings in the CN and PUT of monkeys during iontophoretic-
ally applied DA showed a decrease in spontaneous firing of a large 
number of neurons, whereas during a task an increase in activity 
is still seen (Rolls et al. 1984). Thus, it appears that DA plays 
a modulatory role on the firing threshold of the neurons in the 
CN and PUT, and is therefore involved in the setting of the func-
tional sensitivity of the CN and PUT. 
Single cell recordings from the CW have been done in monkeys 
performing a variety of tasks to demonstrate whether the pre-
dominantly associative cortical input to the CN (see table I.I, 
figs. 1.5 and 1.7) is either part of an internal feedback loop or 
part of a feedforward system in which the CN plays a role in 
planning and execution of behaviour. The finding that the neuronal 
activity in the CN of monkeys is related to movement rather than 
the initation of movement, was a motive for establishing the feed­
back role of the CN (Aldridge et al. 1980, Anderson et al. 1979). 
However, the learned task used in these studies was simple in the 
sense that both 'how to do it' and 'what to do' is answered be­
forehand and therefore (as will be described below) the initiatioo 
of movement is made within the cortex itself. In a visuomotor 
tracking task DeLong et al. (1984) found neurons in the CN which 
are not related to a specific type of movement just as in the SNpc 
is found, but again this task needed no internal decision of 'what 
to do' before the execution. Rolls and his colleagues (for review 
see Rolls 1984) did single cell recordings in the CN of monkeys 
during a visual discrimination task. In this task, the start is 
signalled by a visual or auditory stimulus to draw the monkey's 
attention, then discriminative visual cues appear, randomly indi­
cating a positive or negative reward. The monkeys have learned to 
make lick responses only after the positive reward cue, i.e. the 
monkeys have to decide 'what to do' after the discrimination cue. 
In addition single cell recordings are also made in the CN and 
the ventral striatum (NAcc and ОТ) during the presentation of 
visual stimuli unrelated to the task. It is found that in the 
head of the CN, as in the prefrontal cortex, neurons responded 
either to the visual warning stimulus, the auditory warning sti­
mulus, the positive reward cue or the negative reward cue. How­
ever, unlike the prefrontal cortex neurons, these CN neurons 
responded only when these stimuli and cues are task-related. In 
agreement with the other studies few neurons are found to respond 
in relation to the licking movements. In the tail of the CN the 
majority of the neurons responded only to visual stimuli in and 
apart from the task. These neurons did not discriminate between 
types of visual stimuli, but showed habituation when one visual 
stimulus was repeated several times in a row (Caan et al. 1984), 
in contrast to the neurons in the part of the visual (inferior 
temporal) cortex that projects to the tail of the CN (Ungerleider 
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et al. 1994, Weber and Yin 1984; see table 1.1). Dishabituation is 
easily established by giving an intervening stimulus. The neurons 
in the ventral striatum predominantly responded to novel and emo-
tion provoking (for example positive or negative reward) stimuli. 
From these data and particularly from the observation that the 
majority of the neurons in the CN are activated before the SMA, 
Rolls (1984) confirmed the results of the drug-induced effects 
(see behaviour: drugs): 
a) the head of the CN is involved in utilizing environmental 
stimuli that are cues in the preparation for initiation of move-
ments . 
b) The tail of the CN enables the detection of changes in the 
patterned (visual) stimuli in the environment. 
c) The ventral striatum is involved in behavioural responses to 
novel and emotion provoking visual stimuli, which influence it 
through its inputs from limbic structures (see also drugs: pro-
gramming behaviour). 
Since the primary sensory-motor cortex projects topographical-
ly and somatotopically to the PUT (see fig. 1.6) the role of the 
PUT in motor behaviour has been extensively investigated. I will 
present here the extensive findings of DeLong and co-workers 
(for review see DeLong et al. 1984) and add at some point the 
results of others. In general, single cell recordings are made 
under two conditions. First, monkeys had to perform a visuomotor 
tracking task with assisting and opposing loads (see Crutcher and 
DeLong 1984a, b). In this task the neuronal activity is measured 
related to movement direction (tracking) and/or movement force 
(loads). Simultaneously the electromyographic (EMG) activity is 
taken from the muscles of the active limb as a measure for the 
activity of the primary motor cortex. Second, separate body parts 
of the monkeys are passively moved to establish the specificity 
of sensory (proprioceptive) input to the PUT. It is found that a 
small percentage of the neurons changed their activity prior to 
the earliest changes in the EMG activity, thus before the activa-
tion of the primary motor cortex (Crutcher and DeLong 1984a, b, 
Evarts et al. 1984). In addition it is found that these neurons 
reacted to the stimulus (cue) only in relation to the task (cf. 
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CN; Evarts and Wise 1984). The majority of the neurons changed 
their activity before the movement, but after the first EMG act-
ivity and these responses are predominantly related to movement 
direction rather than movement force. A number of neurons responded 
to the proprioceptive stimuli from the load application with either 
a short latency or a long latency, whereas during the passive move-
ments activation is found only with a short latency. Different 
neurons responded to active and/or passive movements, the direction 
of the movements and the body parts involved in the movements 
(Crutcher and DeLong 1984a, b, Liles 1985). The distribution of 
these neurons confirmed the somatotopically leg, arm and face 
arrangement. Neurons responding to posture disturbances are found 
in all parts of the PUT (Anderson 1977). 
DeLong et al. (1984) and Evarts et al. (1984) concluded that: 
a) The neuronal activity prior to the first EMG activity as well a 
as the long latency responses to the load applications indicates 
that in the PUT movement can be encoded without effectors and af-
ferent feedback, i.e. the PUT plays a role in the initiation of 
movements. 
b) The PUT plays a role in the specification of parameters of 
movements, independent of the activity of specific muscles. 
c) The short-latency response to proprioceptive stimuli indicates 
that the PUT plays a role in ongoing movement. 
The above summarized data on neuronal activity in the cortex, the 
CN and PUT and the conclusions emerged from the studies with spe-
cific drugs (for review: Cools et al. 1984a) led Rolls to the 
following conclusions on the information flow from the cortex to 
the striatum and on the function of the striatum including the 
role of the dopaminergic projection: 
The full information represented in the cortex does not reach the 
striatum but rather, the striatum receives the output of the com-
putation being performed by a cortical area, and can use this to 
switch or alter behaviour. The striatum is particularly involved 
in the selection of behavioural responses, and in producing one 
coherent stream of behavioural output, with the possibility of 
switching if a higher priority input is received. Dopamine plays an 
important role in setting the sensitivity of this response selection 
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function. 
Both the CN and PUT project via the GP to the SNpr. Single 
cell recordings are made from GP neurons in monkeys during the 
same tests as described for the PUT (DeLong et al. 1985). It is 
found that the neurons responded before movement, but after the 
first EMG activity. The distribution of neurons related to spe-
cific movements confirm the somatotopic leg, arm and face ar-
rangement in the GP (fig. 1.6). Both in the task with load 
application and during passive movements, neurons showed a 
short-latency response, which was however longer than from the 
neurons in the PUT. Part of the neurons in the GP responded both 
during active and passive limb movements. Thus, the GP plays pre-
dominantly a role in ongoing behaviour by fitting in proprioceptive 
information (cf. also Aldridge et al. 1980). As already mentioned 
before, Roland et al. (1982) found differences between the changes 
of the rCBF in the ipsilateral and contralateral GP during the 
performance of a one hand task. Thus the bilaterally activated CN 
and PUT in co-operation with the cortical information send differ-
ent output to these parts of the GP. 
Finally, the role of the SNpr has also been studied with single 
cell recordings in monkeys. In a visuomotor task neurons responded 
to sensory stimuli and/or movement (Nishino et al. 1985, Schultz 
et al. 1983). The neuronal activity in the SNpr in relation to eye 
movements (saccades) is studied in monkeys, which are trained to 
remember the location of a spot of light that was presented briefly 
in the visual field while the monkey was looking at a different 
location. A later saccade is rewarded if it was to the location of 
the no-longer-present spot of light. It is found that different 
SNpr neurons responded during the sensory, motor and mnemonic pro-
cesses required to perform this task (for review: Evarts et al. 
1984). These effects underline a direct projection from the CN and 
PUT to the SNpr. 
As already mentioned at the beginning of this section, no real 
evidence exists concerning which part of which neuron was the 
target of the micro-electrode. Still, the changes in activity 
measured in the CN and PUT confirm the drug-induced effects. 
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Thus, each structure has its characteristic activity related to 
particular parts of the tasks. 
CONCLUDING REMARKS 
The flow of information from the entire cortex to the striatum 
provides the latter structure with all the changes in extero-
ceptive, proprioceptive and interoceptive stimuli. The importance 
of the cortical information is determined by the activity of the 
dopaminergic neurons from the SNpc, which sets the susceptibility 
of the striatal interneurons and efferents, whereas the complex 
intrinsic organization of the striatum, especially the arboriza-
tion of the axons within the striatum, (see table 1.4) plays a 
role in the inhibition of unwanted movements during the ongoing 
behaviour. 
From the data of the drug-induced effects on the behaviour of 
animals it can be concluded that the neuronal activity in the 
striatum determines the degree in which non-exteroceptive and 
exteroceptive stimuli are needed in programming motor and non-
motor behaviour. The electrophysiological data confirm that 
within the striatum an integration takes place of relevant ex-
teroceptive and non-exteroceptive information (input) into the 
'planning' (CN and PUT) and during the 'execution' (PUT) of 
movements (output), whereas the ventral striatum adds relevant 
mnemonic information to this function. In this way the striatum 
influences the degree of flexibility of the organism to cope with, 
i.e. survive in, its environment. 
Since lower-order structures also receive input from the cortex, 
but not as abundantly as the striatum, these structures can with 
additional exteroceptive information direct the behavioural 
switching. Therefore, with only a poorly functioning striatum an 
organism will still be able to change its behaviour. Thus, in 
order to conclude whether a drug-induced change in the behaviour 
of an organism is a result of influencing specifically the stria-
tum, a positive answer to the following question is needed on 
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beforehand: 
Is tue behavioural test suitable for revealing the specific 
involvement of the striatum? 
The primary goal needs to be the differentiation between effects 
which are characteristic but not specific for the striatum, i.e. 
effects that are specific for structures receiving information 
from the striatum, and effects which are characteristic and spe­
cific for the striatum (see Section II). 
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SECTION I I 

CHAPTER 3 
INTRODUCTION 
The validity of (animal) models of human neurological diseases 
can be assessed by three sets of criteria (cf. Willner 1984): 
Predictive vaiidity. The model correctly identifies the clinical 
treatments of pharmacological subtypes without making errors of 
omission or commission, and the potency in the model correlates 
with the clinical potency. 
Face validity. The model resembles the disease in a number of 
respects which are specific to the disease; the model should 
not show features which are not seen clinically. 
Construct validity. The behaviour in the model and the features 
of the disease being modelled can be unabiguously interpreted and 
are homologous, and the feature being modelled stands in an esta-
blished empirical and theoretical relationship to the disease. 
Examples of models with predictive validity are the tasks 
performed by human subjects which will be described in Chapter 8 
(Parkinson's disease: pathology). Since animals do not show pure 
'human' neurological disease, no animal model can completely ful-
fil the predictive and face validity. However, it is possible to 
develop animal models, which fulfil construct validity provided 
that the features of the disease being modelled have been esta-
blished. In this section animal models are used which are model-
ling features of a dys functioning striatum in human neurological 
disease (see Chapters 8 and 9). 
The neuronal circuitry with the striatum as a centre is an 
example of complex neuronal integration within the brain (Chapter 
1). The flow of information from the entire cortex and numerous 
subcortical structures to the striatum (input neurons) provides 
the latter structure with all the changes which take place in 
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other parts of the brain and the remainder of the body (non-
exteroceptive stimuli) as well as the environment (exteroceptive 
stimuli). The importance of the cortical information is deter-
mined by the activity of the dopaminergic neurons from the 
substantia nigra, pars compacta, which sets the striatal inter-
neurons and output neurons (efferente) to the cortical input 
(Rolls et al. 1984). The information from all the afférents is 
intermingled by the complex intrinsic organization of the striatum. 
The bundle of output neurons carries the resultant of this integra-
tion via the globus pallidus towards the substantia nigra, pars re-
ticulata (Chapter 1; Gerfen 1985). Beyond these structures neurons 
carry 'information' (back) to numerous cortical and subcortical 
structures (cf. figs. 1.7 and 2.2), which, in turn, influence the 
so-called effector-organs, for example the motor apparatus there-
by inducing changes in behaviour. Thus, changes in neuronal activity 
in the striatum may influence behaviour. 
The observation that a dysfunctioning striatum in man and 
animals causes disturbances in motor behaviour is used to classify 
the striatum to be concerned with some aspect of motor control 
(for review, see Marsden 1980, 1982a, 1984). The finding that 
sensory input influences neuronal activity in the striatum has 
led to the theory of a sensory information gating station (for 
review, see Schneider 1984). Others, however, have claimed that 
the striatum, by its abundant cortical input, as to mediate func-
tions which are not easily labelled either sensory or motor, but 
rather 'higher-order' or 'programming' (Cools et al. 1981, 1984c) 
or 'cognitive' (Divac 1984, Öberg and Divac 1981). Thus, a dis-
turbance of striatal function may appear at the motor level, but 
one has to search for the cause of that disturbance. 
Numerous studies have revealed that changes in neuronal act-
ivity in the striatum of animals induce changes in behaviour (for 
details see Chapter 2). Moreover, it has been found that the 
majority of the behavioural changes may also be induced by changes 
in neuronal activity of other brain structures through which stria-
tal output is funneled, e.g. globus pallidus, subthalamic nucleus, 
substantia nigra (pars reticulata), thalamus, superior colliculus 
(deeper layers) and reticular formation (Chapter 2, behaviour: 
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drugs). It has also been found that the abundant input of non-
exteroceptive and exteroceptive stimuli from the cortex (Chapter 
2, behaviour: neuronal activity) gives the striatum the opportun-
ity to play a unique role in behaviour: determining the degree of 
flexibility of the organism to cope with its environment. In other 
words, neuronal activity in the striatum determines the degree in 
which non-exteroceptive and exteroceptive stimuli are used in pro-
gramming motor and non-motor behaviour, i.e. changing ongoing 
behaviour. However, by using exteroceptive stimuli other structures 
in the brain are also found to change ongoing behaviour (for review: 
Cools et al. 1984c). Therefore further experiments are needed to 
determine the characteristic and specific function of the striatum 
in programming motor and non-motor behaviour. 
Since little research on programming non-motor behaviour 
directed by non-exteroceptive stimuli has been conducted, this was 
studied in depth in the first set of experiments (Chapter 4). For 
that purpose the behavioural effects of intrastriatally applied 
drugs were analyzed in rats placed in an experimental condition 
which demands programming non-motor behaviour directed by non-
exteroceptive stimuli. In addition, attention was paid to the 
complex intrinsic organization of the striatum by delineating 
the influence of dopaminergic input neurons, cholinergic inter-
neurons and GABA-ergic output neurons on programming non-motor 
behaviour. 
Non-exteroceptive stimuli can be divided into two groups of 
stimuli: proprioceptive, i.e. signals emanating from muscles, 
tendons and joints, and interoceptive, i.e. signals emanating 
from the interior of the body (Chapter 2). Since the results of 
Chapter 4 did not provide further information on the contribution 
of the type of non-exteroceptive stimuli on programming non-motor 
behaviour a second set of experiments was performed to study the 
function of the striatum in the ability to use static proprio-
ceptive, i.e. non-exteroceptive, stimuli in programming behaviour 
(Chapter 5). For that purpose the behavioural effects of intra-
striatally applied GABA-ergic drugs were analyzed in rats placed 
in experimental conditions which demand the use of static pro-
prioceptive stimuli in programming motor behaviour. 
93 
The last two sets of experiments were performed to establish 
the relation between the role of the striatum in programming non-
motor behaviour (Van den Bereken 1979, Chapter 4), programming 
motor behaviour (Jaspers et al. 1984, Chapter 5) and motor dis-
turbances (Van den Bereken 1979, Chapter 2) directed by non-
exteroceptive stimuli within the same animals. For that purpose 
the behavioural effects of intracaudate injections of increasing 
doses of carbachol (a cholinergic agonist) were analyzed in Java 
monkeys tested in: 
a) a freely moving and socially interacting condition (Van den 
Bereken 1979), 
b) an isolated and restrained condition (Chapter 6), and 
c) a freely moving and isolated condition (Chapter 7). 
In the latter two conditions no demands were put on the Java 
monkeys with respect to programming behaviour. 
94 
CHAPTER 4 
DIFFERENTIAL EFFECTS OF STRIATAL INJECTIONS OF DOPAMINERGIC, 
CHOLINERGIC AND GABA-ERGIC DRUGS UPON SWIMMING BEHAVIOUR OF RATS 
ABSTRACT 
The present study provides a detailed report about similarities and 
dissimilarities between the effects of neostriatally applied dopa-
minergic (apomorphine, 250-300 ng; haloperidol, 250-500 ng), cholin-
ergic (carbachol, 50-100 ng; scopolamine, 200-500 ng), and GABA-
ergic (muscimol, 1-2 ng; bicuculline, 5-35 ng) drugs upon swimming 
behaviour of rats. The used swimming test (Cools 1980) consisted 
out of 4 parts: A) open-field test for analyzing drug-induced 
changes in normal behaviour, B) 'swimming without escape' test for 
analyzing drug-induced changes in the ability to switch from one 
type of behaviour to another, C) 'swimming with escape' test for 
analyzing drug-induced changes in the ability to switch from on-
going swimming behaviour to climbing behaviour by allowing the rats 
to escape via a rope, and D) 'rope' test for analyzing drug-induced 
changes in the kind of contact behaviours needed to switch to the 
latter climbing behaviour. In the open-field test the drugs pro-
duced neither abnormal behaviour nor motor disturbances which pre-
vented the display of normal behaviour in the remaining tests. 
Both apomorphine and carbachol produced identical effects in all 
tests. Muscimol produced overall effects which were not only op-
posite to those of apomorphine and carbachol, but also comparable 
to those of scopolamine. All effects elicited by apomorphine, car-
bachol and muscimol were antagonized by their corresponding antag-
onists: haloperidol, scopolamine and bicuculline resp., whereas 
the effects of the latter were suppressed by their corresponding 
agonists. These data globally show that dopamine and acetylcholine 
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act in the same direction but opposite to that of GABA as far as it 
concerns the regions investigated. The finding that haloperidol in­
jected into the GABA target area produced effects which were not 
only similar to those of haloperidol injected into the dopamine 
target area, but also dissimilar to those of muscimol and bicu-
culline injected into the GABA target area, shows that the effects 
were drug-specific rather than region-specific. Though three dis­
tinct cholinergic regions were investigated, cholinergic-specific 
effects could only be elicited from one region suggesting that the 
neostriatum is heterogeneous in this respect. 
Finally, well-delineated dissimilarities between haloperidol-, 
scopolamine-, and muscimol-treated rats were found in the rope 
test. These data show that behaviour-relevant information trans­
mitted by GABA-ergic drugs surmounted that transmitted by cholin­
ergic drugs which, in turn, surmounted behaviour-relevant infor­
mation transmitted by dopaminergic drugs. 
INTRODUCTION 
Several years ago Marshall and Berrios (1979) as well as Cools 
( I9B0) described the effects of intrastriatal micro-injections of 
dopaminergic drugs on swimming behaviour of rats. Cools found that 
rats, forced to swim in an inescapable situation, displayed two 
classes of behaviour: one class of items which were directed by 
sensory input, іг. exteroceptively directed behaviours, and one 
class of items which were not directed by sensory input, viz. 
non-stimulus directed behaviour (Cools 1985, Cools et al. 1984a). 
Enhancing the dopaminergic activity in the neostriatum increased 
the rat's ability to switch to non-stimulus directed behaviours. 
Reducing the dopaminergic activity in the neostriatum suppressed 
the rat's ability to switch to non-stimulus directed behaviours 
and made the rat more dependent on exteroceptive stimuli as shown 
by the increased amount of exteroceptively directed behaviours. 
Intracaudate injections of cholinergic drugs in Java monkeys 
elicited effects on the social behaviour of these monkeys which 
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were comparable to the above-mentioned phenomena (Van den Bereken 
and Cools 1982). Both in the rat and monkey studies an enhanced 
neurotransmission of either dopamine (DA) or acetylcholine (ACh) 
was found to increase the animal's ability to switch to non-stimu-
lus directed behaviour, whereas a reduced neurotransmission of DA 
or ACh was found to make the animals more dependent on exteroceptive 
stimuli. Recent experiments on motor behaviour of cats are in agree-
ment with these results (Jaspers et al. J984). 
The neostriatum of rats is a heterogeneous structure: it con-
tains a diversity of neurotransmitters such as DA, ACh and gamma-
aminobutyric acid (GABA) (Graybiel and Ragsdale 1983). These 
neurotransmitters are located in afferent, intrinsic or efferent 
neurons (Graybiel and Ragsdale 1979). Dopaminergic afférents pro-
ject on cholinergic interneurons and/or GABA-ergic efferents. The 
cholinergic interneurons were found to be the targets of either a 
suppressing (Bartholini 1980, Consolo et al. 1974, Scheel-Krüger 
1985, Stoof et al. 1979, Trabucchi et al. 1975) or an activating 
(Cools et al. 1975a, Howard and Garcia-Rill 1983, Scheel-Krüger 
1985, Westermann 1981, Wolfarth and Kolasiewicz 1977) influence 
of DA. These two types of interaction between DA and ACh seem to 
be located in different areas of the neostriatum (Cools 1977, 
Scheel-Krüger 1985). Furthermore, stimulation of the dopaminergic 
or cholinergic neurons in the neostriatum was found to produce an 
activation of GABA-ergic efferents in one part of the neostriatum, 
but a suppression of GABA-ergic efferents in another part of the 
neostriatum (Besson et al. 1982, Cools and Janssen 1976, Herrera-
Marschitz and Ungerstedt 1982, Scheel-Krüger 1983, Slater and 
Dickinson 1982). Accordingly, the behaviour effects of neostria-
tally applied dopaminergic drugs can be expected to require 
cholinergic interneurons and/or GABA-ergic efferents for their 
expression. Given this starting point it is reasonable to assume 
that the effects elicited by dopaminergic, cholinergic and GABA-
ergic drugs will show certain similarities. Therefore, the present 
study deals with a detailed analysis of similarities and dissimi-
larities between the effects of neostriatally applied dopaminergic, 
cholinergic and GABA-ergic drugs with the help of a very sensitive 
behaviour test, viz. the swimming test (Cools 1980). Because of the 
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lack of details about the micro-circuitry within the neostriatum, 
the known sensitivity of distinct parts of the neostriatum for 
each set of compounds served as criterion for selecting the target 
structures. It will be evident that all these target structures 
should form part and parcel of the region containing terminals of 
dopaminergic nigrostriatal afférents. The dopaminergic target re-
gion was located in the most rostral, latero-dorsal part of this 
terminal field within the neostriatum (Albanese and Minciacchi 
1983, Beckstead et al. 1979, Fallon and Moore 1978), viz. a region 
in which DA is functionally effective (Ellenbroek et al. 1985b). 
One cholinergic target region was located in a less rostral, medio-
dorsal part of this terminal field within the neostriatum (Albanese 
and Minciacchi 1983, Beckstead et al. 1979, Fallon and Moore 1978), 
viz. the 'dorsal' region in which DA was found to facilitate the 
function of the cholinergic fibres (Scheel-Krüger 1985). A second 
cholinergic region was located in a less rostral, medio-ventral 
part of this terminal field within the neostriatum (Albanese and 
Minciacchi 1983, Beckstead et al. 1979, Fallon and Moore 1978), 
viz. the 'ventral' region in which DA was found to suppress the 
function of cholinergic fibres (Scheel-Krüger 1985). The GABA-
ergic region was located in a less rostral and more medial part of 
this terminal field on the border of the neostriatum and the palli-
dum (Albanese and Minciacchi 1983, Beckstead et al. 1979, Fallon 
and Moore 1978), viz. the region in which GABA was found to be 
functionally effective (Scheel-Krüger 1983, Turski et al. 1984). 
Since the primary goal of this study was to investigate whether 
the effects elicited by dopaminergic, cholinergic and GABA-ergic 
drugs are similar or dissimilar, no detailed mapping of the neo-
striatum was intended. Still, two additional series of experiments 
were performed in order to exclude the following possibilities. 
First, the efficacy of a particular neurotransmitter might differ 
per striatal subregion. And, second, the elicited effects might 
be characteristic of the subregion under study rather than of the 
drug used. As mentioned above, there are at least two distinct 
cholinergic-sensitive regions marked by the opposite effects of 
DA upon ACh. Therefore, we studied both regions including the 
intercalated region (the so-called 'middle' region) as far as it 
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concerned the cholinergic drugs. In order to exclude that the sub-
region rather than the drug might determine the effects we also 
studied the effects of dopaminergic and GABA-ergic drugs within one 
and the same subregion, viz. the above-mentioned GABA region. 
By using the swimming test we were able to detect subtle dif-
ferences between the influence of the three neurotransmitters. It 
was found that behaviour-relevant information transmitted by GABA-
ergic drugs surmounted that transmitted by cholinergic drugs which, 
in turn, surmounted behaviour-relevant information transmitted by 
dopaminergic drugs. Moreover, it was found that DA and ACh acted in 
the same direction but opposite to that of GABA. 
MATERIALS AND METHODS 
Animals 
Male Wistar rats weighing 190+20 gr at the time of operation were 
anaesthetized with sodium pentobarbital (60 mg/kg, i.p.) and placed 
in a stereotaxic apparatus. All rats were implanted bilaterally 
with two stainless steel guide cannulas aimed at the neostriatum. 
After the operation the rats were allowed to recover for at least 
10 days in a temperature controlled room illuminated from 6.00 
a.m. to 6.00 p.m. Food and water were given ad libitum, except 
during the testing periods. Each rat had its own home cage. On 
completion of the behavioural studies the rats were deeply anaes-
thetized with pentobarbital, their brains were removed and fixed 
in formalin, then sectioned and stained (cresyl violet) to deter-
mine the injection sites, which were found in the following regions: 
DA region 
'dorsal' ACh region 
'middle' ACh region 
'ventral' ACh region 
GABA region 
A 8.6-8.9, L 2.2-2.6, D 1.2-1.6 
A 6.6-7.2, L 2.6-3.4, D 0.8-1.6 
A 6.6-7.2, L 2.6-3.4, DV (-0.5)-0.8 
A 6.6-7.2, L 2.6-3.4, V 0.6-1.2 
A 6.7-7.0, L 2.2-3.2, V 0.0-1.0 
(figs. 4.1, 4.2, 4.3; according to König and Klippel (1963)). 
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Fig. 4.1 Frontal sections of the rat bram according to Konig 
and Klippel (1963), illustrating the DA target region 
(shaded areas, according to Cools (1980)). 
Experimental procedure 
At the beginning of the experiments the rats received bilateral 
intrastriatal injections of either the solvent of each drug (dis­
tilled water) or one of the following drugs: the dopaminergic ag­
onist apomorphine (apomorphine chloride; Brocades), the dopamin-
ergic antagonist haloperidol (Serenase ; Janssen Pharmaceutica), 
the cholinergic agonist carbachol (carbamylcholine chloride; 
Sigma), the cholinergic antagonist scopolamine (scopolamine 
hydrobromidum; De Onderlinge Pharmaceutische Groothandel), the 
GABA-ergic agonist muscimol (Serva) and the GABA-ergic antagonist 
bicuculline (bicuculline methiodide; Pierce). The specificity of 
the cholinergic and GABA-ergic effects was determined by a single 
injection of carbachol and scopolamine (separate injections led 
to motor deficits) resp. separate injections of bicuculline and 
muscimol with a time interval of 5 min. The injections (0.5 μΐ 
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Fig. 4.2 Frontal sections of the rat brain according to König 
and Klippel (1963), illustrating the ACh target regions 
α . injections restricted to the 'dorsal ' region * 
О injections restricted to the 'middle ' region * 
Δ . injections restricted to the 'ventral' region * 
ι = the number of injection sites shown per side dif­
fers because of overlap in one, but not the other, side. 
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Fig. 4.3 Frontal sections of the rat brain according to König 
and Klippel (1963), illustrating the GABA target 
region (see also fig. 4.2) 
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per side) were given free-hand to non-restrained, conscious animals 
by means of a Hamilton syringe with the needle placed 0.5-2.5 mm 
below the guide cannula. The injection itself lasted 10 sec, where­
as the needle was held on its place for an additional period of 10 
sec. Since motor disturbances could be expected to affect the swim­
ming behaviour per se, pilot experiments were performed to select 
doses which did not produce gross motor disturbances. For that 
reason the following doses were used: apomorphine: 250-300 ng, 
haloperidol: 250-500 ng, carbachol: 50-100 ng, scopolamine: 200-
500 ng, muscimol: 1-2 ng, and bicuculline: 5-35 ng. 
Following their drug treatment the rats were immediately 
transferred to an empty cage (38 χ 26 χ 14 cm), identical to their 
home cage; however, food, water and characteristic smells were now 
absent (test 1 open-field, see below). The swimming test was started 
5 min later. Use was made of a cylindrical, perspex tank (height 
47 cm, diameter 34 cm) filled with warm water (30 C) kept on tem­
perature by means of a thermostat (fig. 4.4a; test 2 'swimming 
without escape', see below). Six minutes later a rope (diameter 
2 cm) consisting of a rigid and a flexible part was introduced 
(fig. 4.4b). The rigid part was centered 20 cm above the midpoint 
of the tank and the flexible part hanged perpendicularly downwards 
into the centre of the tank (test 3 'swimming with escape', see 
below). Two minutes later the rats were directly confronted with 
9 Э 
A В 
Fig. 4.4 Schemes of the experimental set-up in: 
A. the 'swimming without escape' test 
B. the 'swimming with escape' test 
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the rope if necessary. The experiments were recorded and analyzed 
with the help of a video set-up. All rats were used only once. 
Since the swimming test was primarily used for analyzing 
drug-induced effects upon the ability of rats to switch from one 
behaviour to another, we have selected a restricted set of depend-
ent variables (see below). Accordingly, drug-induced effects on 
classic parameters such as duration and incidence of single behav-
ioural items were only taken into account when they provided rel-
evant information in the above-mentioned sense. 
Behavioural tests 
A
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The behaviour displayed in the home-like cage was quantitatively 
analyzed, checking 1) the presence of behavioural items which are 
characteristic of normal rats (table 4.1A), and 2) the putative 
presence of motor disturbances (table 4. IB). This test lasted 5 
min. 
В. 'Swiniming_without_esca2e ' test 
The swimming test was started by bringing the snout of the rats, 
held by their tail, to a distance of 30 cm above the surface of 
the water and, then, dropping them into the water. After a period 
of environmentally oriented swimming behaviour, viz. exterocept-
ively directed behaviour (table 4.2A), the rats displayed a number 
of non-stimulus directed behaviours. In fact, the rats forced to 
swim in a stable environment from which there was no escape did 
not cling anymore to exteroceptive stimuli such as the wall, 
bottom or surface, but started to switch to behaviours which were 
at best guided, but not directed, by exteroceptive stimuli (table 
4.2B). This latter swimming behaviour was both qualitatively and 
quantitatively analyzed. Three dependent variables were chosen: 
a) 'variability' defined as the presence of more than two differ­
ent non-stimulus directed behavioural items, b) 'continuous sink­
ing' defined as the presence of sinking behaviour for a period of 
1 min, and c) 'continuous planing' defined by the presence of 
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TABLE 4. 1 
Test 1: open-field; glossary of normal 
behavioural items and motor disturbances 
A. 'Normal' behaviour 
lying down, sitting, walking, rearing, scanning, grooming snout, 
grooming body, grooming genitals, sniffing air, object sniffing, 
licking and gnawing 
B. Motor disturbances 
adduction of the limbs, abduction of the limbs, tremor, torti-
collis, tongue protrusion, blepharoptosis, catalepsy, uncoor-
dinated movements, and uncoordinated movement patterns 
planing behaviour for a period of 30 sec. The test came to an end 
after the performance of 'continuous planing' or after 6 min counted 
from their first contact with the water in case the rats were unable 
to reach the planing criterion. 
C. 'Swimming_with escape^ test 
At the end of the 'swimming without escape' test the rope was 
placed in position. The behaviour following this intervention was 
analyzed during a 2 min period in a quantitative manner. The de-
pendent variable was defined as the presence of 'successful escape'; 
a rat was considered to show 'successful escape' when the hindlimbs 
came above the surface. The purpose of this analysis was to de-
tect to which degree a well-defined change in exteroceptive stimuli 
could be used for switching the ongoing behaviour to exteroceptively 
directed behaviour. 
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TABLE 4.2 
Test 2: 'swimming without escape'; glossary of behavioural items 
A, Exteroceptively directed behaviour (for definition, see text) 
- scanning the wall : swimming against the wall, sniffing the 
air above the surface and trying to 
cling to the wall with the nails of the 
forepaws 
- scanning the air : swimming through the tank while sniffing 
in the air 
- scanning the bottom: diving to and swimming along the bottom 
B. Non-stimulus directed behaviour (for explanation, see text) 
- swimming along the side of the wall 
- swimming in circles free from the wall 
- treading water in the centre 
- treading water while keeping contact with the wall 
- sinking: immobile sinking following the disappearance of the 
snout under the surface 
- planing: keeping the head above the surface and the forelegs 
immobile in front while having a spherical shaped 
body and making nearly no movements with the hind-
legs 
Rats showing no escape within the time limit of test 3 were pur-
posely brought into contact with the rope. The behaviour following 
the contact with the rope was analyzed in a quantitative manner; 
the dependent variable, viz. 'contact behaviour', was defined as 
the presence of switching to rope climbing following visual, 
snout, foreleg or hindleg contact. The purpose of this analysis 
was to detect drug-induced changes in the degree in which the 
rats needed exteroceptive information to switch from their ongo-
ing behaviour to the rope climbing behaviour. 
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The outcome of the tests on the effectiveness of the dopaminergic, 
cholinergic and GABA-ergic injections into the mentioned target 
regions was compared with the outcome of identical dopaminergic 
manipulations reported earlier (Cools 1980). In addition, the ef-
fects of haloperidol injected into the GABA region were analyzed. 
Statistics 
Use was made of the Fisher exact probability test with Yates cor-
rection (two-tailed). 
RESULTS 
Test 1 : open-field 
All behaviours shown by the corresponding controls in the open-
field were also displayed by the drug-treated rats. In table 4.3 
the percentages of the rats showing the only motor disturbance 
observed, viz. adduction of the hindlimbs, are given. As will be 
discussed later, these motor disturbances did not lead to equi-
vocal interpretations of the outcome of the swimming tests. 
Effects of cholinergic drugs in the dorsal region resp. ventral 
region 
The specificity of the cholinergic injection site was determined 
by injecting either the solvent, carbachol or scopolamine (resp. 
100 ng and 500 ng) in the dorsal or ventral region (fig. 4.2). 
In tables 4.4A and 4.4B the results of these experiments are 
given. The drug-treated rats were compared to their own controls. 
Dorsal region 
Carbachol increased 'successful planing', whereas both carbachol 
and scopolamine decreased 'continuous sinking'. 50% of the car-
bachol-treated rats performed 'successful escape': they needed 
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TABLE 4.3 
Percentage of rats showing adduction of the hindlimbs in test 1 
drug 
AD 
APO 
APO 
HALO 
HALO 
HALO 
+ 
APO 
DA region 
dose 
(ng) 
-
250 
300 
250 
500 
250 
300 
Ν 
10 
9 
9 
7 
7 
9 
% 
0 
0 
0 
0 
57.2 
0 
'middle' ACh 
drug 
AD 
CARB 
CARB 
SCOP 
SCOP 
SCOP 
+ 
CARB 
SCOP 
+ 
CARB 
dose 
(ng) 
-
50 
100 
200 
500 
100 
100 
500 
100 
reg 
N 
10 
7 
8 
7 
7 
8 
8 
ion* 
% 
0 
ih. 
25. 
0 
0 
12. 
0 
,3 
,0 
5 
drug 
AD 
MS С 
MSC 
BMI 
BMI 
BMI 
+ 
MSC 
BMI 
+ 
MSC 
GABA reg. 
dose 
(ng) 
-
1 
2 
5 
35 
5 
2 
35 
2 
ion 
Ν 
15 
6 
7 
β 
7 
7 
7 
% 
0 
0 
0 
0 
0 
0 
0 
* - none of the injections into the 'dorsal' and 'ventral' ACh region induced 
adduction of the hindlimbs 
Abbreviations: DA = dopamine, ACH = acetylcholine, GABA = gamma-aminobutyric 
acid, AD = distilled water, APO =• apomorphine, HALO = halo-
pendol, CARB = carbachol, SCOP = scopolamine, MSC = muscimol, 
BMI = bicucullme 
only visual contact with the rope to switch to climbing behaviour. 
The rest of the carbachol-treated rats as well as all scopolamine-
treated rats needed snout contact to switch to climbing behaviour, 
either within the time limit of test 3 or after confronting them 
with the rope. Since both carbachol and scopolamine elicited iden­
tical effects with respect to three out of five dependent variables, 
viz. 'variability', 'continuous sinking' and 'contact behaviour', 
the cholinergic specificity of the effects elicited from this dorsal 
region was evidentially equivocal. Therefore, these effects will not 
be considered further. 
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TABLE 4.4A 
Behavioural effects of cholinergic drugs injected into the 
'dorsal', 'middle' resp. 'ventral' region of the neostriatum 
of the rat on the dependent variables of the swimming test 
Neostriatal injection 
drug dose N 
(ng) 
Ζ of rats performing 
successful successful 
planing escape 
variability continuous 
(> 2 items) sinking 
'dorsal' 
control 
CARB 100 
SCOP 500 
'middle' 
control 
CARB 100 
SCOP 500 
'ventral' 
15 
8 
8 
10 
8 
7 
0 
37.5 
0 
20.0 
87.5» 
0 
13.3 
50.0 
12.5 
10.0 
75.0* 
0 
33.3 
75.0 
62.5 
70.0 
87.5 
0* 
73.3 
12.5 
0 
40.0 
0 
100.0 
control 10 
CARB 100 7 
SCOP 500 7 
30.0 
0 
0 
30.0 
14.3 
28.6 
30.0 
85.7 
71.4 
* - significantly different from corresponding control group (p < 0.05) 
For abbreviations, see table 4,3 
Injections of carbachol and scopolamine in this region increased 
'continuous sinking', although no statistical significance was 
reached. All carbachol- and scopolamine-treated rats needed snout 
contact to switch from their ongoing behaviour to climbing behav­
iour, either within the time limit of test 3 or after confronting 
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TABLE 4.4В 
Behavioural effects of cholinergic drugs injected 
into the 'dorsal', 'middle' resp. 'ventral' region 
of the neostriatum of the rat on the dependent 
variable 'contact behaviour' in the 'rope' test 
Neostriatal injection 
drug dose N 
(ng) 
'switching' to climbing requiring: 
a b b+c b+c+d 
'dorsal' 
control 15 
CARB 100 8 
SCOP 500 8 
13.4 
50.0 
12.5 
59.9 
25.0 
75.0 
6.7 
25.0 
12.5 
20.0 
0 
0 
control 
CARB 
SCOP 
control 
CARB 
SCOP 
'middle' 
100 
500 
'ventral' 
100 
500 
10J 
8 
7 
10 
7 
7 
10.0 
100.0 
0 
30.0 
0 
0 
50.0 
0 
0 
20.0 
0 
100.0 
50.0 
100.0 
71.4 
20.0 
0 
14.3 
10.0 
0 
0 
0 
0 
14.3 
* = one rat did not climb after the usual procedure of offering the 
rope 
Abbreviations: a = visual contact, b = snout contact, с = foreleg 
contact, d = hindleg contact 
for the other abbreviations, see table 4.3 
them with the rope. Again, the effects of carbachol and scopol­
amine showed more similarities than dissimilarities. Therefore, 
these effects too will not be considered further in the remainder 
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of this section. As it will be shown below, the effects of carba-
chol and scopolamine elicited from the 'middle' region were not 
only dissimilar, but also counteracting each other. Accordingly, 
only the effects elicited from the latter region will be com-
pared with those elicited by dopaminergic and GABA-ergic drugs. 
Effects of dopaminergic, cholinergic and GABA-ergic drugs injected 
in their corresponding sensitive target regions 
Test_2¿_'swimming withoyt_esca£e' 
General. During the initial period marked by the display of ex-
teroceptively directed behaviour, all rats independent of their 
treatment behaved similar: they all displayed normal, exterocept-
ively directed behaviour. 
As shown in fig. 4.5A the control group of the rats treated with 
dopaminergic drugs differed from the other control groups during 
the period marked by the display of non-stimulus directed behav-
iour, viz. the period during which the differential effects of 
the various drugs became apparent. The 'variability' of the con-
trol group of the dopaminergic-treated rats was significantly 
lower than that of the remaining control groups (p < 0.005). 
Hence, the results of each drug-treated group were compared with 
those of their own control group. 
Both apomorphine and carbachol increased the display of non-sti-
mulus directed behaviours and ultimately elicited 'continuous 
planing'. Muscimol, on the contrary, inhibited the display of 
non-stimulus directed behaviour. The rats kept in touch with the 
wall and sank continuously. When their tail and/or hindlegs ac-
cidently touched the bottom, they could swim to the surface; then 
they sank again to the bottom, etc. Both haloperidol and scopol-
amine inhibited the non-stimulus directed behaviours. Haloperidol-
treated rats performed just one behavioural item, which varied 
from rat to rat. But unlike haloperidol, scopolamine increased 
'continuous sinking'. As soon as their head and forelegs became 
below the surface, the rats did swim to the surface; then, they 
sank again, etc. The rats remained in the vicinity of the wall. 
I l l 
Bicuculline-treated rats performed a particular kind of behaviour. 
They permanently changed their ongoing behaviour while swimming 
vigorously through the water and/or along the side of the wall, 
with their nose just above the surface. This behaviour had a 
stereotyped character in the sense that it was normally not dis-
turbed by relevant exteroceptive information such as contact with 
the wall or the rope. 
The dependent variables. Apomorphine increased the 'variability' 
the effect of which was antagonized by haloperidol; the dopaminergic 
drugs did not elicit 'continuous sinking' (figs. A.5A and 4.5B) 
(Cools 1980). Scopolamine (dose-dependently) and muscimol (both 
doses) decreased the 'variability' and increased 'continuous 
sinking' (figs. 4.5A and 4.5B). The effects of scopolamine were 
suppressed by carbachol; the effects of muscimol were dose-de-
pendently antagonized by bicuculline. Apomorphine and carbachol 
(dose-dependently) increased 'continuous planing'; these effects 
were antagonized by their corresponding antagonists haloperidol 
and scopolamine. Muscimol had no effect on this variable (fig. 
4.5C). Although bicuculline-treated rats showed planing, they 
were not able to maintain this behaviour until the criterion of 
30 sec was reached (see above). 
Test 3¿_'swiniming_with_escage ' 
A variety of behaviours was displayed after the introduction of 
the rope. A detailed description is given in the following para-
graph. Here we just summarize the effects of the treatments on 
the dependent variable 'successful escape' (fig. 4.5D). The three 
control groups differed very little: nearly no rat performed 
'successful escape'. Both apomorphine and carbachol increased 
dose-dependently 'successful escape'; these effects were antag-
onized by their corresponding antagonists haloperidol and sco-
polamine. Muscimol decreased 'successful escape', but this effect 
did not reach statistical significance. Since bicuculline-treated 
rats permanently changed their ongoing behaviour, the rats rarely 
terminated the whole sequence of climbing into the rope: once 
grasping the rope with the forelegs, the rats often released it 
before the hindlegs came above the surface. 
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4.SA Behavioural effects of intrastriatal injections 
of dopaminergic, cholinergic (into the 'middle' 
region) and GABA-ergic drugs on the 'variability' 
in the 'swimming without escape' t e s t . 
For ab i rev ia t ions . · see table 4.3 
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7o rats continuous sinking 
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5B Behavioural effects of intrastriatal injections 
of dopaminergic, cholinergic (into the 'middle' 
region) and GABA-ergic drugs on the dependent 
variable 'continuous sinking' in the 'swimming 
without escape' test. 
For abbreviations: see table 4.3 
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Fig. 4.5C Behavioural effects of intxastriatal injections 
of dopaminergic, cholinergic (into the 'middle' 
region) and GABA-ergic drugs on the dependent 
variable 'continuous planing' in the 'swimming 
without escape' test. 
For abbreviations: see table 4.3 
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%rats successful escape 
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SD Behavioural effects of intrastriatal injections 
of dopaminergic, cholinergic (into the 'middle' 
region) and GABA-ergic drugs on the dependent 
variable 'successful escape' in the 'swimming 
with escape' test. 
For abbreviations: see table 4.3 
Test_4:_ІЕ0ЕЁІ_'ез£ 
The data are given in table 4.5. All control rats were capable of 
climbing in the rope. The different kinds of contact needed to 
switch from the ongoing behaviour to climbing behaviour, however, 
were heterogeneously distributed throughout the distinct control 
groups. They performed this 'contact behaviour' either within the 
time limit of test 3 or after being confronted with the rope. 
Drug-treated rats too were capable of climbing in the rope. How-
ever, the heterogeneity of different kinds of 'contact behaviour' 
disappeared. Moreover, each distinct group of drug-treated rats 
showed a single type of 'contact behaviour'. Apomorphine- as well 
as carbachol-treated rats showed 'successful escape' and, there-
fore, grasped the rope of their own accord. These rats just needed 
visual contact with the rope in order to switch their ongoing be-
haviour to climbing behaviour. On the other hand, all haloperidol-
treated rats needed snout contact to switch to climbing behaviour. 
They performed this contact either within the time limit of test 3 
or after being confronted with the rope. Scopolamine-treated rats 
not only needed snout contact but also foreleg contact to switch 
their ongoing behaviour to climbing behaviour; this was only per-
formed after being confronted with the rope. Muscimol-treated rats 
needed snout, foreleg and hindleg contact to switch to climbing 
behaviour; in this case too, this was only performed after being 
confronted with the rope. A small percentage of the bicuculline-
treated rats interrupted their ongoing stereotyped behaviour after 
visual contact with the rope (5 ng: 38.1%; 35 ng: 28.6%). The re-
mainder of these rats sometimes grasped the rope, but never 
finished the full sequence of movements in order to climb in the rope. 
Effects of haloperidol in the GABA-ergic target region 
Haloperidol (250 ng, n=7) injected into the GABA-ergic target re-
gion inhibited non-stimulus directed behaviour. The rats showed 
only one behavioural item, which varied from rat to rat. Analysis 
of the effects on the dependent variables shows the following: no 
variety of non-stimulus directed behaviour (n-6), no 'continuous 
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TABLE 4.5 
Behavioural effects of intrastriatal injections 
of dopaminergic, cholinergic ('middle') and 
GABA-ergic drugs on the dependent variable 
'contact behaviour' in the 'rope' test 
Intrastriatal 
drug 
Controls: 
APO/HALO 
CARB/SCOP* 
MSС/BMI 
HALO 
SCOP 
MSC 
APO 
CARB 
BMI 
HALO 
+ 
APO 
SCOP 
+ 
CARB 
SCOP 
+ 
CARB 
BMI 
+ 
MSC 
BMI 
+ 
MSC 
injection 
dose 
(ng) 
250 
500 
2 
300 
100 
35 
250 
300 
100 
100 
500 
100 
5 
2 
35 
2 
N 
10 
10 
15 
7 
7 
7 
9 
β 
7 
9 
8 
8 
7 
8 
'Switch 
a 
% 
0 
10.0 
33.3 
0 
0 
0 
100.0 
100.0 
28.6* 
0 
12.5 
25.0 
14.3 
# 
50.0 
ing' to с 
b 
% 
100.0 
50.0 
46.8 
100.0 
0 
0 
0 
0 
0 
100.0 
75.0 
75.0 
42.9 
0 
limbing re 
b+c 
% 
0 
20.0 
13.2 
0 
100.0 
0 
0 
0 
0 
0 
12.5 
0 
42.9 
37.5 
¡quiring: 
b+c+d 
% 
0 
10.0 
6.7 
0 
0 
100.0 
0 
0 
0 
0 
0 
0 
0 
0 
* = the remainder of the group was not able to complete climbing 
(see text) 
Abbreviations: a = visual contact, b= snout contact, с = foreleg 
contact, d = hindleg contact 
For the other abbreviations, see table 4.3 
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sinking' (n=6), and no 'continuous planing' (n=7) (cf. figs. 4.5 
Α-C). After the introduction of the rope one of the haloperidol-
treated rats showed 'successful escape', 5 of the rats showed 
climbing after snout 'contact behaviour' either within the time 
limit of test 3 or after confrontation with the rope (cf. fig. 
4.5D, table 4.5). The remainder of the haloperidol-treated rats 
did not show any climbing behaviour at all. In general, they 
showed effects which did not differ from those elicited by the 
haloperidol injections into the DA region (see table 4.5 and 
figs. 4.5). 
DISCUSSION 
The present study shows that there are subtle differences between 
the effects of neostriatally applied dopaminergic, cholinergic 
and GABA-ergic drugs on the swimming behaviour of rats. Before 
discussing the data it is relevant to pay attention to the fol­
lowing. 
First, the doses used in the present study were much lower than 
those used by others (cf. Kuruvilla and Uretsky 1984, Neill and 
Grossman 1970, Slater and Dickinson 1982, Turski et al. 1984, 
Wolfarth et al. 1978); they were chosen on the basis of the out­
come of our pilot studies. The latter studies had shown that 
a) 400 or more ng apomorphine and 600 or more ng haloperidol 
produced adduction of the hindlegs in all rats (Cools 1980), 
b) 250 or more ng carbachol produced dyskinetic movements and 
epileptic seizures in all rats, c) 750 or more ng scopolamine 
produced hypoactivity in all rats, d) 10 or more ng muscimol 
produced catalepsy in all rats, and e) 50 or more ng bicuculline 
produced hyperactivity in all rats (unpublished data). Thus, 
lower doses had to be selected in order to avoid unwanted motor 
disturbances. 
Second, certain doses of the selected drugs still produced motor 
disturbances. Detailed analysis, however, revealed that these 
motor disturbances could not have caused the effects seen in the 
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remaining tests. Rats showing motor disturbances after 500 ng 
haloperidol (table 4.3: 57.2%), for instance, behaved like rats 
showing no motor disturbances after 250 ng haloperidol: the ef­
fects of both groups were identical as far as it concerns a) 
'variability', b) 'continuous sinking', c) 'continuous planing', 
and d) 'successful escape' after snout contact (figs. 4.5A-D; 
table 4.5). Furthermore, rats showing motor disturbances after 
100 ng carbachol (table 4.3: 25%) did not differ from the re­
maining 75% rats which did not have any adduction of the hind-
legs: the effects of all rats were identical as far as it con­
cerns: a) 'variability', b) 'continuous sinking', and c) 
'successful escape' after visual contact (figs. 4.5Λ-Β; table 
4.5). 
Third, the effects of carbachol and scopolamine injections into 
the three cholinergic target regions were remarkably different: 
when injected into the 'middle' region carbachol and scopolamine 
induced dissimilar and counteracting effects, whereas they pro­
duced related phenomena when injected into the ventral resp. 
dorsal region (tables 4.4 and 4.5). As mentioned the neostriatum 
is a heterogeneous structure. Several authors have found that the 
terminals of the substantia nigra, pars compacta (SNpc) projec­
tion are scattered throughout the whole neostriatum, whereas the 
terminals of the central resp. the lateral part of the ventral 
tegmental area of Tsai (VTA) are predominantly found in the ven­
tral resp. most medial region of the neostriatum (Albanese and 
Minciacchi 1983, Beckstead et al. 1979, Fallon and Moore 1978). 
Thus, the dorsal and ventral cholinergic target regions receive 
dopaminergic fibres from both the SNpc and VTA in contrast to 
the 'middle' region, which mainly receives dopaminergic fibres 
from the SNpc. This differential input together with the differ­
ential effects of DA upon ACh within these regions (see Intro­
duction) may underly the observation that the cholinergic effects 
differed per region. It may also underly the observation that the 
cholinergic-specific effects could only be elicited from this 
'middle' region. Anyhow, the mentioned data clearly confirm the 
earlier reported finding that the neostriatum is heterogeneous 
as far as it concerns the effects of cholinergic drugs (Guyenet 
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et al. 1977, Neill and Grossman 1970, Scheel-Krüger 1985, Takano et 
al. 1980). 
Fourth, the controls of the various groups showed clear-cut differ-
ences (figs. 4.5). Since rats with cannulas implanted just above 
the neostriatum behaved like naive, non-operated rats, in contrast 
to rats with cannulas implanted into the DA target region which 
behaved like non-operated rats treated with haloperidol (Cools 
1980) (see also figs. 4.5 and table 4.5), the swimming test ap-
pears to be sensitive enough to detect behaviour changes inherent 
to the mechanical lesion of implanted cannulas. From this point 
of view it is evident that the noted differences between the con-
trols simply reflect the functional heterogeneity within the neo-
striatum: as depicted in figs. 4.1 to 4.3 the injections of each 
control group were given in distinct brain regions. 
The drug-induced effects were specific for respectively DA, 
ACh and GABA. The effects of apomorphine on the 'variability', 
'continuous planing' and 'successful escape' were antagonized by 
haloperidol. The effects of carbachol on 'continuous planing' and 
'successful escape' were antagonized by scopolamine, whereas the 
effects of scopolamine on the 'variability', 'continuous sinking' 
and 'contact behaviour' were counteracted by carbachol. The ef-
fects of muscimol on the 'variability', 'continuous sinking', 
'successful escape' and 'contact behaviour' were antagonized by 
bicuculline, whereas the effects of bicuculline on 'contact be-
haviour' were counteracted by muscimol (cf. figs. 4.5; table 4.5). 
Dissimilarities 
Significant dissimilarities in 'contact behaviour' were seen in 
the haloperidol-, scopolamine-, and muscimol-treated rats. Halo-
peridol-treated rats only needed snout contact, whereas scopol-
amine-treated rats needed snout and foreleg contact; muscimol-
treated rats even needed snout, foreleg and hindleg contact to 
switch to climbing behaviour. Before pointing out that the 
mentioned dissimilarities may underly the different effects of 
haloperidol, scopolamine and muscimol on 'continuous sinking', 
it is relevant to stress the following. Animals having lost 
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their ability to program movements that are normally guided by 
one or another exteroceptive stimulus were still able to pro-
gram movements directed by exteroceptive stimuli. Actually, 
these rats only switched to another movement on the condition 
that they were able to track exteroceptive stimuli: in other 
words, the rats became stimulus-bound. Thus, haloperidol-treated 
rats did not show 'continuous sinking'. They permanently used 
both fore- and hindlegs to prevent it. The programming of move-
ments guided by stimuli received by the fore- and hindlegs was 
still intact. In contrast, these rats could only switch to move-
ments which were directed by exteroceptive stimuli received by 
the snout. Scopolamine-treated rats did show 'continuous sinking' 
They only performed movements to reach the surface after their 
snout and forelegs had lost contact with the surface of the water. 
Only the programming of movements guided by exteroceptive stimuli 
received by the hindlegs was intact. In contrast, these rats could 
only switch to movements which were directed by exteroceptive sti-
muli received by the snout and the forelegs. The same reasoning 
holds true for the finding that muscimol-treated rats showed 'con-
tinuous sinking': they were only able to program movements directed 
by exteroceptive stimuli received by the snout, forelegs and hind-
legs. The actual findings show that: 
1) an increased GABA-ergic activity worsened the programming of 
movements which are normally guided by exteroceptive stimuli 
received by the snout, forelegs and hindlegs; 
2) a decreased cholinergic activity worsened the programming of 
movements which are normally guided by exteroceptive stimuli 
received by the snout and forelegs; 
3) a decreased dopaminergic activity worsened the programming of 
movements which are normally guided by exteroceptive stimuli 
received by the snout. 
Thus, the behaviour-relevant information transmitted by GABA-
ergic drugs surmounted that transmitted by cholinergic drugs 
which, in turn, surmounted that transmitted by dopaminergic 
drugs. From the known interactions between DA, ACh and GABA 
(see Introduction) it was expected that the behavioural ef-
fects of neostriatally applied dopaminergic drugs required 
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cholinergic interneurons and/or GABA-ergic efferents. This to-
gether with the present findings suggest that the information of 
dopaminergic drugs is not simply transmitted by cholinergic or 
GABA-ergic neurons, but slightly transformed in resp. cholinergic 
and GABA-ergic information. 
Similarities 
Analysis of the drug-induced effects in the remaining swimming 
tests shows that different groups of rats displayed a great 
number of similar effects (cf. figs. 4.5). The similarities in 
behaviour between the apomorphine- and carbachol-treated rats 
were found in all aspects: maximized resp. stabilized 'variabil-
ity', no resp. minimized 'continuous sinking', and increased 
'continuous planing' as well as 'successful escape'. The similar-
ities in behaviour between the haloperidol- and scopolamine-
treated rats were seen in three out of the four dependent 
variables: no resp. minimized 'variability', and minimized 
'continuous planing'as well as 'successful escape'. Though 
haloperidol-treated rats did not show 'continuous sinking', in 
contrast to the scopolamine-treated ones, both series of rats 
shared an additional common feature apart from the above-men-
tioned ones: all haloperidol- and scopolamine-treated rats just 
performed one behaviour item (see Results). Both muscimol-
treated and scopolamine-treated rats behaved similarly in all 
aspects: minimized 'variability', 'continuous planing' as well 
as 'successful escape' and maximized 'continuous sinking', 
Moreover, all muscimol-treated rats like the haloperidol- and 
scopolamine-treated ones just performed one behaviour item. 
Since bicuculline-treated rats permanently changed their ongoing 
behaviour, assessment of the variables 'continuous planing' and 
'successful escape' was impossible. However, the bicuculline-
treated rats performed similar behaviours as the apomorphine-
and carbachol-treated rats with respect to the other two de-
pendent variables: stabilized 'variability' and reduced 'con-
tinuous sinking'. 
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The analysis of the drug-induced effects on the types of 
'contact behaviour' needed to switch to climbing behaviour also 
revealed a similarity between the groups of rats (cf. table A.5): 
both the apomorphine- and carbachol-treated rats were able to 
switch to climbing behaviour after visual contact with the rope. 
Bicuculline-treated rats also reacted to the rope after visual 
contact, but did not complete the sequence of climbing into the 
rope because of the fact that they permanently switched from one 
behaviour to another: the vast majority (fig. 4.5D) simply inter-
rupted their ongoing climbing behaviour before having reached the 
criterion of 'successful escape'. From these data it can be con-
cluded that both DA and ACh appear to work into the same direction 
but opposite to GABA (cf. Besson et al. 1982, Cools et al. 1984b, 
Cools and Janssen 1976, Scheel-Krüger 1983, Slater and Dickinson 
1982). The region in which the injected cholinergic drugs elicited 
effects comparable to the effects of the dopaminergic drugs, was 
restricted to a well-delineated part of the neostriatum, viz. the 
part which mainly receives a dopaminergic innervation from the 
SNpc. Apart from the fact that the present findings concerning DA 
and ACh are fully in agreement with those reported by other authors 
(Cools et al. 1975a, Howard and Garcia-Rill 1983, Scheel-Krüger 
1985, Westermann 1981, Wolfarth and Kolasiewicz 1977), they are 
not in conflict with studies showing that DA acts opposite to ACh 
(Bartholini 1980, Consolo et al. 1974, Kuruvilla and Uretsky 1984, 
Scheel-Krüger 1985, Stoof et al. 1979, Trabucchi et al. 1975). 
Since DA is found to have a suppressing influence upon ACh in 
regions which are located outside the so-called 'middle' region 
(Scheel-Krüger 1985), it is evident that the nature of the DA-ACh 
interaction depends on the striatal area studied (Cools 1977b, 
Scheel-Krüger 1985). Given the notion that the 'middle' region 
is mainly influenced by the SNpc, in contrast to the remaining 
neostriatal tissue (see Introduction), it appears that only DA 
released by the nigrostriatal fibres activates ACh. 
Haloperidol injected into the GABA-ergic region elicited 
effects similar to those elicited by haloperidol injected into 
the dopaminergic region (see Results, paragraph 4 vs figs. 4.5 
and table 4.5): minimized 'variability', 'continuous sinking', 
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'continuous planing' as well as 'successful escape', and maxi-
mized dependency on snout contact to switch to climbing behav-
iour. These effects become understandable in view of the fact 
that both areas are located within the terminal fields of the 
nigrostriatal fibres (Albanese and Minciacchi 1983, Beckstead 
et al. 1979, Fallon and Moore 1978). Moreover, these findings 
show that the described effects are drug-specific instead of 
locus-specific. 
As a final remark, the present study clearly shows that 
it becomes possible to delineate whether afferent, intrinsic 
or efferent fibres are involved in symptoms inherent to a 
particular, dysfunctioning brain structure such as the neo-
striatum of rats and, possibly, the caudate nucleus of patients. 
It is evident that each type of disturbance requires its own 
pharmacotherapeutic approach. The present study reports that 
dopaminergic, cholinergic and GABA-ergic disturbances within 
the neostriatum elicit transmitter-specific effects. This opens 
the perspective that specific diagnostic tools may be developed 
for differentiating diseases in which the caudate nucleus is 
known to be involved. 
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CHAPTER 5 
DISTURBANCES IN HINDLIMBS AND FORELIMBS: 
ESSENTIAL FOR STRIATALLY ELICITED CATALEPSY 
ABSTRACT 
It was postulated that striatally elicited catalepsy in rats re-
quires dysfunction in both hindlirabs and forelimbs. To test this 
hypothesis the effects of the intrastriatally injected GABA agonist 
muscimol (0.5 yl per side) were investigated in rats using several 
specific behaviour tests of catalepsy. The time required for re-
tracting free-hanging hindlimbs was dose-dependently prolonged by 
2-10 ng muscimol. The time required for releasing a rod that was 
clasped with the forelimbs of otherwide free-hanging rats was dose-
dependently prolonged by 5-10 ng muscimol. Likewise the time re-
quired for retracting the free-hanging forelimbs was dose-depend-
ently prolonged over the same dose range. Finally, the time during 
which standing rats kept their forelimbs on a block of 9 cm height 
(the dependent variable used in 'classic' tests of catalepsy) was 
only prolonged at the highest dose (10 ng) of muscimol. The effects 
of the latter dose, which lasted at least 30 minutes, were inhibited 
by the GABA antagonist bicuculline (50 ng) for a minimum period of 
5 minutes. The present data show that striatally elicited catalepsy 
requires dysfunction in both hindlimbs and forelimbs. 
The data are discussed in view of the concept that the 'nonlimbic' 
trans-striatal channel directs the animal's ability to use static 
proprioceptive stimuli inherent to the hindlimbs, in contrast to 
the 'limbic' trans-striatal channel, which directs the animal's 
ability to use static proprioceptive stimuli inherent to the fore-
limbs. 
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INTRODUCTION 
Intraperitoneal (ip) injections of the dopaminergic antagonist 
haloperidol (5-10 mg/kg) in freely moving rats produce catalepsy 
next to simultaneous tonic co-contractions in the antagonistic 
flexor and extensor muscles in both forelimbs and hindlimbs (De 
Ryck and Teitelbaum 19Θ3). 
Catalepsy can also be induced by injection of high doses of halo­
peridol into the neostriatum (25-100 μ$: Costali et al. 1972, 
Dunstan et al. 1981, Hartgraves and Kelly 1984; 1.5-2.5 yg: 
Ellenbroek et al. 1985b). In contrast low doses of haloperidol 
(250-750 ng) into the rostral neostriatum of rats induce only 
tonic electromyographic activity, reflecting muscular rigidity, 
in the hindlimb (Ellenbroek et al. 1985b). Thus, the question 
arises whether striatally elicited catalepsy requires rigidity 
not only in the hindlimbs but also in other parts of the body. 
Recently, it has been found that destruction of both the nigro-
striatal (A9) dopamine system and the mesolimbic (AIO) dopamine 
system are prerequisites for the elicitation of catalepsy (Koob 
et al. 1984). 
Evidence exists that the A9 dopaminergic neurons are involved in 
hindlimb rigidity but not catalepsy, since blocking the activity 
of the cell bodies of these neurons in the substantia nigra, pars 
compacta with muscimol induces hindlimb rigidity without cata­
lepsy (Havemann et al. 1983). In contrast, the AIO dopaminergic 
neurons may be involved in forelimb disturbances, since stimu­
lating dopaminergic receptors in the nucleus accumbens with B-HT 
920 results solely in effects on the forelimbs (Grabowska-Andén 
and Andén 1983). In view of these data it is reasonable to sug-
gest that striatally elicited catalepsy requires both abnormal-
ities of the hindlimbs through interaction with the A9 system, 
and abnormalities of the forelimbs through interaction with the 
AIO system. This problem is addressed in the present study. 
It has become evident that both the A9 and AIO dopaminergic 
neurons project to the neostriatum with a large overlap in the 
ventral and medial regions (Beckstead et al. 1979, Simon et al. 
1979, Veening et al. 1980). The dopaminergic afférents of the 
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neostriatum are known to influence the activity of GABA-Cgamma-
aminobutyric acid)-ergic efferents (Dichiara et al. 1981, Scheel-
Krüger 1983). Injections of the GABA-ergic agonist muscimol (25-50 
ng) into neostriatal regions known to contain A9 and AIO terminals 
elicit immediately catalepsy and tonic EMG activity in the hindlimb 
comparable to the haloperidol-induced effects (Scheel-Krüger et al. 
1981, Turski et al. 1984). 
In view of these data, intrastriatally injected muscimol is here 
used to investigate whether dysfunctions of both the forelimbs and 
hindlimbs are required for the expression of striatally elicited 
catalepsy. 
MATERIALS AND METHODS 
Animals and surgery 
Male Wistar rats (Central Animal Laboratory, Nijmegen) weighing 
190+20 g at the time of operation were aneasthetized with sodium 
pentobarbital (60 mg/kg ip) and placed in a stereotactic apparatus. 
All rats were implanted bilaterally with two stainless steel guide 
cannulas (outer diameter 0.5 mm, inner diameter 0.3 mm) aimed at 
the neostriatum. After the operation the rats were allowed to re-
cover for at least 7 days in a temperature controlled room illumi-
nated from 6.00 am to 6.00 pm. Food and water were given ad libitum 
except during the testing periods. Each rat has its own home cage. 
During the four days preceding the experimental day the rats were 
handled to become familiar with the injection procedure. 
Injection procedure and drugs used 
At the beginning of the experiments the rats received bilateral 
intrastriatal injections of either the solvent of each drug (dis-
tilled water), the GABA-ergic agonist muscimol (MSC; Serva) or 
the GABA-ergic antagonist bicuculline methiodide (BMI; Pierce). 
The specificity of the GABA-ergic effects was determined by 
129 
separate injections of BMI and MSC with a time interval of 5 min. 
The injections (0.5 μΐ per side) were given free-hand to non-re­
strained, conscious rats by means of a Hamilton syring with the 
needle placed 3 mm below the guide cannula. The injection itself 
lasted 10 seconds, wheras the needle was held on its place for 
an additional period of 10 seconds. 
Behavioural tests 
All rats were test-naive, whereas some of the rats (n=40) were 
also drug-naive; the remainder had undergone a single, intra­
cerebral injection of MSC, BMI or their solvent, viz. distilled 
water, in a previously performed study 4 days before the present 
experiments. In this study the rats were treated with solvent, 
increasing doses of MSC, 50 ng BMI and/or 50 ng BMI and 10 ng 
MSC randomly. The rats were tested 5 and 30 minutes after the 
injection(s) in the following design: 
'classic' tests of catalepsy (fig. 5.1) 
The rats were placed on a table with both forepaws on a wooden 
block ( 5 x 5 cm) with a height of 3 cm. Only rats that kept 
standing immobile for 10 seconds were considered to be 'cataleptic' 
fig. 5.1 'Classic' test of catalepsy 
Drawing of a rat standing immobile with both forepaws 
on a wooden block of 9 cm height 
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in this test. The test was repeated using a wooden block of 9 cm 
height. Again rats were considered 'cataleptic' after standing 
immobile for 10 seconds (Scheel-Krüger et al. 1981). 
'grip' test (fig. 5.2) 
The forepaws of the rats were brought into contact with a hori-
zontal iron rod (length 30 cm, diameter 2 mm), 60 cm above a tray 
filled with soft material. The time (sec) was measured in which 
the rats hung immobile with stretched forelimbs (Altman and 
Sudarshan 1975). 
'paw' test (fig. 5.3) 
This test was designed by analogy with the bar test in cats (Cools 
et al. 1983b; see Discussion). The rats were placed on a box that 
contained five holes: the limbs and the tail, put through the 
Fig. 5.2 'Grip' test 
Drawing of a rat hanging immobile with stretched forelimbs 
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holes, protruded freely from the floor. The time (sec) was measured 
until both forelimbs and/or both hindlimbs were retracted. After 60 
seconds the test was finished. 
Fig. 5.3 'Paw' test 
Top drawing: a rat placed on a box, with the limbs and 
tail put through holes 
Bottom drawing: sizes and distances of the holes in cm 
A separate group of rats, treated with solvent or increasing doses 
BMI, were tested in an open field. Use was made of a half-round 
cage (front 80 cm, diameter 50 cm, height 60 cm). The behaviour 
was observed for 30 minutes and qualitatively analyzed by scoring 
the presence of a) 'normal' behaviours, viz. locomotion, rearing, 
sitting, lying, sniffing, licking, gnawing, grooming, and b) motor 
disturbances, viz. uncoordinates movements of head, limbs and/or 
body, uncoordinated locomotion patterns, and convulsions. 
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Histology and statistics 
On completion of the behavioural tests the rats were deeply anaes-
thetized with pentobarbital (120 mg/kg), their brains removed and 
fixed in formalin, then sectioned and stained (cresyl violet) to 
determine the injection sites which were found in the following 
region: A 6.7-7.0, L 2.2-3.2, V 0.0-1.0 (according to König and 
Klippel 1963; fig. 5.4). 
Statistical evaluation was carried out by means of the two-tailed 
chi square test with Yates correction for the 'catalepsy' test, 
and with the Mann-Whitney test for the 'paw', 'grip' and open 
field test. 
Fig. 5.4 Frontal sections of the rat bruin according to König 
and Klippel (1963), illustrating the injection sites. 
The number of injection sites shown per side differs 
because of overlap in one, but not in the other, side. 
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RESULTS 
All rats with significant brain damages (n=5: 57. of the rats used) 
were excluded from the analysis of the effects. 
Since rats, that had received a single, intracerebral injection 4 
days before the present study, showed no significant after-effects 
as manifested by the absence of any difference between them and 
drug-naive rats in the present study, no further attention was paid 
in the analysis to the individual drug-history. 
Solvent-induced effects 
The vast majority of solvent-treated rats was unable to fulfil 
the criterion of catalepsy in the 'classic catalepsy' test (table 
5.1). All control rats firmly grasped the rod, hanged with stretch-
ed forelimbs during 5 seconds and, then, released the rod or tried 
to climb on it. In the 'paw' test it was difficult to keep the con-
trol rats in the correct position. After releasing the rats, they 
immediately lifted their forelimbs and within 2 seconds their hind-
limbs (table 5.1). 
In the open field all the normal responses mentioned in the Materials 
and Methods section were observed, whereas no gross motor dis-
turbances were detected. Because BMI induced an increase in rearing 
(see below), the total frequency of rearing was also counted for 
solvent-treated rats (fig. 5.5). 
Muscimol-induced effects 
Bilateral injections of increasing doses of MSC resulted in dose-
and time-dependent effects (table 5.1). 
Five minutes after an injection of 1 ng MSC, rats showed a tendency 
to retract their hindlimbs later than controls in the 'paw' test; 
this slight, but not significant, disturbance was the only one found 
after this dose. 
Five minutes after an injection of 2 ng MSC, the latency to retract 
the hindlimbs was just increased (p < 0.02); this was the only dis-
turbance seen at that test-time. Thirty minutes after the injection, 
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TABLE 5 1 
Effects of intrastriatally applied GABA-ergic drugs on the behaviour of ratb in 
the 'paw' test, 'grip' test and 'catalepsy' test (for explanation, see text) 
Post-injection 
t m e 
(mm) 
Int rastnatal 
injection 
paw test 
(ng/0.5 jl) 
hindlimbs 
s e c * SEK 
1.83 *0.2\ 
2.76 + 0 . 4 0 
Э . В 5 Ь + 0 . 4 6 
l 4 . 1 3 b + 5 . 5 
4 2 . 7 5 С + 7 . 4 1 
І . 1 Э Ь * 0 . 0 9 
2 . 6 2 e l o . 4 7 
f o r e l i m b s 
s e c + SLM 
0 . 0 8 + 0 . 0 8 
0 . 1 1 + 0 . 1 1 
0 . 4 6 + 0 . 2 7 
7 . 2 5 а + 5 . 4 6 
2 3 . 5 в С + 7 . 6 7 
0 . 0 
0 . 4 6 d + 0 . 2 2 
^ п р ' test 
sec + SEM 
'catdlepsy' test 
3 c-n 
% 
9 cm 
7. 
c o n t r o l s 
MSC 
BMI 
BMI/MSC 
1 
2 
5 
10 
50/10 
9 
13 
8 
12 
15 
13 
5 33 +0 57 
4.44 +0.84 
5 62 +0.90 
9 . 8 8 b + l . 1 9 
I 4 . 2 2 C + 1 79 
2 . 5 3 a + 0 . 7 0 
5 . 5 4 e + l . 3 5 
22 
21 
50 
8 4 c 
0 
0 
25 
6 7 Ь 
0 
30 controls 
MSC 
BMI 
BMI/MSC 
1 
2 
5 
10 
50 
10 
12 
9 
13 
8 
12 
15 
13 
1.92 +0.26 
5.22 +2.54 
5 . 9 2 b + l . 0 5 
гв.ав'чэ. 14 
51.25' : +5.35 
1.27 +0.15 
4 8 . 6 2 C + 5 . 2 9 
0 . 17 +0.17 
0.56 +0.44 
0.46 +0.27 
І 0 . 5 0 а + 7 . 2 9 
3 9 . 4 2 C + 7 . 8 9 
0 . 0 
2 6 . 4 6 C + 7 . 2 0 
5-25 +0.75 
5.33 +1.20 
8.54 +1.62 
13.00 C +] 58 
1 9 . 1 7 C + I . 9 7 
4 . 5 3 +0.60 
I 9 . 7 7 C + 3 . 9 1 
8 
10 
23 
75 Ь 
100C 
0 
100C 
0 
0 
0 
37 
IOO' 
0 
85' 
a - ρ < 0.05, b = ρ < 0.02, с = ρ < 0.002 drug-treated vs contrais, d - p<0.02, e - ρ < О 02 10 пд Н5С vs ВЧІ/HSC, 
f = ρ < 0.02 BMI vs BMI/MSC 
total number of rearing in 30 mm 
2 0 0
 Ί » p < 0 0 l (Mann-Whrtney) 
150 
100 -
5 0 i I 
control 5 
(AD) 
I 
τ 
number of rats 
10 25 50 ng BMI/05/JI AD 
Fig. 5.5 Rearing activity of rats in tne open field test after 
mtrastriatal injections of bicucullme methiodide 
(BMI) m increasing doses 
the rats still needed more time than controls to retract their 
hindlimbs in the 'paw' test (p < 0.02). In the remainder of the 
tests these rats did not differ from the controls. 
The injection of 5 ng muscimol elicited significantly different 
effects from controls after 5 minutes in the 'paw' test (hindlimbs: 
ρ < 0.02; forelimbs: ρ < 0.05) and the 'grip' test (p < 0.02). No 
further differences were found at that test-time. Thirty minutes 
after the injection of 5 ng MSC, the rats differed even more from 
controls in the 'paw' test (hindlimbs: ρ < 0.002; forelimbs: 
ρ < 0.05) and the 'grip' test (p < 0.002). In addition, the rats 
showed catalepsy on the block of 3 cm (p < 0.02) but not on the 
block of 9 cm. 
Ten ng of MSC elicited significant effects (p < 0.002) in the 'paw' 
test and the 'grip' test after 5 minutes as well as after 30 minutes. 
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Moreover, catalepsy was seen in both 'classic catalepsy' tests at 
all test-times (for p-values, see table 5.1). 
Bicuculline-induced effects 
Five minutes after the BMI injection rats needed less time to re-
tract their hindlimbs in the 'paw' test (p < 0.02) and resisted 
grasping the rod (p < 0.05). Thirty minutes after the injection, 
the BMI-treated rats no longer differed from the controls. In the 
open field, the only effect of BMI (5-50 ng) was a dose-dependent 
increase in the total amount of rearing (fig. 5.5). A dose of 100 
ng BMI elicited severe motor deficits, viz. uncoordinated locomotion 
patterns and convulsions. BMI-treated rats were no longer different 
from the controls in the open field 30 minutes after the injection. 
GABA-specificity of the effects 
50 Ng BMI was able to inhibit the effects of 10 ng MSC in all tests 
during the first 5 minutes (p < 0.002; table 5.1). MSC in turn was 
able to reduce the effects of 50 ng BMI (table 5.1). Thirty minutes 
after the injections the MSC effects reappeared (table 5.1). 
DISCUSSION 
The present data show that increasing, but nevertheless still low, 
doses of MSC successively elicited disturbances in hindlimbs, dis-
turbances in forelimbs, and catalepsy when injected into the inter-
mediate-medial neostriatum and the adjacent part of the globus pal-
lidus. MSC was found to be a relatively long-lasting drug: it produced 
movement disorders in both fore- and hindlimbs as well as catalepsy 
during a minimum period of 30 minutes (table 5.1). BMI injections 
resulted in a decreased latency to retract the hindlimbs in the 'paw' 
test, resistance to grasp the rod and an increase in rearing. These 
effects may be due to the ability of striatally injected BMI to 
change permanently the ongoing behaviour (Chapter 4). BMI turned out 
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to be a relatively short-lasting drug: the effects were already dis­
appeared within 30 minutes after the injection (table 5.1). The MSC-
induced effects were GABA specific: BMI inhibited the MSC-induced 
effects in the 'paw' and 'grip' test, and reduced the MSC-induced 
catalepsy. MSC counteracted the BMI-induced effects in the 'paw' 
and 'grip' test. Thirty minutes after the combined BMI and MSC in­
jections the rats showed all the typical MSC-induced effects again 
in the 'paw' and 'grip' test as well as catalepsy (table 5.1). 
These data clearly show that striatally elicited catalepsy requires 
movement disorders not only of the hindlimbs but also of other parts 
of the body, especially the forelimbs (see below). 
The disturbances in the limbs after MSC resemble the proprio­
ceptive disturbances in the forelimbs of rats after bilateral globus 
pallidus lesions (Schneider and ОІгаЬаІ 1984) and the proprioceptive 
disturbances in the hindlimbs of cats after the injection of a GABA 
antagonist in the substantia nigra, pars reticulata (SNpr; Cools et 
al. 1983b). In those studies, as well as in the present one, the 
animals were unable to use static proprioceptive information to 
grasp a food pellet with their forepaw (rats; Schneider and 01-
zabal 1984), to lift the hindlimbs when suspended with their fore­
limbs on a bar (cats; Cools et al. 1983b) and to lift their fore­
limbs and hindlimbs in the 'paw' test (rats; present study). In 
the first two studies none of the animals showed any catalepsy; 
in the present study too the rats did not show catalepsy until 
severe proprioceptive disturbances were seen in all limbs (table 
5.1). Proprioceptive disturbances in the hindlimbs alone were not 
correlated with catalepsy (p > 0.3, two-tailed chi square test, 
5 min and 30 min after the injections). Since proprioceptive dis­
turbances occurring only in the forelimbs were not observed, the 
correlation between forelimb disturbances and catalepsy could not 
be calculated. Anyhow, catalepsy only occurred when strong disturb­
ances were seen in both forelimbs and hindlimbs. In the Introduction 
it has already been mentioned that selective inhibition of A9 dopa­
mine activity in the neostriatum induces hindlimb rigidity but no 
catalepsy (Ellenbroek et al. 1985b). The selective inhibition of 
AIO dopamine activity in the nucleus accumbens induces neither 
hindlimb rigidity nor catalepsy (Ellenbroek et al. 1985b, Johnels 
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1983), whereas stimulation of this activity induces forelimb dis-
turbances (Grabowska-Andén and Andén 1983). In the present study 
it was found that injection of MSC into the neostriatal region 
known to contain both A9 and AIO terminals elicited catalepsy as 
well as disturbances in all four limbs. From these data it can be 
concluded that catalepsy requires at least disturbances in both 
forelimbs and hindlimbs. 
Catalepsy is defined as a behavioural state in which an animal 
remains immobile. However, they can still move when forced by sti-
muli that induce postural imbalance (De Ryck et al. 1980). In other 
words, cataleptic rats have lost their capacity to respond to static 
proprioceptive stimuli, although they are still able to respond to 
dynamic proprioceptive stimuli. Moreover, they are bound to extero-
ceptive stimuli (De Ryck et al. 1980, Schallert et al. 1979). We 
suggest that the latter phenomenon has to be considered as a kind 
of stimulus substitution: an increased ability to use exteroceptive 
stimuli may substitute the reduced ability to use static proprio-
ceptive stimuli (Marchand and Amblard 1984). The finding that the 
grip of rats treated with 5-10 ng MSC was significantly stronger 
than that of control rats (table 5.1) may accordingly be ascribed 
to their increased dependence on external stimuli. The observation 
that rats treated with 5 ng MSC showed catalepsy on a block of 3 
cm, but not on a block of 9 cm when tested 30 min after the injec-
tion (table 5.1), becomes understandable in view of the fact that 
proprioceptive stimuli inherent to 'stand on a block' of 3 cm are 
less intense than those inherent to 'stand on a block' of 9 cm. 
Anyhow, it now understandable why the results of studies on cata-
lepsy vary according to the test used: it is the test-situation 
that determines whether the rat can use static and/or dynamic pro-
prioceptive stimuli or, even, static and/or dynamic exteroceptive 
stimuli to manage with its drug-induced disturbances (cf. Scheel-
Krüger et al. 1981, Turski et al. 1984). 
As mentioned above, a dysfunctioning striatal output innervated 
directly or indirectly by the A9 dopaminergic neurons, viz. the 
'nonlimbic' trans-striatal channel, results in a reduced ability to 
use static proprioceptive stimuli inherent to the hindlimbs• On the 
other hand, a reduced ability to use static proprioceptive stimuli 
inherent to the forelimbs appears to be the consequence of a dys-
functioning striatal output innervated directly or indirectly by 
the AIO dopaminergic neurons, viz. the 'limbic' trans-striatal 
channel. In other words, the present study allows the conclusion 
that striatally elicited catalepsy is the consequence of a re-
duced ability to use static proprioceptive stimuli inherent to 
all 1imb s. 
As a final remark, it is interesting to refer to the clinical 
data of Zetusky et al. (1984), who analyzed the correlation be-
tween different symptoms in patients with Parkinson's disease. In 
general, gait disturbances, viz. manifestations of dysfunctioning 
A9 neurons in animals (see Introduction), and tremor, viz, a mani-
festation of dysiunctioning AIO neurons in animals (Dickinson and 
Slater 1982), were not correlated. In contrast, the overall rigid-
ity in arms and legs turned out to be correlated with gait dis-
turbances as well as tremor. Although it is highly speculative to 
extrapolate to human studies, the present data open the real per-
spective that the occurrence of rigidity in patients with Parkinson's 
disease may reflect the dysiunctioning of the dual striato-fugal 
pathways, viz. the 'nonlimbic' and 'limbic' trans-striatal channels. 
It will be evident that this insight offers a new guideline for a 
better adjusted pharmacotherapy. 
In conclusion, the present study clearly confirms previous 
findings of catalepsy after intrastriatally injected MSC. Moreover, 
evidence is provided that striatally elicited catalepsy requires at 
least disturbances in both forelimbs and hindlimbs. 
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CHAPTER 6 
FURTHER EVIDENCE FOR THE ROLE OF THE CAUDATE NUCLEUS IN 
PROGRAMMING MOTOR AND NONMOTOR BEHAVIOUR IN JAVA MONKEYS 
ABSTRACT 
This study describes the short-term effects of intracaudate micro-
injections of carbachol in temporarily isolated and restrained Java 
monkeys. The monkeys were found to display a series of motor disturb-
ances including blepharoptosis, facial twitches, tongue protrusions, 
ear flattening, torticollis, and compulsive alternations of rapid 
flexions and extensions of the extremities. In general, carbachol 
was found to produce consistent effects as far as it concerns its 
ability to elicit motor disturbances. Three of the five tested mon-
keys had previously received another series of carbachol injections 
when they were freely moving and living in a stabilized social group. 
Accordingly, the present study enabled us to compare the effective-
ness of threshold doses of carbachol in the same monkey in two dis-
tinct situations. We concluded first, that motor disturbances and 
disturbances in social communication were closely coupled in rela-
tion to the involvement of a particular cholinoceptive substrate 
within the caudate nucleus of Java monkeys. Second, the motor dis-
turbances under study appeared to require a larger degree of dys-
functioning of this substrate than did subtle disturbances in social 
communication of these monkeys. And, finally, stress inherent to 
restraint increased the susceptibility of the cholinoceptive sub-
strate within the caudate nucleus. The clinical impact of our 
findings is discussed in view of differences between the premorbid 
and manifest phases of Parkinson's disease. 
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INTRODUCTION 
In patients with Parkinson's disease, i.e. a disease in which the 
caudate nucleus is known to be involved, certain mental symptoms 
are characteristic of the premorbid phase (Korten 1969, Lit 1956). 
During the progression of this disease the well-known motor symp-
toms such as tremor, rigidity, and hypokinesia appear. 
It has been reported that a small disturbance of the rat neo-
striatum, i.e. the caudate nucleus and putamen, resulted solely in 
changes in behavioural strategies; a larger disturbance was required 
to produce motor disturbances (Cools 1980). Against this background 
the question arises of whether or not the above-mentioned successive 
appearance of nonmotor and motor disturbances reflects differences 
in the degree of pathology within the caudate nucleus and the neo-
striatum, respectively. 
The caudate nucleus, however, is heterogeneous in terms of its 
neuronal structure, neurochemical substrates, and electrophysiologic 
responses as well as in terms of its afferent and efferent fibres 
(Divac and Oberg 1979, Dray 1980, Fibiger 1982, Grabiel and Rags-
dale 1979, Scheel-Krüger 1985). Of special interest are the 
afferent fibres from the cortex: the caudate nucleus receives a 
highly organized projection from nearly all areas of the cortex 
including areas with no apparent function in motor performance 
(Goldman and Nauta 1977, Grabiel and Ragsdale 1979, Jones et al. 
1977, Künzle 1975). From this point of view the question arises 
of whether or not the above-mentioned successive appearance of 
nonmotor and motor disturbances after manipulations producing an 
increasing pathology is actually due to the successive involvement 
of different neuronal substrates within the structure under dis-
cussion. Neither the mentioned rat studies nor the monkey studies 
below allow us to answer this question because of methodologie 
reasons. In both studies increasing doses of a single intracere-
brally injected drug were used to provoke an increasing degree of 
dysfunctioning. Given the fact that higher doses resulted in higher 
diffusion regions (Myers 1974), such a method is, by definition, 
inappropriate for drawing conclusions about the problem in question. 
In this study we chose a design allowing us to establish whether 
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or not the display of nonmotor and motor disturbances were due to 
the involvement of similar or dissimilar neuronal substrates. The 
starting point for this study was the reported finding that intra-
caudate injections of 20 to 30 pg carbachol, a cholinergic agonist, 
elicited only disturbances in social communication of Java monkeys 
(Macaca fascicularis), whereas at least 40 pg carbachol was re-
quired to elicit motor disturbances in such monkeys (Van den 
Bereken 1979, Van den Bereken and Cools 1982). Comparison of these 
experiments with those of others (Baker and Kratky 1980, Connor et 
al. 1966, Cools 1974, Cools et al. 1975a, Dill et al. 1976, Matthews 
and Chiou 1979, Murphey 197 1, Murphey and Dill 1972, Scheel-Krüger 
1985, Slater and Dickenson 1982, Standefer and Dill 1977) reveals 
two highly relevant differences: the threshold dose of carbachol 
for motor disturbances (40 to 60 \ig) was much higher than those 
found by others ( 1 to 10 pg); and, the animals tested were freely 
moving and living in a stabilized social structure, whereas all 
other investigators used animals in isolation and, in some cases, 
restraint as well. From stress experiments reported in the litera-
ture it appears that isolation and, in a higher degree, isolation 
plus restraint change not only the organism's behavioural state, 
but also its hormonal and neurochemical state (Anisman and Sklar 
1981, Bliss and Ailion 1971, Boyer et al. 1978, Brunello et al. 
1981, Сое et al. 1979, Costa et al. 1980, Delgado et al. 1976, 
DeTruck and Vogel 1980, Eberhart et al. 1983, Holcombe et al. 
1979, Perlow et al. 1979, Sterman and Kovalesky 1979). Indeed, 
pilot studies with rhesus monkeys (M. mulatta) in two different 
experimental surroundings, i.e. isolation vs isolation plus re­
straint, revealed a clear-cut difference in the effect of intra-
caudate injections of a single dose of carbachol (10 yg); little 
motor disturbances vs very severe dyskinetic movements and, even, 
epileptic seizures (Cools et al. 1974, Cools: personal communica­
tion) . 
This insight forms the cornerstone of the present design. 
Java monkeys were tested in a so-called monkey chair (isolation 
plus restraint) after having been tested earlier in a social 
situation. Intracaudate injections of carbachol were again used 
as a tool to elicit motor disturbances. The threshold dose of 
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carbachol to elicit motor disturbances in the monkey chair was re-
tested in a volume comparable to that of doses required to elicit 
solely disturbances in social communication behaviour in the same 
monkey. In that manner it became possible to establish whether 
motor disturbances can be elicited from an intracaudate region 
similar or dissimilar to that involved in the display of social 
communication behaviour. 
This study provided direct evidence that motor disturbances 
could be elicited from an intracaudate region which is also in­
volved in the appearance of disturbances in social behaviour. 
METHODS 
Four male and one female, adult Java monkeys (Macaca fascicularis), 
weighing 2.5 to 4.5 kg, were used. Concerning three of the male 
monkeys (Dries, Freek, and Sjors) the following data were already 
available (Van den Bereken 1979). In a stabilized social situation 
the display of disturbances limited to alterations in their social 
communication required 20 pg/1.8 μΐ (the α-male Dries) and 30 yg/ 
2.7 μΐ (the lower-ranked animals Freek and Sjors), whereas the ad­
ditional display of pure motor disturbances required 40 pg/3.6 μΐ 
and 60 μg/5.4 μΐ, respectively. Neither before nor after the latter 
experiments did the animals receive any pharmacological treatment. 
After the social interaction study, which was carried out 2 years 
earlier, the Java monkeys born in the Philippine Islands were 
placed in a single cage in which they lived during 1 month before 
the present study commenced. As these monkeys still had their 
permanently implanted cannulas at the time of this study, it be­
came possible to retest them in the situation described below. 
In addition, one female (Miep) and one male (Karel) monkey were 
included in order to compare the latter naive animals with the 
former, non-naive ones. Miep had lived in a social group, in 
which she had a nondominant position. Karel was placed in a 
group after the chair experiments; he turned out to be a dominant 
male. 
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For each series of experiments a so-called monkey chair was 
used (Peters 1980; fig. 6.1): the degree of freedom was restricted 
by neck, waist, and upperarm restraints. To reduce unwanted ef-
fects of placing the animal in the primate chair, a light and 
rapidly acting anaesthetic agent, i.e. ketamine hydrochloride 
(Vetalar, Parke-Davis; 3-5 mg/kg, i.m.) was administered just 
before removal from the home cage. Two hours later the animal 
was fully recovered as manifested by its responses to auditory, 
visual, and tactile, stimuli (Bacopoulos et al. 1979) after this 
pretreatment. 
All animals were habituated to this chair for 7 days, 3 h/ 
days, during which they were deprived only of food. On the ex-
perimental days the habituation lasted only 2 h, during which 
they were also deprived of water. The behaviour during the fol-
lowing period of 15 min, i.e. the preinjection period, was ana-
lyzed only when intracaudate injections of distilled water, i.e. 
Fig. 6.1 Miep sitting in the monkey chair 
(Peters 1980, with permission) 
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the vehicle of carbamylcholine chloride (Carbachol, Sigma) was ad-
ministered at the end of this period (see below). The behaviour 
during the subsequent postinjection period of 45 min was analyzed 
in all experiments. From pilot studies it was known that the ef-
fects of small doses of carbachol lasted 35 to 45 min. The spon-
taneously occurring and drug-induced behaviour was recorded on 
tapes by means of a closed TV circuit in order to allow objective 
and blind analysis. The resulting motor disturbances were described 
with the help of the glossary in table 6.1; the glossary itself was 
TABLE 6.1 
Glossary of motor disturbances 
Blepharoptosis 
Convulsion 
Ear flattening 
Facial twitches 
Pillroll movement 
Tongue protrusion 
Prolapse of the upper eyelid 
Secondary epileptic seizures 
Involuntary hyperkinesis of the ear mueles, 
which causes abnormal repetitive movements 
of the ear 
Clonic-tonic twitches of the facial muscles 
Involuntary movements in which the thumb 
and index finger are rubbed 
Involuntary hyperkinesis involving the 
muscles of the tongue, which causes a re-
petitive or persistent protrusion of the 
tongue 
Involuntary hyperkinesis involving the 
muscles of the neck, which causes an ab-
normal turn and/or posture of the head 
Rhythmic, regular, oscillating movements 
of limbs, trunk, head, or part thereof 
Compulsive alternations of rapid flexions and extensions of ex-
tremities or parts of the extremities; they are compulsive in the 
sense that they could not be ascribed to changes in external stimu-
li1') 
Torticollis 
Tremor 
a = the signs can occur unilaterally or bilaterally 
b = cf. hyperkinetic chorea, etc., i.e. the terminology used by 
Murphey and Dill (1972J 
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derived from the available literature in this respect (Cools 1972, 
Cools et al. 1975a, Murphey and Dill 1972). Solvent-induced effects 
were assessed by comparing pre- and postinjection intervals in 
terms of qualitative differences. Data collected during the post-
injection intervals following the solvent administration served 
as baseline for the carbachol-induced effects. In principle, each 
monkey underwent: six tests with solvent injections; a variable 
series of tests in which increasing doses of carbachol were ad­
ministered to assess the threshold dose for eliciting significant 
motor disturbances; a retest with the latter threshold dose to 
assess the intra-individual variability; a test in which the 
volume of the latter dose was adjusted to that used to elicit 
only disturbances in social communication behaviour; and, final­
ly, a repetition of the latter test to establish its reproduc­
ibility. As pilot experiments had shown that kindling can occur 
when the intertrial interval is less than 3 days, all experiments 
were conducted at intervals of 4 to 5 days between 10.50 and 11.50 
h. As a final remark, only an ascending dose-effect determination 
was made in order to prevent the occurrence of seizures which may 
damage the brain that follow too large doses of carbachol (cf. 
Cools et al. 1975a). At termination of each experiment the monkey 
was returned to its home cage. 
A detailed account of the techniques required has been re­
ported (Cools et al. 1975b, Van den Bereken and Cools 1982). 
Briefly, all monkeys were equipped with a small, head-mounted 
box in which the chemical stimulation device (chemistor) could 
be placed. Guide cannulas with an outer diameter of 0.4 mm were 
bilaterally implanted into the head of the caudate nucleus at 
coordinates A 18.5, L 5.0 and H 14.0 according to the atlas of 
Shanta et al. (1968). The chemistor reservoirs were sterilized 
and filled with the required solution; when filled, the reservoir 
contained 25 μΐ, which could be injected in steps of 0.9 μΐ via 
the sterilized inner cannulas (outer diameter 0.25 mm, extending 
I to 1.5 mm below the outer cannula) after having been placed in 
the head-mounted box. Depending on the doses of carbachol, which 
were determined per monkey (see Results), several experiments 
could be carried out with the help of a single reservoir. Remote 
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control was used for directing the chemistors. 
Injection sites 
After completion of the entire experimental series, three tested 
monkeys were killed under anaesthesia (pentobarbital) and perfused 
transcardially (saline and subsequently 10% formaldehyde). The 
brains were removed stereotaxically, immersed in 4% formaldehyde, 
and embedded in paraffin wax. Slices of brain were made along the 
paths of the guide cannulas. The injection sites were located with 
the help of Shanta's atlas (Shanta et al. 1968). The sites found 
were confined to the head of the caudate nucleus (A 20.0 to 16.0; 
L 4.0 to 6.0; H 12.0 to 16.0) (fig. 6.2). The histologically 
verified positions were considered to be representative in view 
of the proven reliability of the chosen implantation technique 
(Van den Bereken 1979). 
RESULTS 
General 
Habituation_2hase 
During the initial period of habituation to the monkey chair, all 
monkeys showed severe escape behaviour: twisting the body and head 
from left to right and visa versa; stretching the neck to free the 
head from the neck band; wringling the arms in trying to free them 
from the upperarm bands; waving the legs up and down, from left to 
right and visa versa, not necessarily in relation to the body and 
head movements; trying to stand on their feet in order to free the 
body from the waist band. Two monkeys gave up struggling early in 
the habituation phase: Dries and Karel. Sjors kept showing periods 
of mild escape behaviour: stretching the neck in trying to free 
the head from the neck band and wringling the arms in trying to 
free them from the upperarm bands. Freek and Miep continued show-
ing periods of severe escape behaviour (see above). 
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Fig. 6.2 The injection sites projected onto the coronal plane 
A 13.5 of Shanta's atlas (Shanta et al. 1968) 
(Van den Bereken 1979, with permission) 
Odd numbers refer to sites in the right hemisphere and 
even numbers to sites in the left hemisphere. 
ca = nucleus caudatus, ci = capsula interna, pu = put-
amen, cc = corpus callosum, II = ventriculus lateralis 
The solvent injections neither induced any of the signs listed in 
the glossary nor altered the individual, characteristic escape be-
haviour. 
CaEÌ!a£Ì!2ì_ÌDÌ£££Ì22£ 
In general, carbachol elicited a variety of motor signs varying 
from unusual positions of a single part of the body to severe 
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motor disturbances involving the whole body. In practice, each mon­
key showed its own repertoire which even varied from trial to trial 
(see below). As mentioned in Methods, the efficacy of carbachol was 
assessed by establishing the occurrence of postural attitudes and/ 
or movements which were not observed in any of the six control 
sessions of the monkey under study. In principle, two types of ab­
normalities were seen: pathological behaviours such as tremor, 
tongue protrustions, and blepharoptosis, i.e. manifestations which 
never occur in any healthy monkey; and behaviour such as rapid 
flexions in one leg, i.e. manifestations which can occur in healthy 
monkeys when appropriate changes in their immediate environment are 
present. As the immediate surroundings of the tested monkey were 
invariant throughout the trial, the latter behaviours too were, in 
principle, pathological. 
In table 6.2 an overview is shown of the outcome of the ex­
periments with bilateral injections of carbachol in the nucleus 
caudatus of monkeys sitting in a monkey chair (for details see 
below) and/or living in a social group. 
Motor disturbances: individual-specific responses 
Algha-males 
Non-naive (Dries). Given the previously collected knowledge that 
this alpha-male was relatively sensitive to small doses of carba­
chol (see Methods), the dose of carbachol was slowly increased in 
steps of 1 pg/0.9 μΐ during successive trials. The smallest dose 
that elicited motor disturbances was 5 pg/4.5 μΐ; the following 
disturbances were seen at the dose of 6 ug/5.4 μΐ (fig. 6.3a): 
blepharoptosis, tongue protrusions, facial twitches, and flexions 
and extensions in all toes. Doses to 9 μg did not increase the 
severity of the disturbances. When the volume of 6 μg carbachol 
(threshold dose) was fully adjusted to the volume which was pre­
viously tested in the social situation (1.8 μΐ), 6 μg carbachol 
was still able to elicit motor disturbances as shown in fig. 6.3a,*. 
The latter effect was reproducible as far as it concerned the abil­
ity to elicit motor disturbances (fig. 6.3a,*); the motor disturb-
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TABLE 6.2 
Summary of the experiments with intracaudate 
microinjections of carbachol in Java monkeys 
in the social and/or monkey chair environment 
Threshold dose of carbachol (yg) in 
monkey chair social group 
for disturbances for disturbances for disturbances 
in motor in social , in motor 
Monkey behaviour communication behaviour 
Driesd'e 
Karele'f 
Freekd'g 
d,h Sjors ' 
Miepf'1 
Boris 
Karel 1 
Sara 
X + SE 
6 
6 
12 
12 
12 
-
-
-
9.6 + 1.5 
20 
-
30 
30 
-
30 
20 
20 
25 + 2.2 
40 
-
60 
60 
-
60 
40 
40 
50 + 
a = data previousJy published (Van den Bereken and Cools 1982) 
b = matched-pair volumes; с = larger volumes (methodological reasons)· 
d = non-naive; e = alpha-male; f = naive; g = gamma-male; 
h = beta-male; i = female 
anees themselves, however, differed per trial: flexions and exten­
sions in the right foot and all toes were seen in the first trial, 
whereas tongue protrusions and blepharoptosis were seen in the 
second trial. 
Waive (Karel). In this alpha-monkey too, the dose of carbachol 
was slowly increased in steps of 1 ug/0.9 μΐ during successive 
trials. The first motor disturbances appeared at a dose of 6 pg/ 
2.7 μΐ (fig. 6.3b): tremor in the left foot, blepharoptosis, tor-
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ticollis, ear flattening, flexions and extensions in both legs, 
arms, the right hand and all fingers, and facial twitches. Larger 
doses of carbacol (8 yg/3.6 yl and 10 ug/4.5 μΐ) did not increase 
the severity of the disturbances. When the dose of 6 pg (threshold 
dose) was dissolved in a smaller volume, i.e. a volume assessed in 
the above-mentioned experiments with the non-naive alpha-male, car-
bachol (6 pg/1.8 yl) still elicited motor disturbances (fig. 6.3b,«): 
in the first trial, tremor in the left foot, blepharoptosis, facial 
twitches, and flexions and extensions in both legs and the right 
foot appeared, whereas only flexions and extensions in both legs, 
all toes and fingers were seen in the second trial. 
Lower-ranked_animals 
Non-naive (Freek and Sjors). Freek (gamma-male). From the pre­
vious experiments it was known that this lower-ranked monkey was 
less sensitive to carbachol than the alpha-monkey Dries (see 
Methods). The dose of carbachol was therefore increased in steps 
of 2.5 ug/0.9 yl. Although few motor disturbances appeared at 
doses of 5.0 and 7.5 yg (a single tremor in the right foot and a 
single flexion and extension in the toes), the dose of 10 yg/3.6 yl 
elicited more and stronger motor disturbances, effects also occur-
ing at doses of 12.5 yg/4.5 yl and 15 yg/5.4 yl (fig. 6.3c): tremor 
in both feet and lips, tongue protrusions, torticollis, flexions 
and extensions in both legs, all toes and fingers. A dose of 12 yg 
carbachol (threshold dose) was repeated twice in a volume equal to 
the smallest volume used in the social situation in the same monkey 
(2.7 yl). This small dose of carbachol was still able to elicit 
motor disturbances as shown in fig. 6.3c,». Again, the motor dis­
turbances themselves differed per trial: tremor in the right foot 
and lips, blepharoptosis, tongue protrusions, and flexions and ex­
tensions in both legs and all fingers in the first trial versus 
tremor in the lips, tongue protrusions, and ear flattening in the 
second trial. A larger dose of carbachol (16 yg/3.6 yl) elicited 
secondary epileptic seizures in this monkey. 
Sjors (beta-male). Although the sensitivity to carbachol of this 
lower-ranked monkey was the same as that of Freek (see Methods), 
the hierarchically higher rank of Sjors was the reason to increase 
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Fig. 6.3 Dose-dependency of carbachol-induced motor disturbances 
in Java monkeys. Each figure represents in a single ani­
mal the total number of different body parts which were 
affected by intracaudate injections of carbachol (Car. 
\ig/\il). For description of the signs, see Results. 
* = outcome of experiments in which an effective amount 
of carbachol was retested after having been dissolved 
in an 'adjusted' volume (see text) 
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the dose of carbachol in steps of ] yg/0.9 μΐ to 6 yg/5.4 yl. No 
motor disturbances appeared at those doses (fig. 6.3d). Larger 
doses of carbachol were increased in steps of 2 yg/0.9 yl. Few 
motor disturbances appeared at doses of 8 yg/3.6 yl and 10 yg/ 
4.5 yl (tongue protrusions and flexions and extensions in the 
right toes), but stronger disturbances were seen after 12 yg/5.4 
yl (blepharoptosis and flexions and extensions in the right leg, 
right arm, right foot, right hand and all toes and fingers), see 
fig. 6.3d, When the volume of 12 yg carbachol (threshold dose) 
was adjusted to that tested previously in the social situation 
(2.7 yl), 12 yg carbachol was still able to elicit motor disturb­
ances (fig. 6.3d,*): blepharoptosis and flexions and extensions in 
both legs, all toes and the right fingers; the latter effects were 
fully reproducible apart from an additional torticollis. 
Naive (Miep, female). The scheme of increasing the dose of carba­
chol was identical to that for Sjors; 10 yg/5.4 yl carbachol 
elicited few motor disturbances (flexion and extension in all toes) 
but the dose of 12 yg/5.4 yl elicited stronger motor disturbances 
(fig. 6.3e): tremor in the left leg and flexions and extensions in 
the right arm and all toes and fingers. Doses to 16 yg/3.6 yl did 
not extend the severity of the disturbances. Just as in Freek and 
Sjors, the dose of 12 yg (threshold dose) was repeated in 2.7 yl. 
The latter experiment was conducted only once due to problems with 
the injection system of the monkey. 12 yg Carbachol injected in 
2.7 yl still elicited motor disturbances (fig. 6.3e,*): blepharop­
tosis, tremor in the left foot, left hand, and left arm, and 
flexions and extensions in all toes. 
DISCUSSION 
General 
Considering the finding that all carbachol-treated, but not solvent-
treated monkeys showed clear-cut motor effects, the present study 
confirms earlier studies that injections of carbachol into the head 
of the caudate nucleus of subhuman primates elicit motor disturb-
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anees (Cools et al. 1975a, Murphey and Dill 1972, Van den Bereken 
1979, Van den Bereken and Cools 1982). As mentioned, both naive and 
non-naive monkeys were tested. Table 6.2 clearly shows that the 
threshold doses of monkeys with a carbachol history did not differ 
from those of monkeys without such a history: both naive alpha-
male (Karel) and the non-naive alpha-male (Dries) required 6 yg 
carbachol, whereas both the naive lower-ranked animal (Miep) and 
the non-naive ones (Freek and Sjors) required 12 μ§ carbachol. 
Thus, carefully selected time intervals between successive carba­
chol treatments can indeed prevent unwanted alterations in the 
monkey's sensitivity to carbachol (Connor et al. 1966, Dill et al. 
1976, Murphey 1971); this finding confirms reported data in carba­
chol studies on Java monkeys (Van den Bereken and Cools 1982). 
A new finding is the observation that the susceptibility to 
carbachol-induced motor disturbances appears to vary between 
alpha-males and lower-ranked animals: the threshold dose of alpha-
males (6 yg) was only 50% of that of the lower-ranked monkeys (12 
pg). In this context it is relevant to note that the alpha-males 
and lower-ranked animals also differed with respect to their be­
haviour during the habituation phase: in contrast to the lower-
ranked animals, which did not habituate, the alpha-males habituated 
(see Results). Although the present data are insufficient to draw 
hard conclusions in this respect, it opens the possibility that 
differences in the basal activity of the cholinoceptive system 
under study may underly the noted distinction between alpha-males 
and lower-ranked animals; such a central difference might be the 
counterpart of the peripheral, hormonal differences between monkeys 
with different ranks (Bellarosa et al. 1980, Сое et al. 1979, Del­
gado et al. 1976, Eberhart et al. 1983, Miczek and Gold 1983, 
Poignant and Avril 1978). In this context it is interesting to re­
call that the naive monkey Karel - being a solitary-living animal 
before the chair experiments - turned out to be a group leader 
after having been placed into a group at termination of the chair 
experiments. Given the notion that the original degree of the 
basal activity of the monkey's cholinoceptive system will at least 
parly determine its sensitivity to carbachol, it is not unlikely 
that the individual degree of basal activity of this system pre-
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disposes the monkey to a particular rank in the social structure. 
Future studies are necessary to provide evidence in that respect. 
Concerning the motor disturbances themselves, two remarks 
should be made. First, the carbachol-induced effects were mainly 
restricted to the limbs, especially the more distal parts (foot, 
toes, and fingers), and to the orofacial musculature (tongue, lip, 
and upper eyelid; table 6.3). Second, there was no consistency 
throughout the experiments as far as the affected body parts were 
concerned. Only the rapid flexions and extensions of foot, hand, 
toes, and fingers were seen in all tested monkeys during the first 
trial of injections with a so-called adjusted volume; even this ef-
fect was replaced by other motor disturbances when the former 
manipulation was repeated with the same monkey under identical 
circumstances (table 6.3). In fact, carbachol produced consistent 
effects only with regard to its ability to elicit motor disturb-
ances: all carbachol-treated monkeys showed one or another type 
of motor effect. Although the intra- and interindividual vari-
ability could not be fully explained, it is worthwhile to con-
sider two possible factors. As mentioned, stressors influence the 
TABLE 6.3 
Percentage of isolated and restrained Java monkeys showing motor dis-
turbances in particular parts of their body after intracaudate micro-
injections of the threshold dose of carbachol in 'adjusted' volumes 
Percentage 
Affected body parts 1st test (n»5) 2nd test (n=4) 
Distal parts of the extremities 100 50 
Proximal parts of the extremities 60 50 
Orofacial musculature 80 75 
Torticollis 0 25 
a = see Results 
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hormonal and neurochemical state of organisms. Accordingly, both 
individual and state-dependent differences in susceptibility to 
stress might have contributed to the variability noted. Another, 
more powerful, explanation is based upon the observation that the 
carbachol-treated monkeys were able to suppress experimentally in-
duced movements, especially those involving the limbs, hands, feet, 
toes, and fingers: pressing the affected limbs etc. against the 
body, catching the affected body part with the non-affected hand or 
foot and, even, beating the affected body part were effective ma-
noeuvres in this respect. These observations were supported by 
experiments in which monkeys received their threshold dose after 
being placed in a chair equipped with bars: these monkeys did, 
indeed, sooner or later grasp the bars with the carbachol-affected 
body parts with the result that the symptoms disappeared. 
Motor disturbances in restrained and non-restrained monkeys 
As mentioned in the Introduction, a dose of 40 to 60 yg carbachol 
has been found to be required for eliciting motor disturbances in 
Java monkeys which were living in a stabilized hierarchic structure. 
The present study shows that only 6 to 12 yg carbachol was required 
for eliciting such effects in restrained monkeys (table 6.2). Be-
fore discussing the effects of carbachol in restrained monkeys in 
relation to those in non-restrained monkeys (see next two para-
graphs), it is necessary to consider the following. The noted dif-
ferences might be attributed to a) differences in the carbachol 
history of the individual animals, b) differences in the affected, 
neuronal substrates, and c) differences in the monkey's ability to 
suppress the motor disturbances. However, the threshold doses of 
carbachol did not differ between naive and non-naive monkeys as 
mentioned above, excluding thereby possibility a. Moreover, three 
of the five tested monkeys participated in both studies and, con-
sequently, received their injections into one and the same brain 
region. Since the volume given to the restrained monkeys was, in 
addition, even smaller than that given to non-restrained monkeys, 
it could never have affected a brain region larger than that af-
fected in non-restrained monkeys. In other words, the greater 
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efficacy of carbachol in restrained monkeys could not be due to the 
activation of additional neurons, excluding thereby possibility b. 
Given the monkey's ability to suppress the carbachol-induced motor 
disturbances (see above), one might wonder whether the lower effi-
cacy of carbachol in freely moving monkeys resulted simply from 
an increased capacity to mask their signs. The following finding 
rejects this explanation too: restrained monkeys show secondary 
epileptic seizures after 10 to 20 pg carbachol (see Results; 
Cools et al. 1975a) in contrast to non-restrained monkeys which 
show these effects after a minimum amount of 50 to 70 \ig carba-
chol (unpublished data. Van den Bereken). 
Taking the above considerations altogether, the noted differ-
ence between restrained and non-restrained monkeys can be ascribed 
only to factors inherent to differences in the chosen environmental 
circumstances in which the monkeys were tested. Since various de-
grees of stress affect the neurochemical state of animals (Anisman 
and Sklar 1981, Bliss and Ailion 1971, Brunello et al. 1981, Costa 
et al. 1980), it is not surprising that the response to carbachol 
of a monkey in a chair significantly differed from that of a free-
ly living monkey. Our findings actually indicate that the stress 
inherent to the restraint anyhow increased the susceptibility of 
the cholinoceptive substrate within the caudate nucleus. 
Caudate nucleus: disturbances in social communication behaviour 
and motor behaviour 
The ultimate purpose of our study was to establish whether motor 
disturbances could be elicited from intracaudate regions similar 
or dissimilar to those involved in the display of disturbances in 
social communication. Considering table 6.2, our results provide 
direct evidence that the brain region involved in the display of 
motor disturbances is either similar to the brain region involved 
in disturbances in social communication or, even, lies within the 
latter brain region. First, the doses required for eliciting motor 
disturbances in restrained monkeys (6 to 12 pg; n=5) were much 
smaller than those required for eliciting disturbances in social 
communication of non-restrained monkeys (20 to 30 yg; n-6). 
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Second, the effective volumes were fully matched. Both facts exclude 
the possibility that the motor disturbances were elicited from struc-
tures lying outside the region responsible for the disturbances in 
social communication. Recently it has become possible to show that 
motor symptoms, which are elicited in cats with a dys functioning 
caudate nucleus, are actually manifestations of a reduced ability 
to switch arbitrarily to non-exteroceptively directed movements 
(Cools et al. 1984a, Jaspers et al. 1983). Because the disturbances 
in social communication of Java monkeys with a dysfunctioning 
caudate nucleus also turned out to be manifestations of an altered 
ability to switch arbitrarily to non-exteroceptively directed 
social interactions (Van den Bereken and Cools 1982), it now be-
comes understandable why both types of disturbances (at the level 
of social communication and at the level of motor behaviour) share 
identical features. Both types of disturbances are the consequences 
of changing the function of one common substrate: the present study 
shows that there is no distinction between motor disturbances and 
disturbances in social communication as far as the involvement of 
the cholinoceptive substrate(s) within the caudate nucleus of Java 
monkeys is concerned. 
Degree of dysfunctioning: relation between disturbances in social 
communication and motor behaviour 
It has been reported that the threshold dose of carbachol for elicit-
ing motor disturbances in freely moving monkeys is far greater than 
that required for eliciting disturbances in social communication in 
such monkeys (Van den Bereken and Cools 1982). Considering those 
data in view of the absence of any significant distinction between 
the involvement of a circumscribed neurochemical, intracaudate re-
gion in motor disturbances and disturbances in social communication 
(see above), it appears justified to suggest that the dose-dependent 
appearance of nonmotor and motor disturbances reflects differences 
in the degree of dysfunctioning of the brain region under study. 
This suggestion implies that distinct behavioural consequences of 
different doses of carbachol should be due to different conse-
quences at the level of the output stations of the caudate nucleus 
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rather than due to different consequences within the caudate 
nucleus itself. Indeed, there is already evidence that a grossly 
dysfunctioning caudate nucleus produces a dysfunctioning sub-
stantia nigra, pars reticulata, i.e. a main output station of the 
caudate nucleus, in contrast to mildly dysfunctioning caudate 
nucleus which does not produce such a dysfunctioning at the nigral 
level (Cools et al. 1984a). From this point of view it may become 
understandable why small doses of carbachol produce only disturb-
ances in social communication in contrast to larger doses, which 
also produce motor disturbances: in the former case the doses are 
too small to alter the nigral function; in the latter case, how-
ever, the doses are at least able to produce a dysfunctioning at 
the nigral level and, possibly, hierarchically lower levels within 
the brain. 
Clinical impact 
Given the animal data that motor disturbances inherent to a dys-
functioning caudate nucleus require a larger degree of dysfunc-
tioning than nonmotor disturbances, it appears justified to pre-
dict that motor disorders of patients with a dysfunctioning 
caudate nucleus of which the degree of pathology slowly progresses, 
will be preceded by other manifestations. Because patients with 
Parkinson's disease, a disease in which the caudate nucleus is 
known to be involved, have been recently found to suffer from 
both subtle cognitive and overt motor disturbances which are 
fully analogous to the above-mentioned disorders in animals with 
a dysfunctioning caudate nucleus (Cools et al. 1984c), our study 
opens the possibility that the latter cognitive manifestations 
may, indeed, appear in an earlier stage of the disease than the 
well-known motor disorders do in these patients. This, in turn, 
implies that these cognitive manifestations may be useful tools 
to diagnose such patients at a very early stage of their disease. 
In fact, the latter holds true for all diseases inherent to a 
slowly progressing pathology of the caudate nucleus, for example, 
Huntington's disease, Wilson's disease, etc. 
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In sum, the present study provides evidence in favour of the 
following conclusions. First, motor disturbances and disturbances 
in social communication are closely coupled as far as the involve-
ment of a particular cholinoceptive substrate within the caudate 
nucleus of Java monkeys is concerned. And, second, the motor dis-
turbances under study appear to require a larger degree of dys-
functioning of this substrate than do the subtle disturbances in 
the social communication of these monkeys. The clinical impact of 
our findings is significant in view of differences between the pre· 
morbid and manifest phases of Parkinson's disease. 
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CHAPTER 7 
EFFECTS OF INTRACAUDATE INJECTIONS OF CARBACHOL IN JAVA MONKEYS 
ON NON-EXTEROCEPTIVEI/r AND EXTEROCEPTIVELY DIRECTED BEHAVIOUR 
INTRODUCTION 
Small changes in neuronal activity at the level of dopaminergic or 
cholinergic receptors in the striatum of animals have been found to 
influence the animal's ability to change ongoing behaviour without 
the use of exteroceptive stimuli, i.e. non-exteroceptively directed 
behaviour, whereas larger changes induce 'pure' motor disturbances, 
i.e. dyskinetic movements (for review: Cools et al. 1984c; Chapter 
2). Thus,increasing cholinergic activity by local injections of the 
cholinergic agonist carbachol into the caudate nucleus of Java mon-
keys living in a social group induces increased variability of be-
haviours not directed by the partner after low doses (20-30 pg), 
and dyskinetic movements after higher doses (40-60 pg; Van den 
Bereken 1979, Van den Bereken and Cools 1982). Moreover, decreasing 
cholinergic activity in the caudate nucleus of the monkeys by local 
injections of the cholinergic antagonist atropine induces an in-
crease in behaviours directed by the partners. Comparable effects 
have been found after peripherally applied drugs known to change 
striatal dopaminergic activity. Low doses of the dopamine-releasing 
agent amphetamine in Squirrel monkeys or the dopamine agonist apo-
morphine in ferrets increase behavioural activities not directed by 
the partner(s), whereas higher doses of the drugs induce stereo-
typies in both species (Miczek and Gold 1983, Schmidt 1984 resp.), 
and a low dose of the dopaminergic antagonist haloperidol in fer-
rets induces an increase in behavioural activities directed by the 
partner (Schmidt 1984). Given the fact that small changes in the 
striatal cholinergic activity alter non-exteroceptively directed 
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behaviour, the question arises whether the dyskinetic effects elicit-
ed by greater changes in the striatal cholinergic activity are also 
limited to non-exteroceptively directed motor acts. In that case 
both disturbances in programming motor behaviour and disturbances 
in programming non-motor behaviour can be reduced to one and the 
same programming disturbance, viz. a change in the ability to switch 
to non-exteroceptively directed behaviour. Accordingly, it would 
just be the degree of pathology that determines whether a striatal 
disturbance manifests itself at the non-motor or motor level. For 
that purpose the present study analyzes the nature of striatally 
elicited dyskinetic movements in more detail. 
Apart from this, the present study analyzes the putative differences 
betweeen dominant and non-dominant monkeys in this respect for the 
following reason. The above-mentioned study with Java monkeys has 
also shown that changes in the non-exteroceptively directed behav-
iour of the dominant monkeys require a smaller dose of carbachol 
(20 pg) than changes in the non-exteroceptively directed behaviour 
of the non-dominant monkeys (30 yg) (Van den Bereken 1979). Such 
differences are maintained, even when the experiments are performed 
with isolated monkeys that are, in addition, restrained (Chapter 
6). Thus, an isolated dominant monkey that is restrained requires 
a smaller dose of carbachol to display dyskinetic movements (6 yg) 
than a non-dominant monkey requires (12 pg). The differences have 
been suggested to result from a difference in striatal cholinergic 
activity between both kinds of monkeys: the dominant monkeys have 
been suggested to have a higher cholinergic activity than the non-
dominant monkeys. Given the fact that the striatal cholinergic act-
ivity determines the degree of independence of non-exteroceptive 
stimuli, it can be postulated that dominant and non-dominant monkeys 
will show fundamental differences as far as it concerns the carba-
chol-induced appearance of non-exteroceptively directed and extero-
ceptively directed behaviour. 
The present study shows that the carbachol-induced dyskinetic move-
ments affected only behaviours which are specific to the function 
of the striatum, i.e. the non-exteroceptively directed movements. 
Furthermore, it was possible to establish that the baseline activ-
ity of the dominant versus the non-dominant monkey differs in the 
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dependency on exteroceptive stimuli to change ongoing behaviour. 
The individual-specificity of that behaviour indeed appears to be 
related to the degree of baseline activity of the cholinoceptive 
substrate in the monkeys, since lower doses of carbachol were needed 
to induce dyskinetic movements in the dominant male as compared to 
the non-dominant male (6 Mg versus 15 pg). 
MATERIALS AND METHODS 
Subjects 
Two adult, male Java monkeys (Macaca fascicularis), weighing 4.5 kg, 
were used. The dominant male (Karel) was previously tested in the 
isolation plus restraint condition in which the display of dyskine­
tic movements required 6 pg/l.8 μΐ (Chapter 6). The non-dominant 
male (Sjors) was previously tested a) in a social situation in 
which the display of disturbances limited to alterations in his 
social communication required 30 pg/2.7 μΐ, whereas the additional 
display of dyskinetic movements required 60 μ§/5.4 μΐ (Van den 
Bereken 1979), b) in an isolation plus restraint condition in 
which the display of pure motor disturbances required 12 pg/2.7 μΐ 
(Chapter 6). 
After isolation plus restraint experiments Karel was placed in a 
group in a large cage (250 χ 200 χ 200 cm); he turned out to be 
a dominant male. The non-dominant monkey Sjors remained living 
solitair in a cage (60 χ 60 χ 80 cm) from which he could have 
visual, auditory and physical contact with other monkeys. 
Before the present experiments the monkeys did not receive any 
other pharmacological treatment. As the monkeys still had their 
permanently implanted (outer) cannulas pointed at the head of the 
caudate nucleus at the time of this study, it became possible to 
retest them in the situation described below. 
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Experimental procedure 
For each series of experiments, the monkeys were placed in an ex­
perimental cage (60 χ 60 χ 65 cm; fig. 7.1) in a separate room. In 
general the experimental procedure was held identical to the pro­
cedure in the monkey chair (see Chapter 6). 
The monkeys were habituated to the experimental cage for 7 days, 
3 h/day. After the habituation phase, Karel underwent six tests 
with bilateral injections of solvent (1.8 μΐ) and five tests with 
bilateral injections of carbachol: three times 3 pg/0.9 μΐ and two 
times 6 μg/l,8 μΐ. Sjors underwent four tests with bilateral injec-
Fig. 7.1 Java monkey sitting in the experimental cage 
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tions of solvent, i.e. distilled water, (2.7 μΐ) and nine tests with 
bilateral injections of carbachol: three times 9 \ig/2.7 μΐ, three 
times 15 ug/2.7 μΐ and three times 21 ]ig/2.7 μΐ. The injections were 
applied through inner-cannulas connected with chemistors, equipped 
with reservoirs, placed on the head of the monkey. Remote control 
was used dor directing the chemistors (for further details, see 
Chapter 6, Cools et al. 1975b, Van den Bereken and Cools 1982). 
Each experiment lasted 60 minutes, divided in a pre-injection period 
and three post-injection periods of 15 minutes each. All experiments 
were conducted at intervals of 4 to 5 days between 10.50 and 11.50 
am. At termination of each experiment the monkeys returned to their 
home cage. 
Data analysis 
The spontaneous occurring and drug-induced behaviour was analyzed 
qualitatively and quantitatively with the help of video tape re­
cordings. The results of the previous experiments were used to 
describe the carbachol-induced dyskinetic movements (Chapter 6). 
In table 7.1 a summary is given of the items used to determine the 
number of changes in motor behaviour (variability). Qualitatively 
it was analyzed: 
1. whether changing ongoing motor behaviour was directed towards 
parts of the body, parts of the cage or auditory stimuli, i.e. 
exteroceptively directed movements, or not, i.e. non-exterocept-
ively directed movements. 
2. what type of behavioural changes occur. 
Quantitatively the total number of movements, i.e. changes in motor 
behaviour, was counted in each experiment per period of 15 min, i.e. 
the pre-injection period and the three post-injection periods. For 
each set of experiments the behavioural variability was determined 
by the mean of the total number of movements per period of 15 min. 
The pre-injection period served as baseline to establish the effect 
of the injections on the behavioural variability in the three sub­
sequent post-injection periods. 
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TABLE 7.1 
Summary of behavioural items 
Movements of oro-facial-lingual-buccal muscles (*/*») 
Movements of the head (*/**) 
Movements of limbs, trunk and tail (*/**) 
Displacements of the whole body (*/**): sit down; walk (quadruped, 
triped or diped); stand up; 
lie down; hang to the wall; 
bounce while hanging to the 
wall; jump up and down on 
the floor 
* Type 1 Exteroceptively directed movements 
- self-directed : grooming parts of the body, chewing 
on hairs pulled from the fur 
- object-directed: licking, biting, picking, rubbing and 
slapping of the cage, walking straight 
towards a corner of the cage 
- directed towards auditory stimuli 
«к Type 2 Non-exteroceptively directed movements 
all movements not directed by the above-mentioned factors 
Injection sites 
After completion of the entire experimental series with Sjors, the 
injection sites in this monkey were histologically verified: A 16.5, 
L 5.0, H 14.0 (according to Snider and Lee 1961). For experimental 
reasons Karel is still alive. 
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RESULTS 
Qualitative analysis 
Throughout the habituation phase, the control experiments and the 
carbachol experiments the monkeys showed individual-specific be­
haviours . 
Karel, in general, was continuously active in the experimental cage, 
in contrast to his rather calm appearance in his home cage. Karel 
displayed all behaviours mentioned in table 7.1 very frequently. 
This monkey showed the following non-exteroceptively directed move­
ments: walking quadruped through the cage, bouncing and jumping. 
All other behavioural changes always involved self-directed and 
object-directed behaviour, or were part of a reaction to auditory 
stimuli. When the door was opened and the experimenter approached 
the cage, Karel did not react aggressively, but sat down in the 
front of the cage. During the transport back to the home cage 
Karel remained sitting in the cage. 
The solvent as well as the lowest dose of carbachol (3 pg/0.9 μΐ) 
induced neither qualitatively observable changes in 'spontaneous' 
behaviour nor dyskinetic movements. The highest dose (6 pg/1.8 μΐ) 
elicited dyskinetic movements, which were not comparable to the 
ones seen in the previous isolation plus restraint experiments 
after б pg/1.8 μΐ. In the present study the dyskinetic movements 
were not observed in isolated parts of the body, but in the non-
exteroceptively directed displacements of the whole body: Karel 
could not correctly perform quadruped walking, jumping and bounc­
ing. During walking the hindlimbs were displaced at the same time. 
During jumping it was as if an uncoupling had taken place between 
the upper and the lower part of the body: first the hands were 
lifted from the floor and not until they were back on the floor 
again the feet were lifted from the floor. This latter disturbance 
probably also played a role in the disturbance of bouncing. The 
display of quadruped walking, jumping and bouncing as well as the 
other body displacements were temporarily decreased, whereas yawn­
ing and chewing, i.e. non-exteroceptively directed behaviours, 
appeared (fig. 7.2A and B). 
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Sjors, in general, displayed the same behaviour as in his home cage: 
predominantly sitting in a corner with the head bent forwards and 
the arms and hands held between the legs. Sjors showed the following 
non-exteroceptively directed movements: infrequent lifting of the 
toes or a foot from the floor, short-lasting movements of an arm, 
hand, leg or the head. Every now and then Sjors walked towards an­
other corner of the cage and sat down again in his characteristic 
posture. Sjors hardly displayed any self-directed or object-directed 
behaviours; however, he reacted to auditory stimuli inherent to the 
opening of the door of the experimental room at the end of the ex­
periment. The latter reaction resulted in a brief period of walking 
through the cage. When the experimenter entered the room and ap­
proached the cage, Sjors reacted aggressively. During the transport 
back to the home cage, Sjors remained walking through the cage and 
reacting aggressively. 
The solvent injections neither induced qualitatively observable ef­
fects on the 'spontaneous' behaviour nor dyskinetic movements. The 
lowest carbachol injection (9 ug/2.7 μΐ) induced no dyskinetic move­
ments; however, an increase in non-exteroceptively directed movements 
was seen: movements of all parts of the body and chewing as well as 
non-exteroceptively directed movements, i.e. displacements of the 
whole body. The first, few, consistent dyskinetic movements appear­
ed at the dose of 15 pg/2.7 μΐ in the non-exteroceptively directed 
movements of the head and limbs: torticollis and extension of the 
legs. The dyskinetic movements were partly counteracted by extero-
ceptively directed body displacements, i.e. lying or standing on 
the disturbed limb. This was even more clearly seen after the high­
est dose (21 pg/2.7 μΐ), which also elicited dyskinetic movements 
in the non-exteroceptively directed movements of head and limbs 
(comparable to the ones seen in the previous study after 12 pg/ 
2.7 μΐ; Chapter 6): flexions and extensions in arms, legs, the 
right foot and toes, as well as torticollis. After 15 \ig and 21 pg 
carbachol non-exteroceptively directed body displacements were 
not observed. 
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Quantitative analysis 
The behavioural variability of the monkeys before and after control 
and carbachol injections is shown in fig. 7.2 (Karel) and fig. 7.3 
(Sjors; Wote the difference in the scale as compared to fig. 7.2). 
In fig. 7.2A and 7.ЗА the total number of movements displayed by 
Karel and Sjors respectively per 15 min (mean of the trials per 
experiment) is depicted in four blocks, i.e. one pre-injection block 
(hatched) and three post-injection blocks. The contribution of the 
movements of the distinct parts of the body is similarily depicted 
in fig. 7.2B and fig. 7.3B respectively. 
Contro1_inject ions 
Karel did not show any change in his behavioural variability after 
the injections with the vehicle (fig. 7.2). Sjors showed a slight 
increase in the behavioural variability after the injections with 
the vehicle, due to a slight increase in the solitary movements 
of parts of the body in the post-injection blocks I and II and in 
the displacements of the whole body in the post-injection block III 
(fig. 7.3). 
Carbachol injections 
After a dose of 3 pg carbachol Karel showed a small increase in the 
behavioural variability (fig. 7.2A), due to increases in movements 
of parts of the body and displacements of the whole body in the 
post-injection periods I and II (fig. 7.2B). After a dose of 6 pg 
carbachol, Karel showed a decrease in behavioural variability in 
the post-injection block I (fig. 7.2A), predominantly due to a 
strong decrease of body displacements (fig. 7.2B), whereas a small 
increase was seen in chewing and yawning as well as movements of 
limbs, trunk and tail. 
After a dose of 9 \ig carbachol Sjors showed a strong increase in 
the behavioural variability in all groups of behavioural items, 
predominantly in the post-injection blocks I and II (fig. 7.ЗА and 
7.3B). After 15 yg as well as after 21 pg carbachol the increase 
in the behavioural variability (fig. 7.ЗА) was only found in the 
post-injection block I and predominantly due to increased movements 
171 
KAREL 
A : Total number of movements 
counted per 15 min : 
mean ì SEM of 2-6 trails per treatment 
600 
500-
400 
300 
200 
100 
è 
r 
I II III I II III I II III 
VEHICLE (n=6) 3 pg GARB (n=3) 6 μ 9 GARB (n=2) 
U l i pre-injection period I I post-Injection periods 
• dyskinetic movements present 
7.2 Effects of intracaudate injections of carbachol 
m the dominant Java monkey (Karel) on non-extero-
ceptively and exteroceptively directed movements 
KAREL 
В Number of movements inherent in distinct parts 
of the body counted per 15 mm · 
mean i SEM of 2-6 trails per treatment 
100-
5 0 -
0-
150 
100 
50 
movements of oro-facial-lmgual-buccal muscles 
TYPE i*/2** 
E£ZJ i H n 
movements of the head TYPE 1 
'Mr1-
Ш 
300-
200 
100 
movements of limbs, trunck and tail . TYPE 1* 
I 
έ 
ш 
ir 
100 displacements of the whole body : TYPE 1* 
X 
displacements of the whole body : TYPE 2 
100n · · · 
I 
M 
I ll III I II III I II III 
VEHICLE (n=6) 3 pg CARB (n-3) 6 щ CARB (n=2) 
i l i pre-mjection period I I post-injection periods 
• dyskmetic movements present 
* TYPE 1: exteroceptively directed movements 
* * TYPE 2· non-exteroceptively directed movements 
Fig. 7.2 continuation 
I73 
SJORS 
A : Total number of movements 
counted per 15 min : 
mean ± SEM of 3-4 trails per treatment 
140 
120 
100 
• · · 
I II III I II III I II III I II III 
VEHICLE (n=4) 9 pg CARB (n-3)15 >jg CARB ( n - 3 ) 2 1 yg CARB (n=3) 
Ι ϋ pre-injection period I I post-injection periods 
• dyskmetic movements present 
Fig. 7.3 Effects of mtracaudate injections of carbachol 
in the non-dominant Java monkey (Sjors) on non-
exteroceptively and exteroceptively directed 
movements 
174 
SJORS 
В : Number of movements inherent in distinct parts 
of the body counted per 15 min : 
mean ì SEM of 3-4 trails per treatment 
40 
20 
movements of the head : TYPE 2** 
^ r a 
• · · 
Φ. 
i 
80 
60-
40 
20 
movements of limbs, trunck and tail : TYPE 2s1 
m 
τ 
40 
20-
displacements of the whole body :TYPE 1* 
^ Ч ^ 
ь. 
χ 
χ 
I II III I II III I II III I II III 
VEHICLE (n=4) 9 pg CARB (n=3)15 pg CARB (n=3)21 pg CARB (n=3) 
m À pre-injection period I I post-injection periods 
• dyskinetic movements present 
* TYPE 1: exteroceptively directed movements 
* * TYPE 2: non-exteroceptively directed movements 
Fig. 7.3 continuation 
175 
of the head, chewing and an increase in body displacements (fig. 7.3B; 
see qualitative analysis). 
DISCUSSION 
Before discussing the results of the present study within the scope 
of non-exteroceptively and exteroceptively directed behaviours, and 
the role played by the (possible) difference between the cholinergic 
activity in the caudate nucleus of the two monkeys in these behav-
iours, the following has to be considered. 
Though differences in home situations, i.e. socially living (Karel) 
versus solitary living (Sjors), might have contributed to the noted 
differences between these monkeys, this is highly unlikely in view 
of the fact that isolating monkeys from either condition induces 
comparable stress-related changes (Vogt et al. 1981, Levine et al. 
1985, respectively). Differential reactivity to the availability 
of food or water can also be excluded, since these items were 
simply not present (cf. Delgado et al. 1976). Thus, the differences 
found have to be ascribed to the differential sensitivity to carba-
chol of the dominant and non-dominant monkey respectively. 
Carbachol-induced dyskinesia 
Drug-induced increases of peri-oral movements in animals are often 
classified as oro-facial dyskinesia (Domino and Kovacic 1983, Ger-
lach 1979, Scheel-Krüger and Arnt 1985, Ushijima et al. 1984, 1985). 
In the present study, however, yawning (Karel) and chewing (Karel 
and Sjors) was not abnormal, but only increased in frequency just 
like the other movements. It is therefore decided not to classify 
them as being dyskinetic. The remaining carbachol-induced movements 
that were unequivocally dyskinetic were solely present in non-ex-
teroceptively directed behaviours: only quadruped walking, bouncing 
and jumping shown by Karel (6 yg) and the solitary and brief move-
ments of the head and limbs shown by Sjors (15 yg and 21 yg). 
Thus, relatively high doses of intra-caudate injected carbachol 
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produced dyskinetic movements that were not directed by external 
stimuli. In other words, both carbachol-induced changes in the 
social interaction (Van den Bereken 1979) and carbachol-induced 
dyskinetic movements are marked by one and the same disturbance, 
i.e. an increase in non-exteroceptively directed behaviour. Since 
carbachol-induced changes in the social interaction of freely mov­
ing monkeys require a small er dose of carbachol than carbachol-
induced dyskinetic movements in freely living monkeys (Van den 
Bereken 1979), it can be concluded that it is just the degree of 
pathology that determines at which level of the behavioural or­
ganization carbachol-induced disturbances manifest themselves. 
Carbachol-induced changes in normal behaviour 
The relative increase in behavioural variability is low in Karel 
(10-30%; fig. 7.2A), but high in Sjors (75-300%; fig. 7.ЗА) after 
intracaudate injections of carbachol in a dose not yet inducing 
dyskinetic movements, 3 pg and 9 pg respectively. Comparable ef­
fects have been found in animals performing a lever-pressing task 
as well as in an active avoidance test, i.e. a maximal basal rate 
of performance cannot be improved, whereas a low basal rate of 
performance can (Prado-Alcalá and Cobos-Zapiain 1979, Prado-Alcalá 
et al. 1984). The present results may imply that the different 
rate of performance in a task between animals of the same species 
may be due to a difference in basic neuronal activity in these 
animals. Anyhow, the present results show that carbachol could not 
ameliorate the ability of switching to non-exteroceptively directed 
behaviour in the dominant monkey, whereas it did in the non-dominant 
monkey. Since lower doses of carbachol were needed to elicit dys-
kinetic movements in the dominant monkey than those eliciting ana-
logous movements in the non-dominant monkey, both sets of data to-
gether support the hypothesis that the striatal cholinergic activ-
ity of the dominant monkey is higher than that of the non-dominant 
monkey. Additional evidence in favour of this hypothesis is pro-
vided by the data collected in the control periods. 
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Differences in baseline activity 
The analysis of the baseline activity of the dominant monkey Karel 
reveals that he very frequently changed ongoing behaviour (fig. 
7.ЗА), either non-exteroceptively directed, i.e. quadruped walking 
through the cage, bouncing and jumping, or exteroceptively directed, 
i.e. self-directed grooming and object-directed behaviour such as 
cage manipulations (fig. 7.2B). 
The analysis of the baseline activity of the non-dominant monkey 
Sjors reveals that he very infrequently changed his ongoing behav­
iour (fig. 7.ЗА; Wote the difference in scale as compared to fig. 
7.2A), predominantly non-exteroceptively directed, i.e. solitary 
and brief movements of facial muscles, head, limbs, trunk and tail 
(fig. 7.3B), and few exteroceptively directed, i.e. walking from 
one corner of the cage towards another. Sjors clearly reacted to 
stimuli from the environment (see Results). 
Given the fact that striatal cholinergic activity determines the 
degree of independence of exteroceptive stimuli (Chapter 4), the 
noted differences between the dominant and non-dominant monkey 
imply that the striatal cholinergic activity of the dominant 
monkey surmounts that of the non-dominant monkey. 
Miscellaneous 
The ability of carbachol to elicit dyskinetic movements in 
a) freely living and socially interacting non-dominant monkeys 
(Van den Bereken 1979), 
b) freely living and isolated non-dominant monkey (present study), 
and 
c) restrained and isolated non-dominant monkeys (Chapter 6) 
appears to vary from situation to situation. Thus: 60 \ig carba­
chol elicits dyskinetic movements in the freely living and 
socially interacting non-dominant monkey, 21 yg elicits dyskinetic 
movements in the freely living and isolated non-dominant monkey, 
and 12 yg carbachol elicits these movements in the isolated and 
restrained non-dominant monkey. Since stress is known to alter 
the neuronal and hormonal activity (Brunello et al. 1981, Сое et 
al. 1979, Costa et al. 1980, Eberhart et al. 1983, Glavin 1985, 
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Kant et al. 1985, Keller et al. 1983), on the one hand and is 
found to increase the susceptibility to carbachol on the other 
hand (Chapter 6) it is clear that isolation of freely living 
monkeys is 
a) more stressing than procedures allowing the monkey to inter-
act with its partners, and 
b) less stressing than procedures in which the monkey is isolated 
as well as restrained. 
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EPILOGUE 
The experiments described in this section were carried out to 
determine the characteristic and specific function of the striatum 
in programming motor and non-motor behaviour. For that purpose the 
(drug-induced) behaviour of animals in new and well-known experi-
mental conditions was analyzed on the basis of the conclusions from 
Section I: 
1. the neuronal activity in the striatum determines the degree in 
which non-cxteroceptive and exteroceptive stimuli are needed in 
programming motor and non-motor behaviour; 
2. the behavioural effects of a hypofunctioning striatum may be 
masked when the tests permit the integration of additional extero-
ceptive stimuli by which the organism is able to change ongoing 
behaviour. If that is the case, the organism will show a stronger 
dependence on or a stronger reaction towards those exteroceptive 
stimuli. 
In each experimental condition it was possible to examine the 
influence of non-exteroceptive and exteroceptive stimuli on chang-
ing ongoing behaviour. The overall results of the experiments are 
the following. 
Intrastriatally injected low doses of drugs, which increase 
neuronal activity in the striatum, but do not induce 'pure' motor 
disturbances, lead to an increase of programming motor (Chapter 7) 
and non-motor (Chapter 4) behaviour directed by non-exteroceptive 
stimuli, and allows changing ongoing behaviour independently of 
exteroceptive stimuli (Chapters 4 and 7). 
Intrastriatally injected low doses of drugs which decrease 
neuronal activity in the striatum, but do not induce 'pure' motor 
disturbances, lead to an increase of programming non-motor behav-
iour directed by exteroceptive stimuli (Chapter 4). 
Gradually increasing the activity of neostriatal output 
neurons increases programming motor behaviour directed by non-
exteroceptive stimuli, and decreases the ability of changing on-
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going behaviour directed by exteroceptive stimuli (Chapters 4 and 
5). 
Gradually decreasing the activity of neostriatal output 
neurons increases the dependence on changes in exteroceptive 
stimuli in changing ongoing behaviour (Chapters 4 and 5). 
The experiment condition, in which the organism is tested, 
determines the effect of increasing neuronal activity in the 
striatum on changing non-motor behaviour (Van den Bereken 1979) 
and motor behaviour (Chapter 7) directed by non-exteroceptive 
stimuli, or 'pure' motor disturbances (Chapters 6 and 7). 
Baseline neuronal activity in the striatum determines the 
degree in which behaviour is directed by non-exteroceptive and 
exteroceptive stimuli, as well as the effects of intrastriatally 
injected drugs on that behaviour (Chapters 6 and 7). 
All experimental conditions described in this thesis make 
it possible to establish the influence of baseline neuronal 
activity as well as (unknown) drug-induced changes in neuronal 
activity in the striatum on either an increased ability to use 
non-exteroceptive stimuli in programming behaviour, or a de­
creased ability to use non-exteroceptive stimuli leading towards 
stimulus substitution, i.e. a dependence on changes in extero­
ceptive stimuli, which differ per experimental condition and per 
type of drug used (dopaminergic, cholinergic or GABA-ergic). 
In general 
Animals with an (drug-induced) hyperfunctioning striatum demon­
strate that the common denominator, i.e. the characteristic and 
specific function of the striatum, in each experimental condi­
tion is the ability to use non-exteroceptive stimuli in program­
ing motor and non-motor behaviour on all behavioural levels 
(table 2.2). 
A strong increase in neuronal activity of the striatum induces an 
'abnormal' increase in changing ongoing behaviour directed by non-
exteroceptive stimuli independently of the experimental condition. 
In contrast, animals with a hypofunctioning striatum show that de-
dependent on the experimental condition different exteroceptive 
1Θ2 
Stimuli are used to direct changing ongonig behaviour. 
A decrease in neuronal activity in the striatum induces an 'ab-
normal' increase of changing ongoing behaviour directed by extero-
ceptive stimuli, which differ per experimental condition. Further 
studies are in progress to reveal whether these different extero-
ceptive stimuli are characteristic and specific to the function 
of different 'lower-order' structures in the CNS. 
Finally, in the analysis of drug-induced effects on the 
function of the striatum in behaviour, it must be determined 
whether the experimental condition allows changing ongoing be-
haviour directed by non-exteroceptive stimuli and which extero-
ceptive stimulus is used when neuronal activity in the striatum 
is decreased by the drug. The animal models presented in this 
section are useful for testing substances which are believed to 
infer with neuronal activity in the striatum. 
Thus, it is shown that an optimal functioning striatum en-
ables the animals to use non-exteroceptive stimuli in programming 
motor and non-motor behaviour. In this way, an optimal function-
ing striatum enables the animals to function optimally in every 
environment, i.e. to survive successfully. 
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SECTION I I I 

CHAPTER 8 
PARKINSON'S DISEASE: PATHOLOGY 
INTRODUCTION 
Since James Parkinson first described the clinical symptoms of "the 
shaking palsy" in 1817, extensive work is performed to reveal the 
neuropathology and functional pathology of this phenomenon. 
Several types of so-called 'Parkinsonism' have been found (table 
8.1). For details on the cause and symptoms of type I, III and IV 
the reader is referred to Barbeau (1984), Barbeau and Roy (1984) 
and Duvoisin (1982, 1984). The classification 'idiopathic' al-
ready indicates that the cause of type II, i.e. Parkinson's 
disease, is (still) unknown. Barbeau (1976) proposed that "the 
basic pathogenic mechanism is an accelerated aging phenomenon 
resulting from the selective atrophy of the heavily pigmented 
cells in the brainstem, from whence originate dopaminergic and 
noradrenergic pathways. The acceleration may be due to vascular, 
infectious, and toxic factors, but is conditioned by a deficiency 
in specialized neuroendocrine (A.P.U.D.) cells in the hypothala-
mus". Since the discovery of a neurotoxin, l-methyl-4-phenyl-
1,2,5,6-tetra-hydropyridine (MPTP), which is capable to destroy 
the dopaminergic cell bodies in the human midbrain (for review: 
Burns et al. 1984, Uhi et al. 1985), the possibility that Par-
kinson's disease results from the interaction between toxic 
agents and normal aging is again under discussion (see Barbeau 
et al. 1985, Calne and Längsten 1983, Hurtig 1984, Fisher 1984, 
Längsten 1985, Längsten and Ballard 1984, Ringwald 1984, Ruberg 
et al. 1984). Until now no conclusive evidence has been found of 
any cause. Neurologists and psychiatrists have speculated on the 
possible existence of a distinct pre-morbid personality of Parkinson 
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TABLE 8.I 
Classification of Parkinsonism 
type I Post-encephalitic 
type II Idiopathic 
a. tremor predominance 
b. akineto-rigid predominance 
type III Familial 
a, Parkinson's disease associated with 
autosomal dominant diseases 
b. Parkinson's disease with autosomal 
recessive pattern 
type IV Symptomatic 
a. Parkinsonian multiple system atrophies 
b. Parkinsonism with known triggers 
c. Mechanically induced Parkinsonism 
patients. The reader is referred to Lit (1956) and Korten (1969) 
for an extensive discussion on this subject (for review: Todes and 
Lees 1985). 
In the remaining part of this chapter, attention is paid Co the 
recent knowledge on the neuropathology and functional pathology 
in the light of the animal studies from sections I and II. 
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NEUROPATHOLOGY 
Knowledge on neuroanatomical changes must come from studies on 
autopsy material of patients who died from Parkinson's disease 
and patients in earlier stages of Parkinson's disease, where 
death was due to unrelated non-neurological causes. In the post-
mortem brains, changes in the neuronal network, the neurochemistry, 
i.e. levels of transmitters and activity of related enzymes, and 
receptors, i.e. binding sites, are compared to the same factors in 
post-mortem brains of age-matched persons who died of non-neuro-
logical causes. 
Morphology 
Characteristic of Parkinson's disease is the formation of so-called 
Lewy-bodies in the perikaryon of pigmented cells in the brain. 
Lewy-bodies are an indication for cell degeneration and concomit-
antly the rest of the neuron may degenerate. Pigmented cells are 
found in structures which synthesize DA and NA. Lewy-bodies have 
been frequently found in the SNpc, VTA, LC, nucleus paranigralis 
and nucleus pigmentos is, whereas neuronal changes may be found in 
the areas they project upon (see Chapter 1; see below). However, 
degenerated neurons are also found in regions which are not pro-
jected upon by the aminergic pigmented cells, such as the SI, the 
nucleus of Meynert (Perry et al. 1985; cholinergic) and the raphe 
nucleus (serotonergic). Neurofibrillary tangles may be found next 
to Lewy-bodies in the LC, SI and raphe nucleus (for review: Forno 
1982, Javoy-Agid et al. 1984). Moreover, detailed histological in-
vestigations revealed that no pathological neuroanatomical static 
terminal stage of Parkinson's disease exists because of adaptive 
processes like glial scarring, rearrangement of receptors (see 
below), subtle transsynaptic changes, sprouting and changes in 
the nuclei projected upon by the diseased nerve cell group (see 
below; Forno 1982, Schoenfeld and Hamilton 1977). 
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Neurochemistry 
The neurochemical disturbances are in accordance with the neuronal 
degeneration (for review: Hornykiewicz 1982). 
DA 
Decreased concentrations of DA and to a lesser extent, its meta-
bolite homovanillic acid (HVA) are found in all telencephalic 
areas normally receiving dopaminergic innervation: CN, PUT (> CN), 
NAcc, lateral hypothalamus and paraolfactory gyrus (area 25 of the 
cortex). Decreased activity of the DA synthesizing enzymes tyrosine 
hydroxylase (THydr) and to a greater extent the aromatic amino acid 
decarboxylase (AAAD) have been found in the basal ganglia and SN. 
The degree of the dopaminergic changes in the striatum is positive-
ly correlated with the severity of the clinical symptom hypokinesia 
(bradykinesia and akinesia; see below). Moreover, it has been found 
that mild (i.e. clinically just detectable) motor disturbances are 
not observed until a nearly 80% loss of DA in the striatum. This 
latter effect is ascribed to the homeostatic mechanisms which com-
pensate for the loss of DA: an increased metabolic activity of the 
remaining DA neurons (TH-activity less decreased, (DA) < (HVA)), 
reduced reuptake of DA and postsynaptic receptor supersensitivity 
(see below). 
NA 
Loss of NA has been found in the LC, nucleus paranigralis, nucleus 
pigmentosis and their projection regions, such as hippocampus, 
amygdala, SN, NAcc and cortex. Moreover, the activity of the NA 
synthesizing enzymes THydr and DA-ß-hydroxylase are decreased in 
the LC (Van Dongen 1980). 
Others 
The derangement of DA and NA is thought to elicit a 'chain re-
action', altering the functional state of other interrelated 
neuronal systems. A decreased concentration of 5HT has been found 
in the striatum and SN. Significantly decreased activity of GAD 
has been found in the caudate nucleus, hippocampus, and the frontal 
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and occipital cortex (Monfort et al. 1985). Unaltered activity of 
ChAT has been found in the striatum and SN, whereas a subnormal 
activity of ChAT and AChE has been found in the hippocampus and 
the cortex of demented Parkinson patients (Agid et al. 1984, 
Hornykiewicz and Kish 1984, Marsden 1982b, Perry et al. 1985). 
The many different peptides form a complicated picture, since 
one or the other may be decreased in the PUT, SNpc, GP and/or 
the frontal cortex (Agid and Javoy-Agid 1985). 
Receptors 
A second effect of the dysfunction of the neurotransmitters in 
Parkinson's disease is the changes in number of receptors as re-
vealed by receptor-binding studies (for review: Rinne 1982). The 
number of D-1 receptors is decreased in the striatum, whereas 
the number of D-2 receptors is either increased or decreased in 
the striatum and NAcc. Either increased or decreased numbers of 
D-2 receptors have been found in Parkinson patients not treated 
with L-DOPA, dividing these patients into two subgroups (see 
functional pathology). In contrast, a decreased number of D-2 
receptors has been found in Parkinson patients treated with 
L-DOPA (see Chapter 9), and an increased number of D-2 receptors 
has been found in Parkinson patients treated with neuroleptics 
during psychotic episodes. Therefore, in post-mortem studies of 
DA receptors, it is important to take into account the type of 
treatment before death. Changes in cholinergic, muscarinic re-
ceptors in the striatum are positively correlated with changes 
in the number of D-2 receptors. Furthermore, a decreased number 
of GABA receptors in the SN, a moderate decrease of 5HT receptors 
in the PUT and frontal cortex as well as changes, either increas-
ed or decreased, in peptide receptors are mentioned. In a recent 
study. Cash et al. (1985) describes changes in NA receptors in 
the prefrontal cortex of Parkinson patients: alpha-1 and bèta-1 
increased, alpha-2 decreased and bèta-2 unchanged. All Parkinson 
patients, however, have been treated with drugs which might have 
influenced the numbers or sensitivity of the receptors, by which 
the effect may not be specific for Parkinson's disease. 
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Miscellaneous 
Other methods have also been developed to investigate the structural 
nature of the human living brain, such as electro-encephalography, 
X-ray computed tomography (XCT), proton nuclear magnetic resonance 
XCT (NMR), and positron emission tomography (PET). The PET method 
makes it possible to visualize the rCBF and regional cerebral meta-
bolic rate (CMR; for review: Gelmers 1981, Phelps and Mazziotta 
1985). In general, idiopathic Parkinson patients do not show any 
differences from controls with EEG and XCT, and an increased rCBF 
in the GP (Martin et al. 1984; cf. Chapter 2: neuronal activity). 
Summary 
The pathology described above is a sum of all possible neuro-
anatomical changes, which may be present in Parkinson patients. 
Only the degeneration of the dopaminergic neurons from the SNpc 
and VTA and the noradrenergic neurons from the LC seem primary 
for Parkinson's disease, whereas the other changes may be second-
ary. Thus, a dysfunctioning striatum may exist in patients with 
Parkinson's disease. Furthermore, Parkinson's disease is a pro-
gressive disease and certain neuroanatomical changes may be 
present from the beginning of the disease, whereas others may 
appear later or not at all. From this it will be obvious that 
adequate treatment of Parkinson's disease is very difficult 
when the underlying pathology is not clear. However, with the 
present knowledge derived from animal studies (Sections I and 
II), and the analysis of the functional pathology (see below) 
indications concerning the neuropathology in the Parkinson 
patient under study should become available. 
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FUNCTIONAL PATHOLOGY 
The following clinical symptoms may be seen in Parkinson's disease: 
tremor, rigidity, depression, dementia, hypokinesia or disturbance 
in programming motor and non-motor behaviour directed by non-extero-
ceptive stimuli (see below) and postural instability. Although these 
symptoms will be described separately below, the reader must bear in 
mind that in practice Parkinson patients often show a number of the 
symptoms at the same time. 
The majority of the symptoms in Parkinson's disease are ascribed to 
dysfunctioning of striatal and/or mesolimbic structures. The clinical 
symptoms and the (possible) neuroanatomical pathology underlying 
them will be described in analogy with the results of the animal 
studies from Chapter 2 and Section II. 
Parkinson's disease is diagnosed not until 'pure' motor dis-
turbances are present. Initially, two large subgroups of idiopathic 
Parkinsonism are found (Table 8.1): one with tremor predominating 
(+ 70% of the patients) and one with akinesia-rigidity predominat-
ing (+ 20% of the patients). The remaining patients may initially 
display a variety of symptoms before general Parkinson's disease 
becomes clear. During the course of the disease, the majority of 
the Parkinson patients shew hypokinesia (for review: Martilla 
1983). 
Tremor 
Numerous types of tremor exist (for review: Yung 1983). The typical 
tremor in Parkinson's disease is a static tremor, i.e. present at 
rest and decreased or initially absent during movement, with a fre-
quency of 4 to 8 per second. Tremor is defined as involuntary, 
rhythmically alternating contractions of a given muscle group and 
of its antagonists. Tremor usually starts in the distal parts of 
the extremity (hands, feet), and often first becomes visible under 
emotional stress. The severity of the tremor is largely determined 
by psychological factors such as fear of failure, inferiority com-
plex, distress and external factors such as cold and novelty (Bar-
beau 1984, Fahn 1982, Korten 1969). 
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Parkinson-like tremor, i.e. a tremor with a rate of 4-8 per second, 
may be induced in animals by peripherally injected cholinergic 
agonists (Scheel-Krüger 1985) and this experimentally-induced 
tremor is attenuated by lesions of the NAcc but not of the neo-
striatum (Dickinson and Slater 1982). Furthermore selective 
lesions of the SNpc in monkeys did not induce tremor (Fillion 1979, 
Pechadre et al. 1976). From these studies it is suggested that the 
tremor in Parkinson's disease may be due to dysfunctioning meso-
limbic structures. This suggestion is supported by the findings 
that psychological factors increase the noradrenergic activity in 
the brain (for review: Galvin 1985), and mesolimbic dopaminergic 
activity is subject to an inhibitory influence by NA (Cools and 
Van Rossum 1980). Thus, in that group of Parkinson patients in 
which tremor is the first diagnosed symptom, predominantly de-
creased mesolimbic neuronal activity appears to occur. 
As also described in Chapter 2, a decreased activity at the level 
of the mesolimbic DA(i) receptors is found to result in an in-
creased activity at the level of the nigro-striatal DA(e) recep-
tors (Cools and Van Rossum 1980). In idiopathic Parkinson patients 
this seldom leads to motor disturbances, probably due to the 
gradual course of the disease. In post-encephalitic Parkinsonism, 
however, akathisia or "cruel restlessness" is often seen (Kolb 
and Whishaw 1980). The chronic hyperstimulation of the nigro-
striatal DA neurons activates mechanisms which in turn redress 
this hyperactivation: reducing the firing rate of the nigro-
striatal DA neurons, reducing the release of DA from these neurons 
and reducing the number and/or sensitivity of the postsynaptic 
DA(e) receptors (Carlsson 1975). This (perhaps secondary) effect 
leads to symptoms of a hypofunctioning striatum (see below). The 
treatment of Parkinson's disease in these patients with L-3,4-
dihydroxy phenylalanine (L-DOPA; see Chapter 9) may intensify the 
regulatory processes. Eventually, either due to the prolonged 
hyperstimulation or due to 'normal' cell degeneration in Parkin-
son's disease, the nigro-striatal DA neurons degenerate. 
194 
Rigidity 
Rigidity is defined as resulting from increased muscle tone, in-
volving both agonist and antagonist muscles in a given limb, 
manifested by increased resistance to passive movements of (parts 
of) the limb in any direction. In rats, rigidity may be induced 
by decreasing the dopaminergic or cholinergic activity or increas-
ing GABA-ergic activity in the neostriatum (Ellenbroek 1985b, 1986, 
Turski et al. 1984). However, rigidity may also be induced by de-
creasing the GABA-ergic activity in the SNpr (Havemann et al. 1983) 
and increasing the GABA-ergic activity in the thalamus (Klockgether 
et al. 1985) and in the SCdl (Ellenbroek et al. 1985a). Thus, 
rigidity is characteristic, but not specific for, i.e. not only 
resulting from, a dysfunctioning striatum. Like tremor, the de-
gree of rigidity can be influenced by psychological factors, i.e. 
rigidity is increased under stressful events. This too is in favour 
of the notion that rigidity is not directly related to a decreased 
striatal dopaminergic activity (cf. Keller et al. 1983). In the 
past the degree of ridigity has been thought of as the cause of 
the symptom hypokinesia. However, since surgery is able to con-
trol rigidity but not hypokinesia, the symptom is dealt with 
separately (cf. Narabayashi 1980; see below). 
Depression 
Depression may occur in all stages of Parkinson's disease, un-
related as well as related to the severity of the symptoms (for 
review: Mayeux 1982, Mayeux et al. 1984). Depression too is not 
ascribed to a hypofunctioning striatum, but rather to dysfunction-
ing of (meso)limbic structures (for review: Jesberger and Richard-
son 1985), in particular the degeneration of mesolimbic and meso-
cortical DA neurons in Parkinson's disease (for review: Fibiger 
1984; cf. Willner 1983). 
195 
Dementia 
Dementia may occur in later stages of Parkinson's disease of 
patients in which the disease developed early in life, as well 
as in early stages of Parkinson's disease in elderly patients 
in which the disease developed late in life. Until now, no con-
sensus has existed as to whether dementia in Parkinson's disease 
is due to long-term therapy with anticholinergic drugs or an in-
creased cell degeneration process (Ball 1984, Caltagirone et al. 
1985, Mayeux 1982). Dementia in Parkinson's disease is also not 
ascribed to a hypofunctioning striatum but merely to a decreased 
cholinergic and dopaminergic activity in the cortex (Hornykiewicz 
1984), and a loss of cholinergic neurons in the nucleus of Meynert 
(Perry et al. 1985). 
Hypokinesia (bradykinesia/akinesia) 
In the course of the disease all Parkinson patients show a de-
crease in their ability to move. The initiation of movements 
seems to become impaired (see, however, below). For example 
Parkinson patients may have problems in starting to walk. During 
walk, Parkinson patients may show difficulties in smoothly chang-
ing the direction of walking. Walking itself may be gradually 
performed slower, using smaller and more shuffling steps, and 
eventually 'voluntary' movement may be completely impaired. 
Also a loss of associative movements is often observed in a de-
crease in facial mimicry, rhythmic or postural limb movements 
during walking, speech volume and writing ability (micrographia; 
for review: Barbeau 1984). Under the influence of strong emotion, 
stress or fear, a hypokinetic Parkinson patient may suddenly be 
able to walk or even run (kinesia paradoxa; Fahn 1982, Marsden et 
al. 1982). By 1973, Barbeau had already proposed that brady-
kinesia and akinesia are specific effects of a hypofunctioning 
striatum. Ever since then great effort is made to establish the 
role of the striatum in these symptoms in preclinical (cf. Sec-
tion II) and clinical (see below) studies. 
According to Barbeau (1973, 1984) four main components can 
be distinguished in bradykinesia/akinesia: a defect in 'motor 
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initiative', a defect in 'kinetic melody', a defect in the 'strategy 
of learning', and a rapid 'fatiguability' in repetitive tasks (see 
below). In his description of these features in Parkinson patients, 
Barbeau mentions the importance of sensory and proprioceptive 
stimuli in the initiation and execution of 'voluntary' movements 
(cf. Tatton et al. 1984), as well as the importance of sensory 
stimuli in solving cognitive tasks. Indeed, it has been observed 
that Parkinson patients may use sensory and proprioceptive stimuli, 
either induced by themselves or provided by others, to initiate 
movement (table 8.2). Furthermore, sudden changes in external 
stimuli have been found to provoke an abrupt inability to pro-
TABLE 8.2 
A summary of stimuli used by Parkinson patients to initiate movement 
('tricks', modified from Stern et al. 1980) 
A. Changes in sensory stimuli 
1. Verbal or auditory: 
marching to command like a soldier 
walking or dancing to music or metronome 
swearing at himself 
another person giving verbal commands 
sudden clasping of hands by another person 
2. Visual: 
stepping over objects, including end of walking stick, 
another person's foot, paving stone, carpet patterns 
watching other people walk 
pushing an object e.g. chair, block of wood, in front of foot 
imaging white lines to step over 
B. Dynamic proprioceptive stimuli 
altering distribution of body weight 
walking sideways 'crablike' 
rocking movements of the body 
stamping feet or shaking legs 
longer steps, walking briskly 
consciously lifting one limb higher 
sliden one foot backwards then throwing it forwards 
complex postural movements associated with clicking of fingers 
sudden jerky head movements 
rhythmically pulling or pushing by another person 
passively elevating patient's knee by another person 
ceed ongoing movement. This so-called 'freezing' phenomenon may 
occur in all movements, but it is most disabling in walking: 
Parkinson patients complain that it seems as if their feet are 
'glued' to the floor or their legs are inexplicably 'frozen to 
the spot'. 'Freezing' may last seconds, minutes or even hours 
(Fahn 1982, Marsden et al. 19Θ2, Stern et al. 1980). 
The importance of stimuli in the motor and non-motor (cognitive) 
performance of Parkinson patients is highly interesting in rela­
tion to the function of the striatum in behaviour, as derived from 
the animal studies: enabling the use of non-exteroceptive stimuli 
in programming motor and non-motor behaviour (section II). Increas­
ing neuronal activity in the striatum of animals increases the 
animal's ability to program behaviour directed by non-exteroceptive 
stimuli (section II), whereas decreasing neuronal activity in the 
striatum of animals increases the dependence on exteroceptive sti­
muli to change ongoing behaviour (Chapters 4 and 5). Furthemore, 
it has been found that animals in which the information flow from 
the striatum to the SNpr is decreased show an increased dependence 
on dynamic proprioceptive (exteroceptive) stimuli to change ongo­
ing behaviour (Chapter 5; cf. Sontag et al. 1984). At present, it 
appears that no consensus has existed in defining the symptoms 
belonging to hypokinesia, bradykinesia and/or akinesia. Since, 
however, in Parkinson's disease a hypofunctioning striatum may 
exist, the delineation of these symptoms in Parkinson's disease 
are given below analogous to the disturbance found in animals with 
a hypofunctioning striatum, i.e. the disturbance in programming 
motor and non-motor behaviour directed by non-exteroceptive stimuli. 
Programming motor and non-motor behaviour 
Evidence supporting the disturbance in the ability to use non-
exteroceptive stimuli in programming motor and non-motor behav­
iour is derived from studies in which Parkinson patients and 
controls perform tasks in which the changes in behaviour can be 
analyzed either directed by non-exteroceptive or exteroceptive 
stimuli. In addition, evidence is presented which excludes that 
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the observed disturbances are the results of a cortical disturbance. 
In all examples mentioned below, only those Parkinson patients, 
without or with medication, are asked to co-operate who are basic-
ally capable of performing the tasks, and always matched controls 
are used. With the help of standard tests, Parkinson patients and 
controls are examined to exclude the presence of depression or 
dementia, to avoid their influence on the motor and non-motor tasks 
(Cools et al. 1984c, Mayeux et al. 1984). The motor performance is 
examined either by the performance of the motor task itself before 
the experimental session starts, or by the performance of task-
related movements. 
According to Kornhuber ( 1984) learning a task involves three 
factors in which cortical structures are involved: 'how' to do it 
(procedural memory), 'what' to do (sensory and declarative memory) 
and 'when' to do it (movement initiation). Once a task is learned, 
'how' to do it (long-term memory) is already answered, while it 
depends on the complexity of the task whether 'what' to do (short-
term memory) is still involved. The 'when' to do it remains to be 
decided as long as a sequence of different movements has to be made 
(see also Chapter 2, behaviour: neuronal activity). 
As in animals, voluntary movements performed by human subjects can 
be studied during the performance of so-called motor tasks. In 
Chapter 2 a number of these tasks have been reviewed as well as 
the involvement of cortical and subcortical structures in both 
humans and animals during their different stages. It has been 
shown that the striatum is involved in the preparation to the 
initiation and execution of movements ('when') by integrating 
relevant non-exteroceptive and exteroceptive stimuli, i.e. 'what', 
into the planning and the execution of movements (for references 
see Chapter 2, behaviour: neuronal activity). 
The initiation of voluntary movements can be studied during 
the performance of reaction-time tasks (for review: Marsden 1984, 
Miller and Wing 1984). In simple reaction-time tasks, i.e. per-
formance of the (specified) movement after a 'go' signal, it has 
been found that Parkinson patients initiated the movement after 
a longer time-delay than controls, i.e. Parkinson patients need 
more time to start the movement, but, once initiated, its perform-
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ance is correctly executed. A modified simple reaction-time task 
in which the (known) movement must be executed with a time-delay 
after a warning signal, the extent of the time-delay determines 
whether the initiation-time of movement in Parkinson patients 
improves. However, Parkinson patients still initiate the movement 
with a longer time-delay than controls. Although the 'how' and 
'what' is known in the previous tasks, the initiation ('when') 
seems to be disturbed in Parkinson's disease. In a two-choice 
reaction-time task the 'go' signal, given some time after a warn-
ing signal, provides the information ('what') which movement has 
to be executed. In these tasks Parkinson patients and controls do 
not differ in reaction time, i.e. Parkinson patients still show 
the same temporal delay in initiating the movement, that is found 
in the simple reaction-time tasks. The controls show a prolonged 
time-delay as compared to the simple reaction-time task, which is 
ascribed to the time needed to integrate the ('what') information 
into the initiation ('when') before the execution (for discussion 
Bloxham et al. 1984). In the reaction-time tasks no attention is 
paid towards the execution of the movements itself. To establish 
whether a cortical disturbance is the underlying mechanism of the 
delayed initiation, the subjects are asked to perform a simple 
pursuit-tracking task, in which a cursor has to be kept superim-
posed on a moving target (Bloxham et al. 1984). In pursuit-track-
ing tasks the accuracy of the movement is more crucial than in 
reaction-time tasks. Two kinds of movement can be used to perform 
the tracking tasks (see Flowers 1975, 1976): 
a) 'ballistic', i.e. fast, 'preprogrammed' movement defined as 
movement under 'open-loop', feedforward control ('anticipatory'), 
and 
b) 'ramp', i.e. slow movement defined as movement under 'closed-
loop', continuous feedback control. 
In learning skilled movements normally a refinement of the 
'ballistic' component and a disappearance of the 'ramp' movement 
occurs. Both Parkinson patients and controls are capable of per-
forming the simple pursuit-tracking task. However, Parkinson 
patients show a longer time-lag than controls, i.e. not only is 
the reaction-time prolonged but the cursor is seen to 'walk be-
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hind' the moving target throughout the pursuit. Furthermore, the 
movement of the Parkinson patients appears to be composed of 
'small' jumps, indicating a continuous integration of sensory 
feedback, although the task is learned (Flowers 1975, 1976, Wing 
and Miller 1984; a deficit in 'kinetic melody' according to Bar-
beau 1984). It is concluded that: 
1. Parkinson patients are not impaired in initiating motor be-
haviour, but 
2. Parkinson patients are deficient in using predictive, 'open-
loop' control of movement, and 
3. Parkinson patients are dependent on continuous exteroceptive 
feedback during the performance of voluntary movement, resulting 
in slowness of movement. 
Thus, it seems unlikely that a cortical dysfunction is the cause 
of the observed disturbance. Farmore, a hypofunctioning striatum 
seems to be the cause, i.e. a decreased ability to use non-extero-
ceptive stimuli to direct and change behaviour. Further evidence 
is provided below. 
Reduced neuronal activity in the striatum of animals decreases 
the ability to program motor and non-motor behaviour directed by 
non-exteroceptive stimuli (section II). The programming of motor 
behaviour in humans can be studied in a complex pursuit-tracking 
task: Parkinson patients and controls are asked to keep a cursor 
superimposed on a continuously shifting target, which can be made 
to move with difieren degrees of predictability. The following dif-
ferences from controls are found: 
a) Parkinson patients show a longer time-lag, 
b) the movement of Parkinson patients is broken down into smaller 
movements, 
c) Parkinson patients rarely overshoot the target, 
d) Parkinson patients show pauses between the changes in direction 
of the target (Flowers 1975, 1976). 
When during the pursuit-tracking task the target disappears tempo-
rarily, controls are still able to execute the predictive change in 
movement, whereas Parkinson patients are found to be less accurate 
(Flowers 1978, Stern et al. 1983). Thus without the appropriate 
exteroceptive stimulus Parkinson patients seem no longer able to 
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change ongoing behaviour (cf. Chapter 4). The possibility exists 
that this effect is due to a dysfunctioning premotor cortex, since 
this area is found to be involved in the integration of spatial 
information in the performance of movement (Kalsaka and Hyde 1985, 
Roland et al. 1980a). Bloxham et al. (1984) have found that Par-
kinson patients do not differ from controls in executing a predict-
ive movement, in contrast to the findings of Flowers. Bloxham et 
al. (1984) ascribe this discrepancy to the difference between the 
two tasks, i.e. continuously tracking a circle and tracking a 
target that abruptly changes direction respectively. In the former 
no new movement has to be initiated, whereas in the latter it does. 
Bloxham et al. (1984) conclude that: "Parkinson patients have no 
difficulty in using prior information to plan in advance the form 
of a movement, but do have difficulty of using this information 
to intitiate or select a movement, particularly in the absence of 
an external trigger (e.g. a moving target)". 
The need for continuous visual control (cf. exteroceptive stimuli) 
to initiate changes in motor behaviour is thought to underlie the 
problems Parkinson patients have in performing simultaneous volun-
tary tasks as well as during increased task complexity (Sanes 1985, 
for review: Marsden 1984). 
In another study (Cools et al. 1984c) Parkinson patients and con-
trols are asked to perform a repetitive finger movement task by 
pressing four push-buttons in a fixed sequence during 15 seconds 
without visual contact. Then, the subjects are asked to press the 
buttons in a different sequence for an additional 15 seconds. It 
has been found that Parkinson patients do not differ from controls 
in performing the first sequence correctly, but the Parkinson 
patients do differ in their ability to switch towards the other 
sequence, i.e. they make more mistakes, which are related to the 
previous task. Cools et al. (1984c) introduced the term 'shifting 
aptitude', i.e. the ability to reorganize behaviour according to 
the requirements of the task. They conclude that, in the motor 
task, the Parkinson patients show a diminished 'shifting aptitude'. 
Since in animal studies it has been found that the striatum is 
also involved in the performance of non-motor behaviour (section 
II), attention is also paid to possible striatal specific non-motor 
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(cognitive) impairments in Parkinson's disease. Barbeau (1973) has 
previously described that Parkinson patients, who sorted objects 
according to a particular criterion, have difficulty in resorting 
the same objects according to another criterion by themselves 
(defect in the strategy of learning). Barbeau proposed that "Par-
kinson patients with normal memory and intelligence are relatively 
incapable to 'shift' to a new grouping, unless this is pointed out 
to them. When prompted or guided, Parkinson patients can properly 
execute new groupings". Since it has been found that Parkinson 
patients can execute voluntary movements with the aid of extero-
ceptive stimuli, it will be clear that the last remark of Barbeau 
plays a prominent role in tests which measure 'cognitive' functions. 
In a recent clinical study particular attention is paid to the 
phenomenon in trying to avoid any possibility of solving 'cognitive' 
problems with the help of exteroceptive stimuli (Cools et al. 1984c). 
Verbal and figurai criterion tests are used to measure the ability 
to switch non-motor behaviour. The basic design is that Parkinson 
patients and matched controls learn to solve a test, i.e. learn a 
particular pattern, then the criterion of the test is changed and 
it is measured how many attempts are needed to solve the new pro-
blem (cf. Lees and Smith 1983, who measured types of errors). It 
has been found that, once a repetitive (cognitive) pattern is 
established in which Parkinson patients and controls do not differ, 
the Parkinson patients have more difficulty in changing the pattern 
in comparison to the controls. Parkinson patients were impaired in 
switching non-motor behaviour manifested in both verbal and figurai 
modalities, i.e Parkinson patients show an impaired 'shifting 
aptitude' (cf. Flowers and Robertson 1985). 
A decreased ability to change posture is often observed in 
Parkinson's disease, for example from sitting to standing and from 
standing to walking. This symptom appears to be analogous to that 
found in animals in which the striatal output to the SNpr is re-
duced (Chapter 5): a decreased ability to use static proprioceptive, 
i.e. non-exteroceptive stimuli in programming motor behaviour. In 
addition, the Parkinson patient may be observed to induce dynamic 
proprioceptive stimuli with that part of his body that is still 
controlled by non-exteroceptive stimuli to overcome his disability: 
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a Parkinson patient sitting in a low, deep and soft chair may be 
observed to exert great efforts with his arms and to rock back and 
forth several times in order to rise (Barbeau 1984); a Parkinson 
patient may overcome his inability to turn over in bed by using 
alternative motor strategies (Lakke 1985); a Parkinson patient 
may walk quickly over the stones of a rocky sea beach but not on 
a flat one; a Parkinson patient unable to walk on the level, may 
negotiate stairs (cf. 'tricks' table 8.2). In these examples, the 
indication exists that exteroceptively directed changes in the 
proprioceptive input underlies the observed (sudden) ability of 
Parkinson patients to change posture. Thus,static proprioceptive 
stimuli can no longer be used to direct movements and not until 
dynamic proprioceptive stimuli are induced the Parkinson patient 
can change ongoing behaviour until again only static propriocept-
ive stimuli are present. In addition, the 'over-reaction' of Par-
kinson patients to exteroceptive stimuli resulting in the symptoms 
'kinesia paradoxa' and 'freezing' may be due to an incresed de-
pendence on exteroceptive stimuli analogous to the one found in 
animals with a decreased activity of striatal output neurons 
(Chapter 5). 
In sum, the above described Parkinson patients show an im-
paired ability in programming motor and non-motor behaviour 
directed by non-exteroceptive stimuli ('shifting aptitude dis-
order' according to Cools et al. 1984c). Since in animals ana-
logous symptoms have been found after inducing a hypofunctioning 
striatum, it may be concluded that a hypofunctioning striatum 
exists in these Parkinson patients. 
Postural instability 
In Parkinson's disease even the ability to maintain posture may 
be lost, often resulting in sudden falls. This symptom is thought 
to underlie the appearance of the characteristic posture of Par-
kinson patients: moderate flexion of the trunk and knees, with 
bent elbows and abducted arms, the hands are carried in front of 
the body and the fingers are often flexed, the head has a ten-
dency to fall forward. When pushed a Parkinson patient may be un-
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able to prevent movement into the direction of the push. Once he 
has initiated walking the Parkinson patient may begin to run and 
be unable to stop (festination; Barbeau 1984). In this symptom of 
Parkinson's disease even a dysfunctioning of systems beyond the 
striatum seems to occur. Studies on changes in cutaneomuscular 
reflexes of Parkinson patients also indicate a broad spectrum of 
disturbances already at the level of the spinal cord (for review 
see Horstink 1982). 
Miscellaneous 
The rapid fatiguability, often a complaint heard from Parkinson 
patients during the performance of repetitive movements, is still 
unexplained. However, it may be due to the demand of continuous 
integration of exteroceptive stimuli (attention) to execute the 
movements costing a lot of energy (cf. Roland and Friberg 1985). 
In addition to the above mentioned functional symptoms of Par-
kinson's disease other symptoms, predominantly autonomic, may 
occur. Since these symptoms are not characteristic of Parkinson's 
disease, they will not be mentioned any further (see Barbeau 1984). 
In conclusion, in Parkinson's disease a variety of symptoms are 
observed which may be ascribed to dysfunctioning of the striatum 
in the central nervous system. Since at the time of diagnosis al-
ready a 80% loss of DA appears to exist, only this neuro-
pathology may underlie the clinical (non-)motor disturbances of 
Parkinson's disease. Indeed, the animal studies (Chapters 6 and 7) 
have revealed that the degree of pathology determines whether a 
striatal disturbance manifests itself at the non-motor or motor 
level. However, post-mortem studies (neuropathology) 
reveal the existence of additionally dysfunctioning structures, 
which may also underlie a number of the symptoms (cf. Chapter 2; 
figs. 2.2 and 2.3). 
The knowledge concerning (putative) organic disturbance(s) under-
lying the symptoms may be a guideline to understand the effects 
of the pharmacological therapy (see Chapter 9). 
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CHAPTER 9 
PARKINSON'S DISEASE: THERAPY 
Since the cause of Parkinson's disease is still unknown present 
treatment is directed towards relieve of the symptoms (Chapter 8). 
In this chapter a summary will be given of the strategy and the 
results of the pharmacotherapy in the light of the results from 
section I, section II and Chapter 8. 
THERAPY: STRATEGY 
In table 9.1 present-day antiparkinson drugs are given, arranged 
according to their primary action and mentioning their (putative) 
secondary action(s). In human subjects drugs are either taken 
orally or administered intra-muscularily or intravenously. In that 
way none of the drugs are solely delivered to the precise area of 
the brain, where their effects are most desired. 
Although the neuroanatomical pathology is rather heterogenous, 
the symptoms are predominantly ascribed to the loss of DA in the 
brain (Chapter 8). Consequently the therapy is primary focussed 
on nullifying this loss one way or another, before additional 
treatment is given (for review: Calne et al. 1984, Cools 1984, 
Korten 1969, 1984, Lang 1984, Lieberman and Goldstein 1982). 
Increasing DA synthesis 
DA itself does not pass the blood-brain barrier in contrast to its 
precursor L-3,4-dihydroxy phenylalanine (L-DOPA). Since AAAD, the 
enzyme which takes care of the formation of DA from L-DOPA, also 
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TABLE 9.1 
Present anti-parkinson drugs 
Drugs 
Primary action Clinical use (R) 
Experimental 
in the clinic 
'Putative' 
secondary action 
A. Influencing dopaminergic mechanisms 
Increasing DA synthesis L-DOPA (Eldopa, Larodopa, Levodopa, 
Levodopa, Ragakin) 
L-DOPA + benserazide (Madopar) 
L-DOPA + carbidopa (Sinenet) 
Enhancing DA concentration amantadine (Symnetrel) 
nomi fens in (Alival) 
NA 
indirect DA agonist 
Reducing DA catabolism L-deprenyl indirect DA agonist 
NA, 5HT 
Activating DA receptors 
bromocriptine (Cfl 154, Parlodel) 
lisunde (Lyeenyl, Sofa, Dopergin) 
pergolide 
lergot nl 
ET ή95 (Piribedil, 
TnvastaL) 
D-l, D-2, NA 
D-l, D-2, ΝΛ, 5HT 
D-l, a-2, ΝΛ, 5HT 
D-l, Ü-2 
D-l, D-2, ΝΛ, 5HT 
NA 
B, Influencing cholinergic mechanisms 
Reducing cholinergic activity dexetimide (Tremblex) 
trihexyphenidyl (Artane, Paralest) 
benzatropine (Cogentin) 
orphenadnne (Disipal) 
procyclidine (Kemadrin) 
bipenden (Ak ina ton) 
DA 
DA 
exists outside the central nervous system (CNS) the administration 
of L-DOPA is often combined with inhibitors of AAAD: benserazide 
or carbidopa. These inhibitors do not pass the blood-brain barrier 
in the commonly used doses. Thus, if AAAD is still present in the 
CNS L-DOPA is decarboxylated to DA and, if the postsynaptic neurons 
are still intact, amelioration of clinical symptoms of DA deficiency 
will result. This is the most prominently used therapy. However, it 
must be realized that L-DOPA is also a precursor of NA, and that in 
noradrenergic areas of the CNS (for anatomy: Lindvall and Björklund 
1974, Nieuwenhuys et al. 1978, Ungerstedt 1971) the enzyme AAAD and 
DA-beta-hydroxylase are present by which L-DOPA is converted to NA. 
Enhancing DA concentration 
Enhancing the concentration of DA within the synaptic cleft can be 
achieved either by facilitating the release of DA from the remain-
ing DA neurons (amantadine) or by inhibiting the re-uptake of DA 
into the remaining DA neurons (nomifensine). 
Reducing DA catabolism 
Inhibiting the catabolic enzymes of DA is an approach to increase 
the availability of DA to interact with its receptors. L-deprenyl 
has been found to inhibit МАО-B, i.e. an enzyme predominantly found 
in the mesolimbic DA area (for review: Rinne 1983). At present no 
'safe', i.e. not toxic, inhibitor is available of the other cata­
bolic enzyme COMT (catechol-o-methyl transferase). 
Activating DA receptors 
The basis for the use of direct-acting DA agonists is four-fold: 
First, the progressive degeneration of DA neurons ultimately leads 
to the loss of all presynaptic mechanisms. 
Second, the possibility of synthetizing compounds which have a 
longer beneficial effect than L-DOPA (see below). 
Third, with DA agonists it should be possible to stimulate a more 
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selective population of DA receptors (Chapter 2). 
Fourth, the putative increase of (toxic) free radicals from the 
metabolism of L-DOPA, which might accelerate the demise of DA 
neurons (Chapter 8), can be prevented. 
Reducing cholinergic activity 
Although anticholinergics have already been used in the therapy of 
Parkinson's disease before the discovery of L-DOPA, the mechanism 
of action has long been unsettled. To date it has been found that 
the anticholinergic drugs are a heterogeneous group, which may ac-
count for their confusing effects on either one or more symptoms 
of Parkinson's disease. The anticholinergic drugs which also in-
fluence dopaminergic structures are less effective in reducing 
tremor than the more selective anticholinergics (table 9.1). 
Miscellaneous 
Drugs, which influence primary noradrenergic, peptidergic or 
serotonergic mechanisms are uncommon in the therapy of Parkinson's 
disease since little is known yet concerning the role of the loss 
of these transmitters in the majority of the symptoms in Parkin-
son's disease. Examples of those drugs are still in an experimental 
phase: DL-threo-3-4-dihydroxyphenylserine (DL-threo-DOPS; Narabayashi 
et al. 1984), PLG (pro-leu-gly-NH2) and methylsergide respectively 
(Lieberman and Goldstein 1982). Predominantly the drugs are given 
when, due to the progression of the disease, additional degenera-
tion of other neurons may have occurred (Chapter 8) and the bene-
ficial effect of the usual therapy is diminished. 
The lack of selectively operating in the brain makes the 
present GABA-ergic drugs unsuitable, since a general non-select-
ive manipulation of GABA in the brain does not have much effect 
on movement disorders (Marsden and Sheeny 1981). 
There are two groups of drugs which are believed to counter-
act some of the unwanted side-effects (see below) elicited by the 
former drugs: 
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a) drugs that are assumed to interact with non-classic, i.e. meso-
limbic, DA receptors: oxiperomide (also ΝΑ), tiapride (also ΝΑ), 
sulpiride (D-l and D-2), 3-PPP, CB 154 (Parlodel11), lisuride 
R R (Lysenyl , Spofa ), pergolide and lergotril (cf. Fuxe et al. 1981, 
1985, Ogren et al. 1985); 
b) drugs which influence processes involved in the regulation of 
the sensitivity of DA receptors: tiapride, estrogens, PLG and 
lithium. 
The latter compounds are not (yet) used in the clinical therapy. 
Non-medical therapy 
Physiotherapy and speech therapy are important adjuvants to 
patient care. The degree to which these techniques result in ob­
jective physical improvement is not well-defined. Psychothera-
peutical support of the patients as well as their relatives is 
recommended predominantly to establish understanding for the 
peculiarities of the Parkinson patients, in particular phenomena 
like kinesia paradoxa and 'freezing'. 
Surgery is only used to relieve untreatable symptoms, pre­
dominantly tremor and rigidity, in a small percentage of Parkinson 
patients. Lesioning of the ventral, intermediate nuclei of the 
thalamus appears beneficial in these patients (Narabayashi 1982, 
Van Manen et al. 1984). 
Until now, no consensus has existed as to whether to start drug 
therapy early or late in the course of Parkinson's disease. Three 
phases can be distinguished in Parkinson's disease (Muenter 1984). 
First, mild symptoms do not yet provoke physical nor social dis­
ability. 
Second, increased severity of the symptoms provoke slight physical 
and social disability, but not yet threatening employability, phy­
sical independence or social life. 
Third, disability threatens employability, physical independence or 
social life. 
For discussion on the subject, whether drug therapy should be start­
ed at the second or the third phase, the reader is referred to Fahn 
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and Bressman (1984), Muenter (1984) and Raskol (1984). The overall 
conclusion is, that drug therapy must be started when the symptoms 
are pronounced enough to justify its use. It will be obvious that 
whether or not the symptoms are troublesome to the Parkinson patient 
is highly idiosyncratic. At present, the therapy is started either 
with anticholinergic drugs or L-DOPA. Almost all Parkinson patients 
are eventually treated with L-DOPA, whereas not until L-DOPA is no 
longer beneficial other therapy is added (see below). 
THERAPY: RESULTS 
The available neuro-ethological knowledge about the putative sub-
strates of Parkinson's disease opens perspectives for understand-
ing the clinical effects of antiparkinson drugs. The overall, 
initial results are (for references: Cools 1984, Korten 1984): 
Therapeutical effects 
Tremor 
The stress-sensitive tremor, characteristic of dysfunctioning 
mesolimtjic areas is only slightly decreased by the re-instate-
ment of DA, but highly sensitive to anticholinergics. This effect 
is in accordance to animal studies (Chapter 2): 
a) peripherally applied anticholinergic drugs predominantly affect 
mesolimbic structures; 
b) tremor may be due to a dysfunctioning of, but is not specific 
for the mesolimbic DA neurons. 
Rigidity 
Drugs that influence dopaminergic and/or cholinergic mechanisms 
are found to affect rigidity. In animals rigidity can be elicited 
from the striatum but also from lower-order structures through 
which striatal output is funneled (Chapter 2). Thus, the relief 
of rigidity by dopaminergic drugs may be due to an increased 
212 
striatal activity, whereas the relief by anticholinergic drugs may 
be due to influencing lower-order structures. 
Degression 
Depression can be treated with anti-depressants, which accomplish 
their effects by influencing mesolimbic structures (Mayeux et al. 
1984). 
To date, no adequate treatment exists for dementia in Parkinson's 
disease. 
The disturbance in programming motor and non-motor behaviour 
directed by non-exteroceptive stimuli is alleviated predominantly 
by drugs which influence dopaminergic mechanisms. This is in ac-
cordance with the finding that the disturbance in programming motor 
and non-motor behaviour is ascribed to decreased neuronal activity 
in the striatum (section II, Chapter 8). 
No presently available antiparkinson drug alleviates this symptom 
of Parkinson's disease. 
Side-effects 
Several side-effects may be seen after the administration of the 
antiparkinson drugs, predominantly related to L-DOPA (table 9.2). 
For references the reader is referred to Burton and Calne (1984), 
Cools (1984), Fahn (1982), Horstink (1984), Korten (1984), Lieber-
man and Goldstein (1982), Marsden et al. (1982) and Yahr (1984). 
lêElZ_lE£Ei2lîËESil_fiËêlSÎlË£ii 
usually these side-effects are prevented by using AAAD inhibitors. 
In few Parkinson patients these side-effects may persist, in which 
case additional treatment is needed. 
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TABLE 9.2 
Problems of L-DOPA therapy 
Early 'peripheral' sidereffects 
- nausea, vomiting 
- postural hypotension 
- cardiac arrhythmias 
Early 'central' side-effects 
- psychotic disturbances, e.g. hallucinations 
- oro-facial dyskinesias 
- chorea-athetotic movements 
Late 'central' side-effects 
end-of-dose 
akinesia 
nocturnal and 
early morning 
akinesia 
random on-off 
phenomenon 
peak-dose akinesia 
- peak-dose 
dyskinesia 
- peak-dose dystonia 
early morning 
dystonia 
due to decreased duration of the beneficial 
response symptoms of Parkinson's disease 
re-appear before the next dose of L-DOPA 
due to the long period between the last 
evening dose and the morning dose of L-DOPA 
unexpected, temporary return of a parkinsonian 
state while the patient presumably has a full 
therapeutic response to a dose of L-DOPA and 
a therapeutically adequate plasma concentra-
tion of L-DOPA 
manifested by the loss of speech at a time of 
greatest therapeutical beneficit 
chorea-athetotic movements and oro-facial dys-
kinesia 
a special type of peak-dose dyskinesia in 
which Parkinson patients show parkinsonism -
improvement - dystonia - improvement -
parkinsonism 
preferably affecting the legs and feet 
non-specific syndromes related to the daily L-DOPA dosage: 
myoclonus (jerks of extremities occurring most frequent during 
sleep), and asterixis (involuntary movements associated with 
psychotic disturbances) 
Earl2_'central^ ^ide-effects 
These side-effects after L-DOPA therapy often disappear after a re-
duction of the dose. It is most likely that early 'central' side-
effects are due to the heterogeneity of initial Parkinson's disease 
(Chapter 8), i.e. also undamaged structures are affected by the 
drugs (see below). The analysis of observed symptoms may reveal the 
underlying mechanisms of these early 'central' side-effects. If the 
Parkinson patient shows psychotic disturbances after L-DOPA, this 
may imply a hyperactivity at the level of the DA(e) receptors. The 
latter, in turn, implies that the pathology in the Parkinson patient 
is (still) limited to the mesolimbic circuitry. In theory, a Par-
kinson patient may show oro-facial dyskinesia after L-DOPA, i.e. a 
hyperactivity at the level of the DA(i) receptors, when the patho-
logy is (still) limited to the nigrostriatal circuitry. In practice 
this effect is rarely observed (Horstink, personal communication). 
Chorea-athetotic movements in the limbs may also be observed after 
L-DOPA. This effect implies a hyperactivity at the level of both 
DA(e) and DA(i) receptors. The pathology in these Parkinson patients 
may not be localized (yet) within the DA neurons themselves, but 
rather limited to one or more afférents or efferents of the meso-
limbic and nigrostriatal DA projection areas (Chapters 1 and 2). 
Changing of the therapy should be in place here. 
Late_'central^_side-effects 
Late 'central' side-effects appear after long-term drug treatment 
and are due to either the progression of the disease, the long-term 
treatment or both. The number of reports of late 'central' side-
effects has increased over the years with L-DOPA therapy. One 
reason may be that since L-DOPA has been introduced in the therapy, 
Parkinson patients live longer (for review: Hoehn 1985). Conse-
quently, since the progression of the disease is not stopped, the 
neuronal degeneration may grow worse over these years. Due to this 
increased degeneration, presynaptic mechanisms may be lost more 
and more, which may lead to: 
1• loss of available enzymes to convert L-DOPA to DA (non-re-
sponders); 
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2. loss of storage mechanisms for DA and consequently DA is avail­
able in overdoses in the proximity of the postsynaptic receptors 
(peak-dose dyskinesia) and also more susceptible to the metabolic 
mechanisms (end-of-dose akinesia); 
3. supersensitivity and/or increased number of postsynaptic recep­
tors (peak-dose dyskinesia). The latter effect may be prevented by 
drugs such as PLG, lithium, estrogens or tiapride (still in a pre­
dominantly pre-clinical research phase). 
Another reason for late 'central' side-effects may be the long-term 
treatment of L-DOPA itself, i.e. inducing increased degeneration 
due to stimulating feedback mechanisms and decreasing the sensitiv­
ity of postsynaptic receptors (Chapter 8). Most likely, the side-
effects after chronic therapy will be the result of both an in­
creased neuronal degeneration and the therapy itself (see also 
Melamed and Hefti 1984). The supersensitive and/or increased number 
of postsynaptic DA receptors are confronted with an overdose of DA 
(see above), which gives rise to a feedback mechanism inducing 
hyposensitive postsynaptic DA receptors. After decrease in the 
DA concentration, due to catabolic processes, the postsynaptic 
DA receptors may become supersensitive again. Presently, the 
time-related different biochemical and behavioural characteristics 
of the different DA neurons (Chapter 2) are thought to underlie 
the random on-off phenomenon, peak-dose and biphasic dystonia 
(Fahn 1982). 
An approach to counteract late 'central' side-effects is the 
introduction of so-called 'drug holidays', after which the Par­
kinson patient shows less side-effects when L-DOPA therapy is 
started again. Since this beneficial effect is only temporary 
and during the 'drug holidays' all severe symptoms of Parkinson's 
disease re-appear, this therapy is not commonly used (Kofman 
1984). When L-DOPA is continuously administered intravenously, 
end-of-dose akinesia, nocturnal and early morning dystonia, 
peak-dose dyskinesia as well as on-off phenomena may disappear, 
introducing the need of long-acting antiparkinson drugs: the DA 
agonists (table 9.1; Clough et al. 1984, Hardie et al. 1984). 
ρ 
The ergot derivative bromocriptine (CB 154, Parlodel ) is par­
ticularly beneficial for those Parkinson patients who show 
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dystonic side-effects, whereas bromocriptine is not effective in 
severely affected akinetic patients (Hoehn 1985). Bromocriptine 
may induce peripheral and central side-effects: increased angina 
pectoris, increased postural hypotension, psychotic disturbances 
and increased peak-dose hypotonic akinesia with falling. Often 
the combined therapy of low(er) doses of L-DOPA and bromocriptine 
may be (temporarily) successful in diminishing the symptoms of 
Parkinson's disease as well as the late 'central' side-effects of 
L-DOPA. This combined treatment, however, may induce dyskinetic 
side-effects. A number of other ergot derivatives exists of which 
the potency appears to be stronger than bromocriptine, i.e. lower 
doses may be needed to induce the same effects. These drugs too 
may induce side-effects such as psychotic disturbances and dys-
kinetic movements in combination with L-DOPA (for review: Burton 
and Calne 1984, Lieberman and Goldstein 1982). It is already 
mentioned that psychotic disturbances may result from a hyperact-
ivity at the level of the DA(e) receptors, and dyskinetic move-
ments from a hyperactivity at the level of both DA(e) and DA(i) 
receptors. These side-effects indicate that the ergot derivatives 
may exert their effects at the level of the DA(e) receptors, i.e. 
the nigrostriatal circuitry. Biochemically, the presently used 
ergot derivatives have been classified as D-2 agonists and D-1 
antagonists, except pergolide which has been classified as D-l 
and D-2 agonist. In addition, the majority of the ergot deri-
vatives have also been found to influence noradrenergic and sero-
tonergic receptors. Since the therapy with DA agonists is pre-
dominantly started when L-DOPA induces severe side-effects and 
since these side-effects are predominantly due to the increased 
neuroanatomical pathology in Parkinson's disease, the small 
beneficial effects of DA agonists in this phase of the disease 
is understandable. At present, the lack of more specific, non-
toxic, DA agonists makes it hard to start DA agonist therapy at 
an earlier phase in Parkinson's disease, since no better results 
are achieved in comparison with L-DOPA (cf. Calne et al. 1984, 
Grimes 1984, Lieberman et al. 1984). 
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CONCLUDING REMARKS 
To date, neurologists have been confronted with the following 
problems when treating Parkinson patients: 
1. the problem of selecting the correct time for starting therapy; 
2. the problem of selecting the correct nature of therapy; 
3. the problem of adjusting the pharmacotherapy. 
It will be obvious that the understanding of the neuropathology 
underlying the functional pathology of Parkinson's disease will 
increase the possibility of diagnosing Parkinson's disease at 
an earlier phase and will help to decide which therapy is needed. 
In addition, it will be obvious that the development of more 
specific drugs is needed, i.e. specific (dopaminergic) drugs to 
treat early symptoms of Parkinson's disease and specific (GABA-
ergic) drugs affecting 'lower-order' structures to treat late 
symptoms of the disease. To test whether drugs influence spe-
cifically the specific function of the structure under study, 
specific animal models are needed, which allow the conclusion 
that the structure is involved in the observed (changes in) 
behaviour. The animal models presented in section II reveal 
behavioural effects of an increasingly dysfunctioning neo-
striatum in rats (Chapters 4 and 5) and caudate nucleus in 
Java monkeys (Chapters 6 and 7) in relation to the specific 
function of the striatum: determining the degree in which an 
organism is abla to program motor and non-motor behaviour 
directed by non-exteroceptive stimuli. Thus, these animal 
models are useful for testing substances which are believed 
to infer with neuronal activity in the striatum. 
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SUMMARY 
The aim of the present study was to determine the characteristic 
and specific function of the striatum in programming motor and 
non-motor behaviour. 
In Section I literature is reviewed to provide cornerstones for the 
hypothesis that the striatum in animals is involved in programming 
motor and non-motor behaviour. 
Chapter 1 is a survey of data from the literature pertaining 
to the anatomical aspects of the striatum predominantly in rats and 
monkeys. In the first part of this chapter, attention is paid to 
the afferent connections of the striatum. The data reviewed show 
that the afférents originate from the entire cortex and from numer-
ous subcortical structures. The terminal fields in the striatum of 
the afférents from the cortex, substantia nigra pars compacta (SNpc) 
and ventral tegmental area of Tsai (VTA) are described in detail, 
whereas only some aspects of the remaining afférents are mentioned. 
It appears that the afférents provide the striatum with a flow of 
information concering the changes which take place in other parts of 
the brain and the remaining parts of the body (non-exteroceptive 
stimuli) as well as the environment (exteroceptive stimuli). In the 
second part of this chapter, attention is paid to the efferent con-
nections of the striatum. The data reviewed show that the efferente 
of the striatum are restricted to the globus pallidus (GP) and sub-
stantia nigra pars reticulata (SNpr). From these structures neurons 
project to numerous cortical and subcortical structures which, in 
turn, influence so-called effector organs. In the third part of this 
chapter, an attempt is made to visualize the complex picture of the 
internal organization of the striatum. The survey on the morphology 
of the neurons, the types of receptors on the neurons and the dis-
tribution of transmitters carried by the neurons reveals a network 
in which the flow of information from the afférents is integrated. 
The resultant of this integration leaves the striatum through its 
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efferents. This survey provides anatomical evidence that the striatum 
has to mediate functions which cannot be easily labelled as either 
sensory or motor, but rather as 'higher-order', 'programming' or 
'cognitive'. 
Chapter 2 is a survey of the data pertaining to the functional 
aspects of the striatum. In the first part of this chapter, attention 
is paid to the levels at which the function of a brain structure may 
be studied. In the second part of this chapter, the function of the 
striatum in behaviour is extensively considered in relation to the 
definition that behaviour is the control of the input of the organism 
and the anatomical finding concerning the abundant input of the 
striatum. The data reviewed on the behavioural effects of lesions 
involving afferent or efferent neurons of the striatum reveal that 
the lesions evoke an increased dependence on exteroceptive stimuli 
to change ongoing behaviour. However, it is also shown that the 
lesion method has its limitations due to the ability of the organism 
to recover from and adapt to such lesions. Furthermore, it appears 
that drug-induced changes in the neuronal activity of the striatum 
elicit motor disturbances which, however, are also elicited by drug-
induced changes in the neuronal activity of brain structures through 
which striatal output is funnelled. The data reviewed on the func-
tion of the striatum in programming behaviour reveal that drug-in-
duced changes in neuronal activity of the striatum determine the 
degree in which non-exteroceptive and exteroceptive stimuli are 
needed in programinng both motor and non-motor behaviour. Further-
more, electrophysiological data show that within the striatum an 
integration takes place of relevant non-exteroceptive and extero-
ceptive information (input) into the planning and during the exe-
cution of movements (output). The electrophysiological data also 
show that structures which receive input from the striatum can 
also direct movements with additional exteroceptive stimuli. There-
fore, further experiments are needed to determine the characteristic 
and specific function of the striatum in programming motor and non-
motor behaviour. 
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Section II deals with experimental studies dealing with the function 
of the striatum in programming motor and non-motor behaviour. For a 
short outline of the involved chapters and the overall results of 
the experiments the reader is referred to Chapter 3 and Epiloque 
respectively. 
Chapter 4 is dedicated to the study dealing with the role of 
different transmitters in the striatum in programming non-motor be-
haviour directed by non-exteroceptive stimuli. The behavioural 
effects evoked by local application of dopaminergic, cholinergic 
and GABA-ergic drugs in low doses in rats are described. In addi-
tion, attention is paid to the sensitivity of different areas with-
in the neostriatum to these drugs. The experimental conditions 
allowed the analysis of drug-induced changes in normal behaviour, 
drug-induced changes in the ability to program non-motor behaviour 
directed by non-exteroceptive stimuli, and drug-induced changes in 
the dependence on exteroceptive stimuli. The analysis of the simi-
larities and dissimilarities between the behavioural effects of the 
drugs are discussed. The animal models presented in this chapter 
are useful for testing the differential involvement of input (dopa-
minergic), intrinsic (cholinergic) and output (GABA-ergic) neurons 
in the symptoms inherent to a dysfunctioning striatum, i.e. in the 
ability of programming non-motor behaviour directed by non-extero-
ceptive stimuli. 
Chapter 5 is dedicated to the role of striatal output in pro-
gramming motor behaviour directed by static proprioceptive, i.e. 
non-exteroceptive, stimuli. The behavioural effects evoked by local 
application of increasing doses of GABA-ergic drugs in rats are de-
scribed. The experimental conditions allowed the analysis of drug-
induced changes in normal behaviour, drug-induced changes in the 
ability to program motor behaviour directed by static propriocept-
ive stimuli, and drug-induced changes in the dependence on extero-
ceptive stimuli. The animal models in this chapter are useful for 
testing the degree in which striatal output is disturbed. The dif-
ferential involvement of hindlimbs and forelimbs in the effects of 
the different doses as well as the phenomenon of stimulus substitu-
tion are discussed. 
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Chapter 6 is dedicated to the study dealing with the relation-
ship within the striatum between the cholinoceptive substrate in-
volved in programming non-motor behaviour and the cholinoceptive 
substrate involved in dyskinetic movements. The behavioural effects 
evoked by local application of carbachol (cholinergic agonist) in 
the caudate nucleus of Java monkeys are described. The experimental 
condition enabled the comparison of the effectiveness of threshold 
doses of carbachol to induce disturbances in programming non-motor 
behaviour and dyskinetic movements in the same monkeys in two dis-
tinct situations. It was found that a particular cholinoceptive 
substrate within the caudate nucleus of Java monkeys is involved 
both in programming non-motor behaviour and dyskinetic movements, 
and that the degree of dysfunctioning of this substrate determines 
the appearance of disturbances in programming non-motor behaviour or 
dyskinetic movements. In addition, the observed differences between 
dominant and non-dominant monkeys are discussed. 
Chapter 7 is dedicated to the study dealing with the relation-
ship between the degree of dysfunctioning of the striatum and the 
ability to change non-exteroceptively directed behaviour. The be-
havioural effects evoked by local application of increasing doses 
of carbachol in the caudate nucleus of Java monkeys are described. 
The experimental condition allowed the analysis of drug-induced 
changes in programming motor behaviour directed by non-exteroceptive 
stimuli. It was found that increasing doses of carbachol evoked 
successively an increase in non-exteroceptively as well as extero-
ceptively directed movements and dyskinetic movements , and that 
the carbachol-induced dyskinetic movements affect only the non-
exteroceptively directed movements. It is discussed that just the 
degree of pathology determines whether the striatal disturbance 
manifests itself at the non-motor or motor level. In addition the 
observed differences between the dominant and non-dominant monkey 
are discussed with respect to the baseline activity as well as the 
drug-induced changes in behaviour. 
In the epilogue of section II a summary is given of the re-
sults from Chapters 4 to 7. It is shown that the specific function 
of the striatum is to enable the organism to use non-exteroceptive 
stimuli in programming motor and non-motor behaviour. 
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In Section III the clinical impact of the animal studies is presented. 
Chapter 8 is a survey of data from the literature pertaining to 
the pathological aspects of Parkinson's disease. In the first part 
of this chapter, attention is briefly paid to different types of 
Parkinsonism and the discussion concerning the possible cause of 
idiopathic Parkinson's disease. In the second part of this chapter, 
attention is paid to the neuropathology in Parkinson patients. This 
survey reveals that a dysfunctioning striatum may exist in Parkin-
son patients. In the third part of this chapter, attention is paid 
to the functional pathology in Parkinson's disease predominantly 
in the light of the specific function of the striatum in program-
ming motor and non-motor behaviour derived from the animal studies. 
The data reviewed reveal that when the appropriate tests are used, 
i.e. tests which demand programming motor or non-motor behaviour 
directed by non-exteroceptive stimuli, Parkinson patients show ful-
ly analogous disturbances to those found in animals with a decreas-
ed neuronal activity in the striatum: a reduced ability to program 
behaviour directed by non-exteroceptive stimuli and an increased 
dependence on exteroceptive stimuli. Furthermore, attention is paid 
to symptoms in which Parkinson patients show a decreased ability to 
change ongoing behaviour directed by static proprioceptive stimuli 
analogous to that found in animals with a decreased activity of 
striatal output neurons. 
Chapter 9 is a survey of data from the literature pertaining 
to the pharmacotherapy of Parkinson's disease. In the first part 
of this chapter, attention is paid to the strategy in the pharmaco-
therapy of Parkinson's disease. In the second part of this chapter 
attention is paid to the results of the pharmacotherapy on the 
symptoms of Parkinson's disease. Furthermore, attention is paid to 
the appearance of side-effects after initial and long-term pharmaco-
therapy. It is concluded that more specific antiparkinson drugs are 
needed to treat the symptoms in Parkinson's disease more specific-
ally and that the animal models presented in section II are useful 
for testing substances which are believed to infer with neuronal 
activity in the striatum. 
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SAMENVATTING 
Het doel van de studie waarvan de resultaten zijn weergegeven in 
dit proefschrift was het vaststellen van de karakteristieke en 
specifieke funktie van het striatum in het programmeren van 
motorisch en niet-motorisch gedrag. 
In sektie I wordt literatuur samengevat die de bouwstenen levert 
voor de hypothese dat het striatum betrokken is bij het program-
meren van motorisch en niet-motorisch gedrag. 
Hoofdstuk ] geeft een overzicht van literatuur die betrekking 
heeft op de anatomische aspekten van het striatum, hoofdzakelijk 
bij ratten en apen. In het eerste deel van dit hoofdstuk wordt 
aandacht besteed aan de afferente verbindingen van het striatum. 
De gegevens laten duidelijk zien dat deze afferenten uit de ge-
hele cortex en uit vele subcorticale strukturen voortkomen. De 
eindigingsgebieden in het striatum van de afferenten uit de cortex, 
substantia nigra pars compacta (SNpc) en de area tegmentalis ven-
tralis Tsai (VTA) worden uitgebreid beschreven en daarnaast wor-
den nog"enkele aspekten van de andere afferenten genoemd. Het 
blijkt, dat de afferenten het striatum voorzien van een stroom 
aan informatie over de veranderingen die plaatsvinden in andere 
delen van het brein en in de rest van het lichaam (niet-extero-
ceptieve prikkels) alsmede in de omgeving (exteroceptieve prik-
kels). In het tweede deel van dit hoofdstuk wordt aandacht 
besteed aan de efferente verbindingen van het striatum. De ge-
gevens laten zien dat de efferenten van het striatum zijn beperkt 
tot het globus pallidum (GP) en de substantia nigra pars reticu-
lata (SNpr). Vanuit deze strukturen lopen neuronen naar talrijke 
corticale en subcorticale gebieden die op hun beurt invloed uit-
oefenen op zogeheten effector-organen. In het derde deel van dit 
hoofdstuk is een poging gedaan om de zeer complexe interne orga-
nisatie van het striatum te verduidelijken. Het overzicht van de 
morfologie van de neuronen, de soorten receptoren op de neuronen 
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en de verspreiding van transmitters in de neuronen toont een netwerk 
aan waarbinnen de stroom van informatie uit de afferenten geïnte-
greerd wordt en het resultaat van deze integratie verlaat het 
striatum door de efferenten. Dit overzicht levert het anatomische 
bewijs dat het striatum betrokken moet zijn bij funkties die niet 
eenvoudig zijn aan te duiden als sensorisch of motorisch, maar 
eerder als van 'hogere-orde', 'programmerend' of 'cognitief'. 
Hoofdstuk 2 geeft een overzicht van de gegevens die betrekking 
hebben op de funktionele aspekten van het striatum in gedrag. In 
het eerste deel van dit hoofdstuk wordt aandacht besteed aan de 
nivo's waarop de funktie van een hersenstruktuur bestudeerd kan 
worden. In het tweede deel van dit hoofdstuk wordt de funktie van 
het striatum in gedrag uitvoerig bekeken in relatie tot de defini-
tie dat gedrag de kontrole van de input van het organisme is en de 
anatomische bevinding dat het striatum een grote hoeveelheid input 
(niet-exteroceptieve en exteroceptieve prikkels) ontvangt. De ver-
zamelde gegevens omtrent de effekten op het gedrag door lesies met 
betrekking tot afferente of efferente neuronen van het striatum 
tonen aan dat de lesies een verhoogde afhankelijkheid van extero-
ceptieve prikkels veroorzaken om het gedrag te kunnen veranderen. 
Evenwel, er wordt ook aangetoond dat de lesie methode zijn begren-
zingen heeft ten gevolge van het vermogen van het organisme om te 
herstellen van en zich aan te passen aan zulke lesies. Bovendien 
is gebleken dat farmakon-geïnduceerde veranderingen in de neuronale 
aktiviteit van het striatum motorische stoornissen veroorzaken, die 
echter ook veroorzaakt kunnen worden door farmakon-geïnduceerde ver-
anderingen in de neuronale aktiviteit van hersenstrukturen waar 
striatale output doorheen wordt geleid. De verzamelde gegevens over 
de funktie van het striatum in het programmeren van gedrag tonen 
aan dat de farmakon-geïnduceerde veranderingen in de neuronale akti-
viteit van het striatum de mate bepalen waarin niet-exteroceptieve 
en exteroceptieve prkkels nodig zijn voor het programmeren van 
motorisch en niet-motorisch gedrag. Tevens tonen elektrofysiologische 
gegevens aan dat binnen het striatum een integratie plaatsvindt van 
relevante niet-exteroceptieve en exteroceptieve informatie (input) 
in het programmeren en uitvoeren (output) van bewegingen. De elektro-
fysiologische gegevens tonen eveneens aan dat strukturen die input 
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ontvangen van het striatum ook bewegingen kunnen sturen, echter 
slechts met behulp van additionele exteroceptieve prikkels. Dienten-
gevolge zijn verdere experimenten nodig om de karakteristieke en 
specifieke funktie van het striatum in het programmeren van motorisch 
en niet-motorisch gedrag te bepalen. 
Sektie II handelt over de experimentele studies betreffende de funktie 
van het striatum in het programmeren van motorisch en niet-motorisch 
gedrag. Voor een korte schets van de betrokken hoofdstukken en de 
totale resultaten van deze experimenten wordt de lezer verwezen naar 
respektievelijk hoofdstuk 3 en de epiloog. 
Hoofdstuk 4 is gewijd aan de studie naar de rol die verschillen-
de transmitters in het striatum hebben in het programmeren van niet-
motorisch gedrag gestuurd door niet-exteroceptieve prikkels. De 
effekten op het gedrag die opgeroepen zijn door lokaal toegediende 
dopaminerge, cholinerge en GABA-erge farmaka in lage doses in ratten 
worden beschreven. Tevens wordt aandacht besteed aan de gevoeligheid 
van verschillende gebieden binnen het neostriatum voor deze farmaka. 
De experimentele omstandigheden stonden de analyse toe van farmakon-
geïnduceerde veranderingen in normaal gedrag, farmakon-geïnduceerde 
veranderingen in het vermogen tot het programmeren van niet-motorisch 
gedrag gestuurd door niet-exteroceptieve prikkels en farmakon-geïndu-
ceerde veranderingen in de afhankelijkheid van exteroceptieve prik-
kels. De analyse van de overeenkomsten en verschillen tussen de 
effekten op het gedrag van de farmaka worden bediskussieerd. De in 
dit hoofdstuk weergegeven diermodellen zijn geschikt om de verschil-
lende betrokkenheid te testen van input (dopaminerge), intrinsieke 
(cholinerge) en output (GABA-erge) neuronen in de symptomen karak-
teristiek voor een disfunktionerend striatum, d.w.ζ. in het vermogen 
tot programmeren van niet-motorisch gedrag gestuurd door niet-extero­
ceptieve prikkels. 
Hoofdstuk 5 is gewijd aan de rol van de striatale output in het 
programmeren van motorisch gedrag gestuurd door statisch propriocep-
tieve, d.w.z. niet-exteroceptieve, prikkels. De effekten op het 
gedrag die opgeroepen zijn door lokaal toegediende GABA-erge farmaka 
in toenemende doses worden beschreven. De experimentele omstandig­
heden stonden de analyse toe van farmakon-geïnduceerde veranderingen 
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in normaal gedrag, farmakon-geînduceerde veranderingen in het 
vermogen tot het programmeren van motorisch gedrag gestuurd door 
statisch proprioceptieve prikkels en farmakon-geînduceerde ver-
anderingen in de afhankelijkheid van exteroceptieve prikkels. De 
in dit hoofdstuk weergegeven diermodellen zijn geschikt om de 
mate waarin striatale output is verstoord te testen. Het verschil 
in betrokkenheid van de achterpoten en voorpoten in de effekten 
van de verschillende doseringen alsmede het fenomeen prikkel-sub-
stitutie worden bediskussieerd. 
Hoofdstuk 6 is gewijd aan de studie over de relatie binnen 
het striatum tussen het cholinoceptieve substraat dat betrokken is 
bij het programmeren van niet-motorisch gedrag en het cholinocep-
tieve substraat dat betrokken is bij dyskinetische bewegingen. De 
effekten op het gedrag die opgeroepen zijn door het lokaal toe-
dienen van carbachol (cholinerge agonist) in de nucleus caudatus 
van Java apen zijn beschreven. De experimentele omstandigheid gaf 
gelegenheid tot de vergelijking van de effektiviteit van de diverse 
drempeldoses van carbachol die stoornissen veroorzaken in het pro-
grammeren van niet-motorisch gedrag en dyskinetische bewegingen in 
dezelfde apen in twee verschillende situaties. Er werd gevonden 
dat binnen het cholinoceptief substraat in de nucleus caudatus van 
Java apen zowel stoornissen in het programmeren van niet-motorisch 
gedrag als dyskinetische bewegingen kunnen worden opgeroepen, en 
dat de mate van disfunktioneren van dit substraat bepaalt of er 
stoornissen optreden in het programmeren van niet-motorisch gedrag 
of dyskinetische bewegingen. Tevens worden de gevonden verschillen 
tussen dominante en niet-dominante apen bediskussieerd. 
Hoofdstuk 7 is gewijd aan de studie van de relatie tussen de 
mate van disfunktioneren van het striatum en het vermogen om niet 
exteroceptief gestuurd gedrag te wisselen. De effekten op het ge-
drag die opgeroepen zijn door het lokaal toedienen van carbachol 
in oplopende doses in de nucleus caudatus van Java apen zijn be-
schreven. De experimentele omstandigheid stond de analyse toe van 
farmakon-geînduceerde veranderingen in het programmeren van moto-
risch gedrag gestuurd door niet-exteroceptieve prikkels. Er werd 
gevonden dat oplopende doses carbachol suksessievelijk een ver-
hoging veroorzaken van niet-exteroceptief alsmede exteroceptief 
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gestuurde bewegingen en dyskinetische bewegingen en dat de carba-
chol-geïnduceerde dyskinetische bewegingen alleen de niet-extero-
ceptief gestuurde bewegingen beïnvloeden. Er wordt bediskussieerd 
dat alleen de mate van pathologie bepaalt of een striatale stoornis 
zich manifesteert op niet-motorisch of motorisch nivo. Tevens wor-
den de verschillen tussen de dominante en niet-dominante aap bedis-
kussieerd met betrekking tot de oorspronkelijke aktiviteit en de 
farmakon-geïnduceerde veranderingen in het gedrag. 
In de epiloog van sektie II wordt een samenvatting gegeven van 
de resultaten van de hoofdstukken 4 tot en met 7. Er wordt aange-
toond dat de specifieke funktie van het striatum is: het organisme 
in staat stellen niet-exteroceptieve prikkels te gebruiken bij het 
programmeren van motorisch en niet-motorisch gedrag. 
In sektie III worden de klinische implikaties van de resultaten van 
de dierstudies gepresenteerd. 
Hoofdstuk 8 geeft een overzicht van gegevens uit de literatuur 
die betrekking hebben op de ziekte van Parkinson. In het eerste deel 
van dit hoofdstuk wordt aandacht besteed aan de verschillende typen 
van Parkinsonisme en de diskussie omtrent de mogelijke oorzaak van 
de idiopathische ziekte van Parkinson. In het tweede deel van dit 
hoofdstuk wordt aandacht besteed aan het morfologisch substraat van 
de ziekte van Parkinson. Het overzicht laat zien dat een disfunktio-
nerend striatum aanwezig kan zijn bij Parkinson patiënten. In het 
derde deel van dit hoofdstuk wordt aandacht besteed aan de funktio-
ne Ie pathologie bij patiënten met de ziekte van Parkinson voorname-
lijk met betrekking tot de specifieke funktie van het striatum in 
het programmeren van motorisch en niet-motorisch gedrag afgeleid 
van de dierstudies. De verzamelde gegevens tonen dat, indien de 
juiste testen gebruikt worden, d.w.z. testen die het programmeren 
van motorisch en niet-motorisch gedrag gestuurd door niet-extero-
ceptieve prikkels vereisen, Parkinson patiënten stoornissen vertonen 
die geheel analoog zijn aan de stoornissen die gevonden worden bij 
dieren met een verlaagde neuronale aktiviteit in het striatum. Deze 
kunnen gekarakteriseerd worden als een verminderd vermogen tot het 
programmeren van gedrag gestuurd door niet-exteroceptieve prikkels 
en een verhoogde afhankelijkheid van exteroceptieve prikkels. Boven-
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dien wordt aandacht besteed aan de symptomen waarin Parkinson 
patiënten een verminderd vermogen tot het wisselen van gedrag 
gestuurd door statisch proprioceptieve prikkels laten zien ana-
loog aan de symptomen die gevonden worden bij dieren met een 
verlaagde aktiviteit van striatale output neuronen. 
Hoofdstuk 9 geeft een overzicht van gegevens uit de litera-
tuur die betrekking hebben op de farmakotherapie van de ziekte 
van Parkinson. In het eerste deel van dit hoofdstuk wordt aandacht 
besteed aan de strategie in de farmakotherapie bij de ziekte van 
Parkinson. In het tweede deel van dit hoofdstuk wordt aandacht 
besteed aan de effekten die de farmakotherapie heeft op de symp-
tomen van de ziekte van Parkinson. Bovendien wordt aandacht besteed 
aan het verschijnen van neven-effekten na initiële en langdurige 
farmakotherapie. Konkluderend wordt gesteld dat een adekwate be-
handeling van de ziekte van Parkinson de ontwikkeling van meer 
specifieke farmaka vergt en dat de diermodellen die beschreven 
zijn in sektie II geschikt zijn voor het testen van stoffen waar-
van vermoed wordt dat ze invloed uitoefenen op de neuronale akti-
viteit in het striatum. 
229 
ABBREVIATIONS 
AAAD aromatic amino acid decarboxylase, DA synthetizing enzyme 
ACC nucleus accumbens 
ACh acetylcholine 
AChE acetylcholinesterase, ACh-converting enzyme 
ALLOCTX allocortex 
AM amygdala 
AMPH amphetamine, indirect DA agonist 
APO apomorphine, DA agonist 
ATV ventral tegmental area 
BMI bicuculline methiodide, GABA antagonist 
cAMP 
GARB 
CCK 
ChAT 
CM 
CMN 
CN 
CNS 
COMT 
CS 
CT 
стх 
cyclic adenosine-monophosphate 
carbachol, ACh agonist 
cholecystokiηin 
cholin-acctyltransferase, ACH synthetizing enzyme 
centromedian nucleus of the thalamus 
central motoneuron 
caudate nucleus 
central nervous system 
catechol-o-methyl transferase, DA catabolic enzyme 
superior colliculus 
contralateral turning 
cortex 
DA 
DA(e) 
DA(i) 
DFP 
dors 
DPI 
DRN 
dopamine 
functional excitatory postsynaptic DA receptor 
functional inhibitory postsynaptic DA receptor 
di-isopropylphosphofluoridate, AChE inhibitor 
dorsal 
(3,4-dihydroxy-phenylimino)-2-imidazolidine, DA(i) agonist 
dorsal raphe nuclei 
EEG 
ENK 
ENT 
EP 
EPSP 
EXPY 
electro-encephalogram 
enkephalin 
entorhinal cortex 
entopeduncular nucleus 
excitatory postsynaptic potential 
extrapyramidal motor system 
FR reticular formation, medial part 
GABA 
GAD 
GLU 
GP 
GPD 
gamma-aminobutyric acid 
glutamate decarboxylase, biosynthetic enzyme for GABA 
glutamate 
globus pallidus 
dorsal globus pallidus 
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GPe globus pallidus pars externa 
GPi globus pallidus pars interna 
GPV ventral globus pallidus 
HALO haloperidol, DA antagonist 
HRP horse radish peroxidase 
5HT 5-hydroxytryptamine 
HVA homovanillic acid, DA metabolite 
IPSP inhibitory postsynaptic potential 
IT ipsilateral turning 
LC locus coeruleus 
L-DOPA L-3,4-dihydroxy phenylalanine, DA precursor 
LH lateral hypothalamus 
МАО-B mono amino oxidase B, DA metabolic enzyme 
MLR mesencephalic locomotor region 
MPTP l-methyl-4-phenyl-l,2,5,6-tetra-hydro pyridine 
MRN mesencephalic raphe nuclei 
MSC muscimol, GABA agonist 
NA noradrenaline 
NAcc nucleus accumbens 
NEOCTX neocortex 
NST subthalamic nucleus 
60HDA 6-hydroxy dopamine 
ОТ olfactory tubercle 
Ρ 
PALL 
PaL 
PaM 
PET 
Pf 
PMN 
PTX 
PUT 
PY 
rCBF 
SCdl 
SCOP 
SI 
SMA 
SN 
SNc/pc 
SNr/pr 
SP 
S TN 
STR 
SUB 
putameη 
pallidum (= GP) 
lateral pallidum 
medial pallidum 
positron emission tomography 
parafascicular nucleus of the thalamus 
peripheral motoneuron 
Picrotoxin, GABA antagonist 
putamen 
pyramidal system 
regional cerebral blood flow 
superior colliculus, deeper layers 
scopolamine, ACh antagonist 
substantia innominata 
supplementary motor cortex 
substantia nigra 
substantia nigra, pars compacta 
substantia nigra, pars reticulata 
substance Ρ 
subthalamic nucleus 
striatum 
subiculum 
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TH thalamus 
THydr tyrosine hydroxylase, DA synthetizing enzyme 
TPP nucleus tegmentum pedunculopontine, pars compacta 
VA ventro-anterior nucleus of the thalamus 
VL ventro-lateral nucleus of the thalamus 
VTA ventral tegmental area of Tsai 
XCT X-ray computer tomography 
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PROGRAMMING MOTOR AND NON-MOTOR BEHAVIOUR: 
ROLE OF STRIATUM IN ANIMALS 
Behavioural effects of intrastriatally applied drugs 
SAMENVATTING VOOR BELANGSTELLENDEN 
Maria Vrijmoed-de Vries 
De titel 
In deze huidige tijd wordt bij het woord programmeren meteen gedacht 
aan Komputers. Programmeren van gedrag is echter niet typisch een 
werkwijze van komputers, maar zoals de titel al verder laat zien 
meer iets voor dieren en zoals in sektie 3 van mijn boek wordt be­
sproken ook een menselijke eigenschap. Wordt in het boek dan besproken 
dat de dieren en de mens komputers zijn? Integendeel, het zal laten 
zien dat mens en dier geen statische, d.w.z. ηiet-veranderende systemen 
zijn, maar dynamische systemen, d.w.z. ze kunnen zich aanpassen aan 
veranderingen in de omgeving, veranderingen binnen het lichaam en ver­
anderingen binnen de hersenen. 
Het programmeren van gedrag vindt plaats binnen de hersenen. Het 
programmeren van motorisch gedrag leidt tot bijvoorbeeld het zwaaien 
van een arm, het draaien van het hoofd, gaan lopen of gaan zitten 
(bij mens en dier). Het programmeren van niet-motorisch gedrag leidt 
bijvoorbeeld tot het uitvoeren van ingewikkelde handelingen (bij mens 
en dier), tot sociale interakties (bij mens en dier) of tot het uit­
voeren van intelligentie taken (bij de mens). Het is duidelijk dat 
het resultaat van het prograsmeren van niet-motorisch gedrag tot 
uiting komt in motorisch gedrag. 
In dit proefschrift is de aandacht gericht op de rol die een bepaalde 
hersenstruktuur nl. het striatun speelt in het programmeren van ge­
drag. Het striatum is een struktuur die onder de buitenste laag van 
de hersenen (de schors of cortex) ligt. Bij de mens en 'hogere' 
zoogdiersoorten (b.v. apen en katten) bestaat het striatum uit de 
nucleus caudatus en het putamen (zie figuur 1.1). Bij 'lagere' 
zoogdiersoorten (b.v. ratten) kan dit onderscheid niet gemaakt 
worden en wordt de struktuur als één geheel neostriatum genoemd. 
Tenslotte geeft de subtitel aan, dat het onderzoek met name ge-
richt is op de effekten van plaatselijk in het neostriatum c.q. 
nucleus caudatus gespoten farmakologiache stoffen op het gedrag 
van ratten c.q. apen. 
2 
De basis 
Bij een aantal neurologische (b.v. de ziekte van Parkinson) en psy-
chiatrische (b.v. schizofrenie) aandoeningen bij de mens funktioneert 
(o.a.) het striatum niet goed. Het verkrijgen van een beter inzicht 
in de specifieke rol van het striatum in het funktioneren van de mens 
kan leiden tot een beter begrip en een betere behandeling van stoor-
nissen ten gevolge van een niet goed funktionerend striatum, alsmede 
tot de ontwikkeling van geneesmiddelen die de aktiviteit van het 
striatum (meer) specifiek veranderen. Voor dit soort 'basaal' onder-
zoek is het werken met proefdieren de enige aangewezen methode, daar 
de ingrepen die nodig zijn voor het onderzoek (nog steeds) bij de 
mens niet toelaatbaar zijn. De in dit proefschrift beschreven experi-
menten met dieren zijn verricht met inachtneming van de huidige goed 
omschreven richtlijnen voor het werken met proefdieren. 
Het doel 
Het programmeren binnen de hersenen geschiedt door informatie-over-
dracht via zenuwen binnen en tussen strukturen. De feitelijke 
informatie-overdracht vindt plaats door middel van het afscheiden 
van één of meerdere stoffen in hele kleine hoeveelheden door een 
zenuw waardoor een volgende zenuw wordt beïnvloed. 
In hoofdstuk I wordt een overzicht van de literatuur gegeven over 
de oorsprong van de zenuwen die naar het striatum toe lopen (affe-
renten of input-neuronen genoemd), over de zenuwen die binnen het 
striatum liggen (inter-neuronen genoemd) en over de projektiegebieden 
van de zenuwen die vanuit het striatum naar andere strukturen lopen 
(efferenten of output-neuronen genoemd). De anatomie wordt voor-
namelijk besproken aan de hand van onderzoeken bij apen en ratten. 
Binnen de hierna gebruikte verzamelnaam 'organisme' worden echter 
alle zoogdieren bedoeld, dus ook de mens. 
Het blijkt dat het striatum door middel van de input-neuronen (in-
direkt) informatie krijgt uit de omgeving van het organisme, uit 
het lichaam van het organisme alsmede uit de andere delen van de 
hersenen. De kompleksiteit binnen het striatum van de eindigingen 
van de input-neuronen, de inter-neuronen alsmede de beginfase van 
de output-neuronen geeft aanleiding tot de gedachte dat de binnen-
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komende informatie van de verschillende input-neuronen wordt geïnte-
greerd. Het resultaat van deze integratie wordt gebundeld in de (in 
verhouding) beperkte bundel output-neuronen. Deze output-neuronen 
zijn de input-neuronen van 2 strukturen: het globus pallidas en de 
substantia nigra (zie figuren 1.5-1.7). Vanuit deze strukturen lopen 
output-neuronen naar een groot aantal andere hersenstrukturen en van-
uit deze strukturen lopen ook weer zenuwbanen etc. Er kan gekonkludeerd 
worden dat op deze wijze het striatum een belangrijk tussenstation is, 
dat door de integratie van een grote verscheidenheid aan informatie 
een belangrijke invloed kan uitoefenen op het funkt ioneren van het 
organisme. 
In hoofdstuk 2 wordt hier dieper op ingegaan door een overzicht te 
geven van de literatuur die de funktie van het striatum en enkele 
andere hersenstrukturen in het gedrag beschrijft. 
Het gedrag van een organisme wordt beïnvloed door veranderingen 
(prikkels) in de omgeving van het organisme (exteroceptieve prikkels 
genoemd) en door prikkels uit het lichaam alsmede uit de hersenen 
van het organisme zelf (niet-exteroceptieve prikkels genoemd). Uit 
de beschreven onderzoeken blijkt dat de stoornissen in het striatum 
veranderingen in het gedrag veroorzaken die te beschrijven zijn in 
termen van beïnvloeding van het vermogen om gedrag te programmeren 
met behulp van prikkels uit de omgeving of vanuit het organisme zelf. 
Tevens blijkt uit de beschreven onderzoeken dat een aantal effekten 
op het gedrag ten gevolge van stoornissen in het striatum ook te 
zien is na stoornissen in andere hersenstrukturen. Het denkbeeld 
dat een bepaald stuk van de hersenen een bepaald gedrag stuurt is 
tegenwoordig vervangen door het denkbeeld dat een struktuur binnen 
de hersenen zijn eigen, d.w.z. specifieks rol speelt in het funktio-
neren van het organisme als geheel. Het doel van mijn onderzoek was 
daarom het vaststellen van de specifieke funktie van het striatum in 
het gedrag. De aandacht is speciaal gevestigd op de rol van het 
striatum in het progranmeren van gedrag zonder veranderingen in de 
omgeving daar alleen in die situatie uitsluitsel gegeven kan worden 
omtrent de invloed van prikkels vanuit het organisme zelf op het 
geobserveerde gedrag. 
De methode 
De specifieke invloed van een hersenstruktuur op het gedrag van het 
organisme kan het best bestudeerd worden aan de hand van verande-
ringen in het gedrag ten gevolge van een (licht) verstoorde werking 
van die struktuur (de argumentatie hiervoor is beschreven in hoofd-
stuk 2). 
Een (tijdelijke) verstoring binnen het striatum van de door mij ge-
bruikte proefdieren (ratten en apen) werd teweeg gebracht door het 
injekteren van stoffen in zeer kleine hoeveelheden direkt in het 
striatum. Dit injekteren gebeurde door dunne holle naalden (door-
snede 0.5 mm en 0.4 mm respektievelijk), die enige weken eerder 
onder volledige narkose in de hersenen bij de dieren waren geïm-
planteerd en die waren gericht op van te voren nauwkeurig bepaalde 
plaatsen. Ik heb stoffen ingespoten waarvan bekend was dat ze de 
informatie-stroom door het striatum konden nabootsen of tegenwerken. 
Na de experimenten zijn de dieren opgeofferd met een overdosis nar-
kosemiddel teneinde de exakte plaats te kunnen vaststellen waar de 
stof in het striatum gespoten was. 
De experimenten bestonden uit: 
1. testen voor de ratten waarin specifiek een beroep werd gedaan op 
het vermogen van de dieren om niet-exteroceptieve prikkels te ge-
bruiken teneinde met 'sukses' de testen te volbrengen, d.w.z. 
het vermogen om gedrag te programmeren gestuurd door prikkels 
vanuit het dier zelf. Indien een rat hiertoe niet in staat was, 
werd onderzocht hoe de rat dan vél zijn gedrag veranderde, d.w.z. 
welke prikkels uit de omgeving gebruikt werden teneinde gedrag 
te kunnen programmeren (hoofdstukken 4 en 5); 
2. situaties voor de apen waarin het mogelijk was te onderzoeken of 
het gedrag dat de aap laat zien wordt bepaald door prikkels van-
uit het dier zelf of prikkels uit de omgeving. Door dezelfde apen 
in verschillende situaties te plaatsen (groep, vrijbewegend in 
tijdelijke isolatie en minder vrijbewegend in tijdelijke isolatie) 
kon het effekt hiervan op het gedrag na één bepaalde dosis stof 
vergeleken worden (hoofdstukken 6 en 7). 
De experimenten beschreven in de hoofdstukken 4, 6 en 7 zijn met 
behulp van video-opnames geanalyseerd. 
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De resultaten 
Een lichte verhoging c.q. verlaging van de informatie-stroom vanuit 
het striatum veroorzaakte een verhoogd c.q. verlaagd vermogen om 
niet-motorisch gedrag te programmeren met behulp van prikkels van-
uit het dier zelf, d.w.z. de dieren waren beter c.q. minder in staat 
de juiste strategie te zoeken in een niet-veranderende omgeving. 
Een sterkere verhoging c.q. verlaging van de informatie-stroom van-
uit het striatum veroorzaakte een verhoogd c.q. verlaagd vermogen 
om motorisch gedrag te prograimneren met behulp van prikkels vanuit 
het dier zelf, d.w.z. de dieren vertoonden meer c.q. minder moto-
rische bewegingen in een niet-veranderende omgeving. 
Een zeer ernstige verhoging c.q. verlaging van de informatie-stroom 
vanuit het striatum veroorzaakte motorische stoornissen onafhanke-
lijk c.q. afhankelijk van prikkels uit de omgeving, d.w.z. de dieren 
vertoonden wel c.q. geen motorische stoornissen zolang de omgeving 
niet veranderde. 
In relatie tot de experimentele situaties werd gevonden dat de mate 
van Stress' die de dieren ondergingen bepaalde of een injektie van 
één bepaalde dosis stof bij hetzelfde dier stoornissen in het pro-
grammeren van niet-motorisch gedrag (groep), stoornissen in het pro-
grammeren van motorisch gedrag (vrijbewegend in tijdelijke isolatie) 
dan wel motorische stoornissen (minder vrijbewegend in tijdelijke 
isolatie) veroorzaakte. 
Dieren met een verhoogde informatie-stroom vanuit het striatum 
konden onafhankelijk van de testsituatie hun gedrag wisselen met 
behulp van prikkels vanuit het dier zelf; daarentegen dieren met 
een verminderde informatie-stroom vanuit het striatum waren af-
hankelijk van de door de testsituatie geleverde prikkels uit de 
omgeving teneinde te kunnen wisselen van gedrag. 
De algemene konklusie is dat een optimaal funkt ionerend striatum 
het organisme in staat stelt zijn gedrag te veranderen met behulp 
van prikkels vanuit het organisme zelf (hetgeen natuurlijk niet betekent 
dat het organisme niet in staat is om van gedrag te wisselen met 
behulp van prikkels uit de omgeving!). Een hyperaktief striatum 
leidt tot een toename van gedragingen die gestuurd worden door 
prikkels vanuit het organisme zelf en die onafhankelijk zijn van prik-
kels uit de omgeving, bijvoorbeeld het maken van (onnodig) repe-
6 
terende bewegingen. Een hypoaktief striatum leidt niet alleen tot een 
afname van gedragingen die gestuurd worden door prikkels vanuit het 
organisme zelf, maar tevens tot een toename van gedragingen gestuurd 
door prikkels uit de omgeving, bijvoorbeeld het versterkt reageren 
op veranderingen in de omgeving. 
De betekenis 
De betekenis van deze konklusie voor de mens heb ik geprobeerd weer 
te geven aan de hand van het bestuderen van een ziektebeeld waarbij 
het striatum is betrokken: de ziekte van Parkinson. 
Het beeld dat men over het algemeen heeft van Parkinson patiënten 
is er een van een persoon met tremor (bevingen). Degene die een 
Parkinson patiënt van nabij kent weet ook nog te vertellen dat de 
Parkinson patiënt zich over het algemeen zeer slecht en maar heel 
langzaam kan voortbewegen. Men weet dan ook te vertellen dat de 
Parkinson patiënt soms vrijwel geen en dan weer een heel erge tremor 
heeft maar ook dat de Parkinson patiënt soms handelingen heel goed 
kan uitvoeren, welke hij vlak daarvoor 'nog' niet kon. Hierdoor is 
er in het begin van deze eeuw een korte periode geweest waarin men 
dacht dat de ziekte van Parkinson een psychische aandoening was. 
Tegenwoordig weet men echter dat aan de ziekte van Parkinson een 
versneld afsterven van zenuwen binnen de hersenen ten grondslag 
ligt. De eigenlijke oorzaak is (nog steeds) niet bekend. Onderzoek 
aan de hersenen van overleden Parkinson patiënten heeft aangetoond 
dat bij patiënten die de zgn. Parkinson verschijnselen zoals tremor 
en spierstijfheid nog maar in hele lichte mate vertoonden, al veel 
zenuwen kapot waren. Met andere woorden: pas nadat veel verstoord 
is van de informatie-stroom binnen de hereenen treden motorische 
stoornissen zoals tremor en een verminderde beweeglijkheid op! 
Eén van de strukturen die 'aangetast' zijn door het afsterven van 
zenuwen is het striatum (zie hoofdstuk Θ), d.w.z. bij Parkinson 
patiënten is de informatie-stroom door het striatum verlaagd en 
kan zelfs in de loop van het ziekteproces geheel gestremd worden. 
Hoewel hieronder de aandacht gevestigd is op het striatum dient 
met nadruk opgemerkt te worden dat het striatum zeker niet de 
enige struktuur is die niet meer goed funktioneert bij Parkinson 
patiënten. 
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Aan de hand van de resultaten van de dierexperimenten kan men zich 
afvragen of Parkinson patiënten dezelfde 'gedragsstoornissen' ver-
tonen als dieren met een verlaagde informatie-stroom vanuit het 
striatum. Om dit te onderzoeken heeft men mensen met en zonder de 
ziekte van Parkinson gedragstesten (vergelijkbaar met testen uit 
dierexperimenten) en psychologische testen (alleen bij de mens 
toepasbaar) afgenomen welke specifiek gericht waren op het vermogen 
om motorisch en niet-motorisch gedrag te programmeren met behulp 
van prikkels vanuit de persoon zelf (zie hoofdstuk 8). Deze testen 
hebben uitgewezen dat Parkinson patiënten het vermogen om gedrag 
te programmeren met behulp van niet-exteroceptieve prikkels ver-
loren hebben, d.w.z. Parkinson patiënten zijn niet in staat van de 
ene motorische handeling of denkwijze over te schakelen op een 
andere motorische handeling c.q. denkwijze met behulp van prikkels 
vanuit de persoon zelf. Evenwel Parkinson patiënten zijn zeer goed 
in staat om prikkels uit de omgeving te gebruiken om van gedrag te 
veranderen, d.w.z. in een veranderende situatie kan de Parkinson 
patiënt zijn motorische handeling wel aanpassen en met behulp van 
aanwijzingen ook veranderen van denkwijze. Parkinson patiënten 
hebben in het dagelijkse leven konstant veranderende informatie uit 
hun omgeving nodig om goed te kunnen funktioneren. Tevens is ge-
bleken dat motivatie een grote rol speelt in het vermogen om te 
kunnen wisselen van gedrag, d.w.z. als een Parkinson patiënt alleen 
is zal hij eerder in staat zijn motorische handelingen uit te voe-
ren dan wanneer er iemand in de omgeving is die het voor hem kan 
doen. 
Uit de experimenten met dieren is ook gebleken dat de zgn. stress 
invloed heeft op het gedrag van dieren. Eenzelfde fenomeen is 
waarneembaar bij Parkinson patiënten: de tremor wordt erger in 
situaties waarin de Parkinson patiënt zich niet prettig of sterk 
geobserveerd voelt. 
De ziekte van Parkinson is een progressieve ziekte, d.w.z. in de 
loop van de tijd gaan meer zenuwen in de hersenen stuk waardoor 
de ziekteverschijnselen allengs erger worden. De volgende gedachte 
komt hierdoor naar voren analoog aan de resultaten van de experi-
menten met dieren: voordat de motorische stoornissen optreden, zal 
de Parkinson patiënt reeds stoornissen in het programmeren van 
niet-motorisch en motorisch gedrag met behulp van prikkels vanuit 
de persoon zelf hebben. Deze stoornissen komen normaal gesproken 
niet aan het licht, daar de Parkinson patiënt nog heel lang goed 
kan funktioneren met de grote hoeveelheid aanwezige prikkels uit 
de omgeving (zie b.v. tabel 8.2). Dientengevolge worden er op het 
moment testen ontwikkeld die specifiek gericht zijn op het zo vroeg 
mogelijk konstateren van de stoornis tengevolge van een niet goed 
funktionerend striatum (zie hieibuven en hoofdstuk β). Hierdoor 
hoopt men de therapie beter te kunnen aanpassen aan het stadium van 
het ziekteproces (zie hieronder). 
In het proefschrift wordt ook ingegaan op die therapie bij Parkinson 
patiënten (hoofdstuk 9). Bij de mens worden medicijnen zeer zelden 
direkt op de plaats toegediend waar zij geacht worden heilzaam te 
werken. Dientengevolge kunnen niet-specifiek werkende medicijnen 
ook de niet door de ziekte aangetaste strukturen beïnvloeden en de 
werking van deze strukturen kan zelfs op den duur blijvend verstoord 
raken. Zolang er nog geen genezing mogelijk is bestaat er een be-
hoefte aan specifiek werkende medicijnen afhankelijk van het sta-
dium van de ziekte, d.w.z. indien (bijvoorbeeld) het striatum in 
het geheel niet meer funktioneert zal de therapie die gericht was 
op het herstellen van de stoornis in het striatum niet meer helpen. 
De therapie zal dan gericht moeten worden op het beïnvloeden van 
de strukturen die geen informatie meer krijgen van het striatum. 
Ter bevordering van het onderzoek naar meer specifieke medicijnen 
voor Parkinson patiënten draagt dit proefschrift diermodellen zo-
wel als een onderzoeksmethode aan waarmee het mogelijk is nieuwe 
farmakologische stoffen te testen op hun 'specificiteit' ten aan-
zien van de beïnvloeding van de funktie van het striatum in het 
gedrag. 
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STELLINGEN 
De mate van pathologie bepaalt in hoeverre een striatale stoornis 
zich manifesteert op niet-motorisch nivo dan wel op niet-motorisch 
én motorisch nivo. 
(dit proefschrift) 
Het syndroom dat veroorzaakt wordt door een disfunktionerend 
striatum laat zich differentiëren aan de hand van de afzonder-
lijke rol van afferente, intrinsieke en efferente neuronen van 
het neostriatum in het gedrag. 
(dit proefschrift) 
Een optimaal funktionerend striatum stelt het organisme in staat 
niet-exteroceptieve prikkels te gebruiken in de programmering van 
motorisch en niet-motorisch gedrag. 
(dit proefschrift) 
De invloed van farmaka op de specifieke funktie van het striatum 
in gedrag dient te worden bestudeerd in testsituaties die het 
programmeren van gedrag gestuurd door niet-exteroceptieve prikkels 
vereisen. 
Cdit proefschrift) 
Verschillen in testresultaten tussen dominante en niet-dominante 
dieren kunnen voor een belangrijk gedeelte herleid worden tot 
een fundamenteel verschil in neurochemische aktiviteit tussen 
voornoemde dieren. 
(dit proefschrift) 
Bij gedragsonderzoek is het noodzakelijk zowel kwalitatieve als 
kwantitatieve methoden naast elkaar te gebruiken. 
(Dichiara G, Morelli M (1984) In: McKenzie et al., 
Adv Behav Biol 27. Plenum Press, New York) 
De rol van subcorticale strukturen in de sturing van de wille­
keurige motoriek is veel groter dan tot voor kort werd aangenomen. 
Met deze kennis kan een deel van de resultaten van de therapie 
bij stoornissen in de willekeurige motoriek worden verklaard. 
De energie voor de migratie van neuronen wordt hoogstwaarschijnlijk 
verkregen uit de anaerobe glycolyse. 
(Prick У. et al. (1981) Neurology 31: 398-404) 
Het pleidooi vdn Hoksbergen aangaande het zeer zorgvuldig toepassen 
van openheid omtrent de afkomst van geadopteerde kinderen had de 
overheid wel eens ter harte kunnen nemen alvorens de fiskale nummers 
aan adoptief kinderen van 15 jaar en ouder te doen toekomen. 
(Hoksbergen R (1985) Inaugurele rede Utrecht; 
NRC dd 27 september 1985) 
De uitspraak 'alles wat een man voor heeft op een aap is meegenomen' 
krijgt een speciale betekenis door de observatie dat dominante 
mannetjes apen alleen agressief reageren op mannen. 
Hoewel een promotie doorgaans een hoogst persoonlijke aangelegen­
heid is, worden de kosten zelfs bij de huidige individualisering in 
de beiastingwtitgeving fiskaal niet als persoonlijke aftrekpost be­
schouwd. Dit geeft aanleiding tot de gedachte dat deze wetgeving 
niet geheel aansluit bij de maatschappij waarvoor zij is geschreven. 
Malden, 29 november 1985 
Maria Vrijmoed-de Vries 


